MSH|^~\&|NIST^2.16.840.1.113883.3.72.5.20^ISO|NIST^2.16.840.1.113883.3.72.5.21^ISO|NIST^2.16.840.1.113883.3.72.5.22^ISO|NIST^2.16.840.1.113883.3.72.5.23^ISO|20120821140551-0500||ORU^R01^ORU_R01|NIST-ELR-001.01|T|2.5.1|||NE|NE|||||PHLabReport-NoAck^HL7^2.16.840.1.113883.9.11^ISO
SFT|NIST Lab, Inc.^L^^^^NIST&2.16.840.1.113883.3.987.1&ISO^XX^^^123544|3.6.23|A-1 Lab System|6742873-12||20100617
PID|1||18547545^^^NIST MPI&2.16.840.1.113883.3.72.5.30.2&ISO^MR^University H&2.16.840.1.113883.3.0&ISO~111111111^^^SSN&2.16.840.1.113883.4.1&ISO^SS^SSA&2.16.840.1.113883.3.184&ISO||Lerr^Todd^G.^Jr^^^L~Gwinn^Theodore^F^Jr^^^B|Doolittle^Ramona^G.^Jr^Dr^^M^^^^^^^PhD|20090607|M||2106-3^White^CDCREC^W^White^L^1.1^4|123 North 102nd Street^Apt 4D^Harrisburg^PA^17102^USA^H^^42043~111 South^Apt 14^Harrisburg^PA^17102^USA^C^^42043||^PRN^PH^^1^555^7259890^4^call before 8PM~^NET^Internet^smithb@yahoo.com^^^^^home|^WPN^PH^^1^555^7259890^4^call before 8PM||||||||N^Not Hispanic or Latino^HL70189^NH^Non hispanic^L^2.5.1^4||||||||N|||201206170000-0500|University H^2.16.840.1.113883.3.0^ISO|337915000^Homo sapiens (organism)^SCT^human^human^L^07/31/2012^4
NTE|1|P|Patient is English speaker.|RE^Remark^HL70364^C^Comment^L^2.5.1^V1
NK1|1|Smith^Bea^G.^Jr^Dr^^L^^^^^^^PhD|GRD^Guardian^HL70063^LG^Legal Guardian^L^2.5.1^3|123 North 102nd Street^Apt 4D^Harrisburg^PA^17102^USA^H^^42043|^PRN^PH^^1^555^7259890^4^call before 8PM~^NET^Internet^smithb@yahoo.com^^^^^home
PV1|1|O||C||||||||||||||||||||||||||||||||||||||||20120615|20120615
ORC|RE|TEST000123A^NIST_Placer _App^2.16.840.1.113883.3.72.5.24^ISO|system generated^NIST_Sending_App^2.16.840.1.113883.3.72.5.24^ISO|system generated^NIST_Sending_App^2.16.840.1.113883.3.72.5.24^ISO||||||||111111111^Bloodraw^Leonard^T^JR^DR^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^NPI_Facility&2.16.840.1.113883.3.72.5.26&ISO^^^^^^^MD||^WPN^PH^^1^555^7771234^11^Hospital Line~^WPN^PH^^1^555^2271234^4^Office Phone|||||||University Hospital^L^^^^NIST sending app&2.16.840.1.113883.3.72.5.21&ISO^XX^^^111|Firstcare Way^Building 1^Harrisburg^PA^17111^USA^L^^42043|^WPN^PH^^1^555^7771234^11^Call  9AM  to 5PM|Firstcare Way^Building 1^Harrisburg^PA^17111^USA^B^^42043
OBR|1|TEST000123A^NIST_Placer _App^2.16.840.1.113883.3.72.5.24^ISO|system generated^NIST_Sending_App^2.16.840.1.113883.3.72.5.24^ISO|5671-3^Lead [Mass/volume] in Blood^LN^PB^lead blood^L^2.40^1.2|||20120615|20120615|||||Lead exposure|||111111111^Bloodraw^Leonard^T^JR^DR^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^NPI_Facility&2.16.840.1.113883.3.72.5.26&ISO^^^^^^^MD|^WPN^PH^^1^555^7771234^11^Hospital Line~^WPN^PH^^1^555^2271234^4^Office Phone|||||201206170000-0500|||F||||||V1586^HX-contact/exposure lead^I9CDX^LEAD^Lead exposure^L^29^V1|111&Varma&Raja&Rami&JR&DR&PHD&&NIST_Sending_App&2.16.840.1.113883.3.72.5.21&ISO
OBX|1|SN|5671-3^Lead [Mass/volume] in Blood^LN^PB^lead blood^L^2.40^V1||=^9.2|ug/dL^microgram per deciliter^UCUM^ug/dl^microgram per deciliter^L^1.1^V1|0.0 - 5.0|H^Above High Normal^HL70078^H^High^L^2.7^V1|||F|||20120615|||0263^Atomic Absorption Spectrophotometry^OBSMETHOD^ETAAS^Electrothermal Atomic Absorption Spectrophotometry^L^20090501^V1||20120617||||University Hospital Chem Lab^L^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^01D1111111|Firstcare Way^Building 2^Harrisburg^PA^17111^USA^L^^42043|1790019875^House^Gregory^F^III^Dr^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^NPI_Facility&2.16.840.1.113883.3.72.5.26&ISO^^^^^^^MD
OBX|1|SN|35659-2^Age at Specimen Collection^LN^AGE^AGE^L^2.40^V1||=^3|a^Year^UCUM^Y^Years^L^1.1^V1|||||F|||20120615|||||20120617||||University Hospital Chem Lab^L^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^01D1111111|Firstcare Way^Building 2^Harrisburg^PA^17111^USA^L^^42043|1790019875^House^Gregory^F^III^Dr^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^NPI_Facility&2.16.840.1.113883.3.72.5.26&ISO^^^^^^^MD

MSH|^~\&|NIST^2.16.840.1.113883.3.72.5.20^ISO|NIST^2.16.840.1.113883.3.72.5.21^ISO|NIST^2.16.840.1.113883.3.72.5.22^ISO|NIST^2.16.840.1.113883.3.72.5.23^ISO|20120821140551-0500||ORU^R01^ORU_R01|NIST-ELR-001.02|T|2.5.1|||NE|NE|||||PHLabReport-NoAck^HL7^2.16.840.1.113883.9.11^ISO
SFT|NIST Lab, Inc.^L^^^^NIST&2.16.840.1.113883.3.987.1&ISO^XX^^^123544|3.6.23|A-1 Lab System|6742873-12||20100617
PID|1||18568545^^^NIST MPI&2.16.840.1.113883.3.72.5.30.2&ISO^MR^Sick Kids Hosp&2.16.840.1.113883.3.0&ISO~121121212^^^SSN&2.16.840.1.113883.4.1&ISO^SS^SSA&2.16.840.1.113883.3.184&ISO||HepBee^Harry^G.^Jr^^^L~Ryu^Jae^Kuk^Jr^^^B|HepBee^Lee^G.^Sr^Dr^^M^^^^^^^PhD|20000801|M||2028-9^Asian^CDCREC^A^Asian^L^1.1^4|110 Elm Street^Apt 3^Cambridge^MA^02140^USA^H^^25017~121 Maple^Apt 3^Cambridge^MA^02140^USA^C^^25017||^PRN^PH^^1^617^9990000^4^call before 8PM~^NET^Internet^hepbeeL@yahoo.com^^^^^home|^WPN^PH^^1^617^9990000^4^call before 8PM||||||||N^Not Hispanic or Latino^HL70189^NL^not latino^L^2.5.1^4||||||||N|||201208060000-0500|Sick Kids Hosp^2.16.840.1.113883.3.0^ISO|337915000^Homo sapiens (organism)^SCT^human^human^L^07/31/2012^4
NTE|1|P|Patient is English speaker.|RE^Remark^HL70364^C^Comment^L^2.5.1^V1
NK1|1|HepBee^Lee^G.^Sr^Dr^^L^^^^^^^PhD|MTH^Mother^HL70063^M^Mother^L^2.5.1^4.1|110 Elm Street^Apt 3^Cambridge^MA^02140^USA^H^^25017|^PRN^PH^^1^617^9990000^4^call before 8PM~^NET^Internet^hepbeeL@yahoo.com^^^^^home
PV1|1|O||C||||||||||||||||||||||||||||||||||||||||20120806|20120806
ORC|RE|TEST0001365^NIST_Placer _App^2.16.840.1.113883.3.72.5.24^ISO|system generated^NIST_Sending_App^2.16.840.1.113883.3.72.5.24^ISO|system generated^NIST_Sending_App^2.16.840.1.113883.3.72.5.24^ISO||||||||121121121^Lookafter^Bill^T^JR^DR^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^NPI_Facility&2.16.840.1.113883.3.72.5.26&ISO^^^^^^^MD||^WPN^PH^^1^617^5551234^12^Hospital Line~^WPN^PH^^1^617^2556256^3^Office Phone|||||||Sick Kids' Hospital^L^^^^NIST sending app&2.16.840.1.113883.3.72.5.21&ISO^XX^^^121|Massachusetts Avenue^Building 1^Boston^MA^01236^USA^L^^25025|^WPN^PH^^1^617^5551234^12^Call  9AM  to 5PM|100 Medical Drive^Suite 6^Boston^MA^01236^USA^B^^25025
OBR|1|TEST0001365^NIST_Placer _App^2.16.840.1.113883.3.72.5.24^ISO|system generated^NIST_Sending_App^2.16.840.1.113883.3.72.5.24^ISO|1742-6^Alanine aminotransferase [Enzymatic actiity/Volume] in Serum or Plasma^LN^SALT^Serum ALT^L^2.40^1.2|||20120806|20120806|||||Hepatitis B infection|||121121121^Lookafter^Bill^T^JR^DR^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^NPI_Facility&2.16.840.1.113883.3.72.5.26&ISO^^^^^^^MD|^WPN^PH^^1^617^5551234^12^Hospital Line~^WPN^PH^^1^617^2556256^3^Office Phone|||||201208060000-0500|||F||||||5733^Hepatitis NOS^I9CDX^Hepatitis^Hepatitis^L^29^V1|121&Varma&Raja&Rami&JR&DR&PHD&&NIST_Sending_App&2.16.840.1.113883.3.72.5.21&ISO
OBX|1|SN|1742-6^Alanine aminotransferase [Enzymatic activity/Volume] in Serum or Plasma^LN^SALT^Serum ALT^L^2.40^V1||=^65|U/L^enzymeunitperliter^UCUM^U/L^Units per liter^L^1.1^V1|7-56 units per liter of serum|H^Above High Normal^HL70078^H^High^L^2.7^V1|||F|||20120806|||0262^Spectrophotometry^OBSMETHOD^ALTMETHOD^Photometric rate, L-alanine with Pyridoxal -5- Phosphate^L^20090501^V1||20120806||||Sick Kids' Hospital Laboratory^L^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^01D2121212|Massachusetts Avenue^Building 2^Boston^MA^01236^USA^L^^25025|1790019875^House^Gregory^F^III^Dr^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^NPI_Facility&2.16.840.1.113883.3.72.5.26&ISO^^^^^^^MD
OBX|1|SN|35659-2^Age at Specimen Collection^LN^AGE^AGE^L^2.40^V1||=^12|a^Year^UCUM^Y^Years^L^1.1^V1|||||F|||20120806|||||20120806||||Sick Kids' Hospital Laboratory^L^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^01D2121212|Massachusetts Avenue^Building 2^Boston^MA^01236^USA^L^^25025|1790019875^House^Gregory^F^III^Dr^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^NPI_Facility&2.16.840.1.113883.3.72.5.26&ISO^^^^^^^MD


MSH|^~\&#|NIST^2.16.840.1.113883.3.72.5.20^ISO|NIST^2.16.840.1.113883.3.72.5.21^ISO|NIST^2.16.840.1.113883.3.72.5.22^ISO|NIST^2.16.840.1.113883.3.72.5.23^ISO|20120821140551-0500||ORU^R01^ORU_R01|NIST-ELR-001.03|T|2.5.1|||NE|NE|||||PHLabReport-NoAck^HL7^2.16.840.1.113883.9.11^ISO
SFT|NIST Lab, Inc.^L^^^^NIST&2.16.840.1.113883.3.987.1&ISO^XX^^^123544|3.6.23|A-1 Lab System|6742873-12||20100617
PID|1||18789547^^^NIST MPI&2.16.840.1.113883.3.72.5.30.2&ISO^MR^Shady Tree&2.16.840.1.113883.3.0&ISO~131131313^^^SSN&2.16.840.1.113883.4.1&ISO^SS^SSA&2.16.840.1.113883.3.184&ISO||Sanchez^Abel^G.^Jr^^^L~Caliez^Luis^Munoz^Jr^^^B|Sanchez^Rose^G.^Sr^Dr^^M^^^^^^^CPA|19800320|M||2106-3^White^CDCREC^White^White^L^1.1^4|6 Maple Drive^Apt 1^Philadelphia^PA^19136^USA^H^^42101~131 Broad Street^Apt 31^Philadelphia^PA^19136^USA^C^^42101||^PRN^CP^^1^215^5551214^4^call before 8PM~^NET^Internet^sangel@yahoo.com^^^^^home|^WPN^PH^^1^215^5551214^4^call before 8PM||||||||H^Hispanic or Latino^HL70189^H^Hispanic or Latino^L^2.5.1^4||||||||N|||201208021600-0500|Shady Tree^2.16.840.1.113883.3.0^ISO|337915000^Homo sapiens (organism)^SCT^human^human^L^07/31/2012^4
NTE|1|P|Patient is English speaker.|RE^Remark^HL70364^C^Comment^L^2.5.1^V1
NK1|1|Sanchez^Angela^G.^III^Dr^^L^^^^^^^PhD|SPO^Spouse^HL70063^S^Spouse^L^2.5.1^40544|6 Maple Drive^Apt 1^Philadelphia^PA^19136^USA^H^^42101|^ORN^CP^^1^215^5551214^4^call before 8PM~^NET^Internet^sangel@yahoo.com^^^^^home
PV1|1|O||C||||||||||||||||||||||||||||||||||||||||20120801|20120801
ORC|RE|3456723^NIST_Placer _App^2.16.840.1.113883.3.72.5.24^ISO|system generated^NIST_Sending_App^2.16.840.1.113883.3.72.5.24^ISO|system generated^NIST_Sending_App^2.16.840.1.113883.3.72.5.24^ISO||||||||131131131^Remala^Swathi^T^JR^DR^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^NPI_Facility&2.16.840.1.113883.3.72.5.26&ISO^^^^^^^MD||^WPN^PH^^1^215^5556600^13^Hospital Line~^BPN^BP^^1^215^5553531^131^Beeper number|||||||Shady Tree Free Clinic^L^^^^NIST sending app&2.16.840.1.113883.3.72.5.21&ISO^XX^^^131|900 Emerson Road^Building 1^Philadelphia^PA^19137^USA^L^^42101|^WPN^PH^^1^215^5556600^13^Call  9AM  to 5PM|1200 Professional Way^Suite 114^Philadelphia^PA^19131^USA^B^^42101
OBR|1|3456723^NIST_Placer _App^2.16.840.1.113883.3.72.5.24^ISO|system generated^NIST_Sending_App^2.16.840.1.113883.3.72.5.24^ISO|24467-3^CD3+CD4+ (T4 helper) cells [#/volume] in Blood^LN^2153^ABSOLUTE CD4+ CELLS^L^2.40^1.2|||20120801|20120801|||||Confirmed HIV infection|||131131131^Remala^Swathi^T^JR^DR^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^NPI_Facility&2.16.840.1.113883.3.72.5.26&ISO^^^^^^^MD|^WPN^PH^^1^215^5556600^13^Hospital Line~^BPN^BP^^1^215^5553531^131^Beeper number|||||201208021600-0500|||F||||||042^Human immunodeficiency virus [HIV] disease [42]^I9CDX^HIV^HIV/Aids^L^29^V1|131&Varma&Raja&Rami&JR&DR&PHD&&NIST_Sending_App&2.16.840.1.113883.3.72.5.21&ISO
OBX|1|SN|24467-3^CD3+CD4+ (T4 helper) cells [#/volume] in Blood^LN^2153^ABSOLUTE CD4+ CELLS^L^2.40^V1||=^440|{Cells}/uL^cells per microliter^UCUM^cells/mcL^cells per microliter^L^1.1^V1|649-1346 cells/mcL|L^Below Low Normal^HL70078^L^Low^L^2.7^V1|||F|||20120801|||0251^Flow Cytometry (FC)^OBSMETHOD^FC^Flow Cytometry^L^20090501^V1||201208021100-0500||||Philadelphia City Public Health Lab^L^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^01D7654321|7901 State Road^Building 2^Philadelphia^PA^19137^USA^L^^42101|1790019875^House^Gregory^F^III^Dr^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^NPI_Facility&2.16.840.1.113883.3.72.5.26&ISO^^^^^^^MD
OBX|1|SN|35659-2^Age at Specimen Collection^LN^AGE^AGE^L^2.40^V1||=^32|a^Year^UCUM^Y^Years^L^1.1^V1|||||F|||20120801|||||201208021100-0500||||Philadelphia City Public Health Lab^L^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^01D7654321|7901 State Road^Building 2^Philadelphia^PA^19137^USA^L^^42101|1790019875^House^Gregory^F^III^Dr^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^NPI_Facility&2.16.840.1.113883.3.72.5.26&ISO^^^^^^^MD


MSH|^~\&#|NIST^2.16.840.1.113883.3.72.5.20^ISO|NIST^2.16.840.1.113883.3.72.5.21^ISO|NIST^2.16.840.1.113883.3.72.5.22^ISO|NIST^2.16.840.1.113883.3.72.5.23^ISO|20120821140551-0500||ORU^R01^ORU_R01|NIST-ELR-002.01|T|2.5.1|||NE|NE|||||PHLabReport-NoAck^HL7^2.16.840.1.113883.9.11^ISO
SFT|NIST Lab, Inc.^L^^^^NIST&2.16.840.1.113883.3.987.1&ISO^XX^^^123544|3.6.23|A-1 Lab System|6742873-12||20100617
PID|1||12346^^^NIST MPI&2.16.840.1.113883.3.72.5.30.2&ISO^MR^&2.16.840.1.113883.3.0&ISO||Diode^Maria^^^^^L||19660130|F||2106-3^White^CDCREC^WH^White^L|47 Uptown Way^^Carlisle^PA^17013^USA^H^^42041||^PRN^PH^^^717^5559510|||||||||H^Hispanic or Latino^HL70189^L^Latino^L
ORC|RE|PN-F20120325-1^^2.16.840.1.113883.3.72.5.24^ISO|system generated^^2.16.840.1.113883.3.72.5.24^ISO||||||||||||||||||Posi-Negi Battery Inc.^L^^^^&2.16.840.1.113883.19.4.6&ISO^XX^^^EMP-00347|7001 Industrial Place^^Lemoyne^PA^17043^^B|^WPN^PH^^^717^5557890|7001 Industrial Place^^Lemoyne^PA^17043
OBR|1|PN-F20120325-1^^2.16.840.1.113883.3.72.5.24^ISO|system generated^^2.16.840.1.113883.3.72.5.24^ISO|5609-3^Cadmium [Mass/volume] in Blood^LN^CAD-01^Cadmium Blood^L^2.40|||20120325|||||||||||||||20120328140000-0500|||F
NTE|1|L|Order Comment|RE^Remark^HL70364
OBX|1|SN|5609-3^Cadmium [Mass/volume] in Blood^LN^CaBL^Blood Cadmium^L^2.40||^27.0|ug/L^microgram per liter^UCUM|0.5-2.0 ug/L|H^Above High Normal^HL70078|||F|||20120325|||||201203281400-0500||||Posi-Negi Chem Lab^L|7001 Industrial Place^^Lemoyne^PA^17043^^^^42041


MSH|^~\&#|NIST^2.16.840.1.113883.3.72.5.20^ISO|NIST^2.16.840.1.113883.3.72.5.21^ISO|NIST^2.16.840.1.113883.3.72.5.22^ISO|NIST^2.16.840.1.113883.3.72.5.23^ISO|20120821140551-0500||ORU^R01^ORU_R01|NIST-ELR-002.02|T|2.5.1|||NE|NE|||||PHLabReport-NoAck^HL7^2.16.840.1.113883.9.11^ISO
SFT|NIST Lab, Inc.^L^^^^NIST&2.16.840.1.113883.3.987.1&ISO^XX^^^123544|3.6.23|A-1 Lab System|6742873-12||20100617
PID|1||12346^^^NIST MPI&2.16.840.1.113883.3.72.5.30.2&ISO^MR^&2.16.840.1.113883.3.0&ISO||Caddis^Carol^^^^^L||19851113|F||2106-3^White^CDCREC^W^White^L|452 West North Blvd^Apartment 7C^Pittsburgh^PA^15222^USA^H||^PRN^PH^^^412^5553342|||||||||N^Non-Hispanic or Latino^HL70189^NH^Non-Hispanic^L
ORC|RE|PN-F20120325-1^^2.16.840.1.113883.3.72.5.24^ISO|system generated^^2.16.840.1.113883.3.72.5.24^ISO||||||||||||||||||Maternal Care Inc.^L|982 Fourteenth Avenue^^Pittsburgh^PA^15212^^B|^WPN^PH^^^412^5553342|982 Fourteenth Avenue^^Pittsburgh^PA^15212
OBR|1|PN-F20120325-1^^2.16.840.1.113883.3.72.5.24^ISO|system generated^^2.16.840.1.113883.3.72.5.24^ISO|5609-3^Cadmium [Mass/volume] in Blood^LN^8682^Cadmium, Blood^L^2.40|||20120729|||||||||||||||201208020400-0500|||F
NTE|1|L|Order Comment|RE^Remark^HL70364
OBX|1|SN|5609-3^Cadmium [Mass/volume] in Blood^LN^8682^Cadmium, Blood^L^2.40||^19.5|ug/L^microgram per liter^UCUM|0.5-2.0 ug/L|H^Above High Normal^HL70078|||F|||20120729|||||20120802||||Diagnostic Lab Works^L^^^^CLIA&2.16.840.1.113883.19.4.6&ISO^XX^^^22D2212212|55 East Carson Street^Suite 44^Pittsburgh^PA^15204


MSH|^~\&#|NIST^2.16.840.1.113883.3.72.5.20^ISO|NIST^2.16.840.1.113883.3.72.5.21^ISO|NIST^2.16.840.1.113883.3.72.5.22^ISO|NIST^2.16.840.1.113883.3.72.5.23^ISO|20120821140551-0500||ORU^R01^ORU_R01|NIST-ELR-002.03|T|2.5.1|||NE|NE|||||PHLabReport-NoAck^HL7^2.16.840.1.113883.9.11^ISO
SFT|NIST Lab, Inc.^L^^^^NIST&2.16.840.1.113883.3.987.1&ISO^XX^^^123544|3.6.23|A-1 Lab System|6742873-12||20100617
PID|1||12346^^^NIST MPI&2.16.840.1.113883.3.72.5.30.2&ISO^MR^&2.16.840.1.113883.3.0&ISO||Parmanti^Sandy^^^^^L||19900401|F||2076-8^Native Hawaiian or Other Pacific Islander^CDCREC^PI^Pacific Islander^L|7711 N Broad St^^Pittsburgh^PA^15201^USA^H||^PRN^PH^^^412^5551214|^WPN^PH^^^412^5556311||||||||N^Non-Hispanic or Latino^HL70189
ORC|RE|PN-F20120325-1^^2.16.840.1.113883.3.72.5.24^ISO|system generated^^2.16.840.1.113883.3.72.5.24^ISO||||||||||||||||||Children's Clinical Care^L|311 Clinic Circle^^Pittsburgh^PA^15202^^B|^WPN^PH^^^412^5554499|311 Clinic Circle^^Pittsburgh^PA^15202
OBR|1|PN-F20120325-1^^2.16.840.1.113883.3.72.5.24^ISO|system generated^^2.16.840.1.113883.3.72.5.24^ISO|5671-3^Lead [Mass/volume] in Blood^LN^300098^Lead, Blood^L^2.40|||20120511|||||||||||||||201205120300-0500|||F
NTE|1|L|Order Comment|RE^Remark^HL70364
OBX|1|SN|5671-3^Lead [Mass/volume] in Blood^LN^300098^Lead, Blood^L^2.40||^24|ug/dL^microgram per deciliter^UCUM|<10 ug/dL|H^Above High Normal^HL70078|||F|||20120511|||||20120512||||Diagnostics \T\ Such^L^^^^CLIA&2.16.840.1.113883.19.4.6&ISO^XX^^^22D2312312|9000 Laboratory Place^Suite 1^Pittsburgh^PA^15211


MSH|^~\&#|NIST^2.16.840.1.113883.3.72.5.20^ISO|NIST^2.16.840.1.113883.3.72.5.21^ISO|NIST^2.16.840.1.113883.3.72.5.22^ISO|NIST^2.16.840.1.113883.3.72.5.23^ISO|20120821140551-0500||ORU^R01^ORU_R01|NIST-ELR-003.01|T|2.5.1|||NE|NE|||||PHLabReport-NoAck^HL7^2.16.840.1.113883.9.11^ISO
SFT|NIST Lab, Inc.^L^^^^NIST&2.16.840.1.113883.3.987.1&ISO^XX^^^123544|3.6.23|A-1 Lab System|6742873-12||20100617
PID|1||PATID1234^^^&2.16.840.1.113883.3.56.1.90&ISO^MR^Seminole Cnty Hlth C&2.16.840.1.113883.3.56.1&ISO||Jones^William^A^^^^L||19630615|M||2106-3^White^CDCREC^W^White^L|1955 Seminole Lane^^Oveido^FL^32765^USA^H^^12059||^PRN^PH^^1^407^2351234|||||||||N^Not Hispanic or Latino^HL70189^NL^not latino^L^2.5.1
ORC|RE|ORD723222-4^^2.16.840.1.113883.3.56.1.90^ISO|R-783274-4^LIS^2.16.840.1.113883.3.72.5.24^ISO|||||||||57422^RADON^NICHOLAS^^^Dr.^^^NPI&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI||^WPN^PH^^^407^2341212|||||||Seminole County Health Clinic|555 Orange Ave^^Oveido^FL^32765^USA^B|^WPN^PH^^^407^5761200|555 Orange Ave^^Oveido^FL^32765^USA
OBR|1|ORD723222-4^^2.16.840.1.113883.3.56.1.90^ISO|R-783274-4^LIS^2.16.840.1.113883.3.72.5.24^ISO|625-4^Bacteria identified in Stool by Culture^LN^3456543^CULTURE STOOL^99USI|||20110528123500-0500|||||||||57422^RADON^NICHOLAS^^^Dr.^^^NPI&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI|^WPN^PH^^^407^2341212|||||20110601123500.000-0500|||P
OBX|1|CWE|625-4^Bacteria identified in Stool by Culture^LN^StlC^Stool culture^99USI^2.40|1|66543000^Campylobacter jejuni^SCT^^^^07/31/2012^^Campylobacter jejuni||||||P|||20110528123500-0500|||||20110530123500.000-0500||||Seminole County Health Department Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^03D3113113|6756 Florida Avenue^^Oveido^FL^32765^^B|10092^Pafford^Hamlin^^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
OBX|2|CWE|625-4^Bacteria identified in Stool by Culture^LN^StlC^Stool culture^99USI^2.40|2|85729005^Shigella flexneri^SCT^^^^07/31/2012^^Shigella flexneri||||||P|||20110528123500-0500|||||20110601123500.000-0500||||Seminole County Health Department Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^03D3113113|6756 Florida Avenue^^Oveido^FL^32765^^B|10092^Pafford^Hamlin^^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI


MSH|^~\&#|NIST^2.16.840.1.113883.3.72.5.20^ISO|NIST^2.16.840.1.113883.3.72.5.21^ISO|NIST^2.16.840.1.113883.3.72.5.22^ISO|NIST^2.16.840.1.113883.3.72.5.23^ISO|20120821140551-0500||ORU^R01^ORU_R01|NIST-ELR-003.02|T|2.5.1|||NE|NE|||||PHLabReport-NoAck^HL7^2.16.840.1.113883.9.11^ISO
SFT|NIST Lab, Inc.^L^^^^NIST&2.16.840.1.113883.3.987.1&ISO^XX^^^123544|3.6.23|A-1 Lab System|6742873-12||20100617
PID|1||PATID123487^^^&2.16.840.1.113883.3.17.5.54&ISO^MR||Kamehameha^Lahela^^^^^L||19910615|F||2076-8^Native Hawaiian or Other Pacific Islander^CDCREC^P^Pacific Islander^L|1986 Beach Lane^^Ewa Beach^HI^96706^USA^H^^15003|||||||||||N^Not Hispanic or Latino^HL70189^^^^2.5.1
ORC|RE|ORD723225^^2.16.840.1.113883.3.17.5.54^ISO|T-201278327^LIS^2.16.840.1.113883.3.72.145.2^ISO|||||||||57422^Enteric^Edwin^^^^^^NPI&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI^^^^^^^^MD||^WPN^PH^^^407^2363000|||||||Tampa General Hospital|1 Tampa General Circle^^Tampa^FL^33606^USA^B|^WPN^PH^^^813^8447284|555 Tampa Bay Blvd^^Tampa^FL^33606^USA
OBR|1|ORD723225^^2.16.840.1.113883.3.17.5.54^ISO|T-201278327^LIS^2.16.840.1.113883.3.72.145.2^ISO|6463-4^Bacteria identified in Unspecified specimen by Culture^LN^1390261^BLOOD CUL^L|||201207081200|201207081300||||||||57422^Enteric^Edwin^^^^^^NPI&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI^^^^^^^^MD|^WPN^PH^^^407^2363000|||||201207100230-0500|||P
OBX|1|CWE|6463-4^Bacteria identified in Unspecified specimen by Culture^LN^BACT ID^BACTERIAL IDENTIFICATION^L^2.40|1|372342007^Salmonella species (organism)^SCT^Salm^Salmonella species^L^07/31/2012^^Salmonella species||||||P|||201207081200|||||20110530123500.000-0500||||Tampa General Hospital Clinical Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^10D0290071|1 Tampa General Circle^^Tampa^FL^33606^USA^B|332658^Petersburg^George^^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
OBX|2|CWE|6463-4^Bacteria identified in Unspecified specimen by Culture^LN^BACT ID^BACTERIAL IDENTIFICATION^L^2.40|2|112283007^Escherichia coli (organism)^SCT^E coli^Escherichia coli^L^07/31/2012^^Escherichia coli||||||P|||201207081200|||||201207100230||||Tampa General Hospital Clinical Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^10D0290071|1 Tampa General Circle^^Tampa^FL^33606^USA^B|332658^Petersburg^George^^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI


MSH|^~\&#|NIST^2.16.840.1.113883.3.72.5.20^ISO|NIST^2.16.840.1.113883.3.72.5.21^ISO|NIST^2.16.840.1.113883.3.72.5.22^ISO|NIST^2.16.840.1.113883.3.72.5.23^ISO|20120821140551-0500||ORU^R01^ORU_R01|NIST-ELR-003.03|T|2.5.1|||NE|NE|||||PHLabReport-NoAck^HL7^2.16.840.1.113883.9.11^ISO
SFT|NIST Lab, Inc.^L^^^^NIST&2.16.840.1.113883.3.987.1&ISO^XX^^^123544|3.6.23|A-1 Lab System|6742873-12||20100617
PID|1||2012BJ123498^^^MPI&2.16.840.1.113883.3.7.23.4&ISO^PI||Birdfeather^Jay^^^^^L||19930415|M||1002-5^American Indian or Alaska Native^CDCREC^AN^American Native^L|2 Beach Rd^^St George Island^FL^32328^^H||^PRN^CP^^^850^9276365|||||||||N^Not Hispanic or Latino^HL70189^NH^not hispanic^L^2.5.1
ORC|RE|ORD72387593^^2.16.840.1.113883.3.7.23.4^ISO|2012_783351^LIS^2.16.840.1.113883.3.72.44.4^ISO|||||||||87989^BeachDweller^John^^^^^^NPI&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI^^^^^^^^MD||^WPN^PH^^^850^9273526|||||||George E Weems Memorial Hospital|135 Avenue G^^Apalachicola^FL^32320^^L|^WPN^PH^^^850^6538853|100 5th St^^Apalachicola^FL^32320
OBR|1|ORD72387593^^2.16.840.1.113883.3.7.23.4^ISO|2012_783351^LIS^2.16.840.1.113883.3.72.44.4^ISO|6463-4^Bacteria identified in Unspecified specimen by Culture^LN^1390424^WOUND/LES/SKIN CULT^L|||20120818|||||||||87989^BeachDweller^John^^^^^^NPI&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI^^^^^^^^MD|^WPN^PH^^^850^9273526|||||201208201030-0500|||P
OBX|1|CWE|6463-4^Bacteria identified in Unspecified specimen by Culture^LN^IDENTIFICATION^IDENTIFICATION^L^2.40|1|3092008^Staphylococcus aureus (organism)^SCT^S aureus^Staphylococcus aureus^L^07/31/2012^^Staphylococcus aureus||||||P|||20120818|||||20120820||||SACRED HEART MEDICAL GROUP ON THE GULF^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^10D2036903|55 Avenue E^^Apalachicola^FL^32320^^B
OBX|2|CWE|6463-4^Bacteria identified in Unspecified specimen by Culture^LN^IDENTIFICATION^IDENTIFICATION^L^2.40|2|44470000^Haemophilus influenzae (organism)^SCT^H inf^Haemophilus influenzae^L^07/31/2012^^Haemophilus influenzae||||||P|||20120818|||||20120820||||SACRED HEART MEDICAL GROUP ON THE GULF^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^10D2036903|55 Avenue E^^Apalachicola^FL^32320^^B


MSH|^~\&#|NIST^2.16.840.1.113883.3.72.5.20^ISO|NIST^2.16.840.1.113883.3.72.5.21^ISO|NIST^2.16.840.1.113883.3.72.5.22^ISO|NIST^2.16.840.1.113883.3.72.5.23^ISO|20120821140551-0500||ORU^R01^ORU_R01|NIST-ELR-004.01|T|2.5.1|||NE|NE|||||PHLabReport-NoAck^HL7^2.16.840.1.113883.9.11^ISO
SFT|NIST Lab, Inc.^L^^^^NIST&2.16.840.1.113883.3.987.1&ISO^XX^^^123544|3.6.23|A-1 Lab System|6742873-12||20100617
PID|1||PATID1234^^^&2.16.840.1.113883.3.72.5.24&ISO^MR^Seminole Cnty Hlth C&2.16.840.1.113883.3.0&ISO||Jones^William^A^^^^L||19610615|M||2106-3^White^CDCREC|1955 Seminole Lane^^Oveido^FL^32765^USA^H^^12059||^PRN^PH^^1^407^2351234|||||||||N^Not Hispanic or Latino^HL70189^NL^not latino^L^2.5.1
ORC|RE|ORD723222-4^^2.16.840.1.113883.3.72.5.24^ISO|R-783274-4^LIS^2.16.840.1.113883.3.72.5.25^ISO|||||||||57422^RADON^NICHOLAS^^^Dr.^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI||^PRN^PH^^^407^2341212|||||||Seminole County Health Clinic|555 Orange Ave^^Oviedo^FL^32765^^B|^WPN^PH^^^813^8847284|555 Orange Ave^^Oviedo^FL^32765^^B
OBR|1|ORD723222-4^^2.16.840.1.113883.3.72.5.24^ISO|R-783274-4^LIS^2.16.840.1.113883.3.72.5.25^ISO|625-4^Bacteria identified in Stool by Culture^LN^3456543^CULTURE STOOL^99USI^2.40|||20110528|||||||||57422^RADON^NICHOLAS^^^Dr.^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI|^PRN^PH^^^407^2341212|||||201106010900-0500|||F
OBX|1|CWE|625-4^Bacteria identified in Stool by Culture^LN^Bacteria identified^Bacteria identified^99USI^2.40||85729005^Shigella flexneri^SCT^^^^^^Shigella flexneri||||||F|||20110528|||||20110531130655-0500||||Seminole County Health Department Laboratory^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|6756 Florida Avenue^^Oveido^FL^32765^^B|10092^Pafford^Hamlin^^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
OBR|2||R-783274-5^LIS^2.16.840.1.113883.3.72.5.25^ISO|50545-3^Bacterial susceptibility panel in Isolate by Minimum inhibitory concentration (MIC)^LN^Bact suscept^Bacteria susceptibility^99USI^2.40|||20110528|||||||||57422^RADON^NICHOLAS^^^Dr.^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI|^PRN^PH^^^407^2341212|||||201106010900-0500|||F|625-4&Bacteria identified in Stool by Culture&LN&Bacteria identified&Bacteria identified&99USI^^Shigella flexneri|||^R-783274-4&LIS&2.16.840.1.113883.3.72.5.25&ISO
OBX|1|SN|20-8^Amoxicillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^AmoxClav^Amoxicillin-clavulanic acid^99USI^2.40||=^16|ug/mL^microgram per milliliter^UCUM^^^^1.8.2||I^Intermediate^HL70078^^^^2.5.1|||F|||20110528|||||201106010900-0500||||Seminole County Health Department Laboratory^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|6756 Florida Avenue^^Oveido^FL^32765^^B|10092^Pafford^Hamlin^^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
OBX|2|SN|516-5^Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^TMP-SMX^Trimethoprim-sulfamethoxazole^99USI^2.40||=^8^/^152|ug/mL^microgram per milliliter^UCUM^^^^1.8.2||R^Resistant^HL70078^^^^2.5.1|||F|||20110528|||||201106010900-0500||||Seminole County Health Department Laboratory^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|6756 Florida Avenue^^Oveido^FL^32765^^B|10092^Pafford^Hamlin^^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
OBX|3|SN|185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^CIPROFLOXACIN^CIPROFLOXACIN^99USI^2.40||<=^0.06|ug/mL^microgram per milliliter^UCUM^^^^1.8.2||S^Susceptible^HL70078^^^^2.5.1|||F|||20110528|||||201106010900-0500||||Seminole County Health Department Laboratory^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|6756 Florida Avenue^^Oveido^FL^32765^^B|10092^Pafford^Hamlin^^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI


MSH|^~\&#|NIST^2.16.840.1.113883.3.72.5.20^ISO|NIST^2.16.840.1.113883.3.72.5.21^ISO|NIST^2.16.840.1.113883.3.72.5.22^ISO|NIST^2.16.840.1.113883.3.72.5.23^ISO|20120821140551-0500||ORU^R01^ORU_R01|NIST-ELR-004.02|T|2.5.1|||NE|NE|||||PHLabReport-NoAck^HL7^2.16.840.1.113883.9.11^ISO
SFT|NIST Lab, Inc.^L^^^^NIST&2.16.840.1.113883.3.987.1&ISO^XX^^^123544|3.6.23|A-1 Lab System|6742873-12||20100617
PID|1||PATID1234^^^MPI&2.16.840.1.113883.3.76.7.29&ISO^MR||Lung^Neil^^^^^L||19480802|M||2028-9^Asian^CDCREC|550 8th Avenue South^Apt 10^Goodlettsville^TN^34209||^PRN^PH^^^615^5558585|||||||||N^Not Hispanic or Latino^HL70189
ORC|RE|VM8907334^^2.16.840.1.113883.3.76.7.29^ISO|R-783274^LIS^2.16.840.1.113883.3.32.1.11^ISO|||||||||455701^One^T^B^^Dr.^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI||^WPN^PH^^^555^7771234|||||||Vandermeer University Medical Center|Vandermeer Drive^^Nashville^TN^37211|^WPN^PH^^^555^7771234|Vandermeer Drive^^Nashville^TN^37211
OBR|1|VM8907334^^2.16.840.1.113883.3.76.7.29^ISO|R-783274^LIS^2.16.840.1.113883.3.32.1.11^ISO|40699-1^Mycobacterium sp identified in Unspecified specimen^LN^AFBID^AFB Identification^L^2.40|||20120315|||||||||455701^One^T^B^^Dr.^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI|^WPN^PH^^^555^7771234|||||20120422000000-0600|||F
OBX|1|CWE|11475-1^Microorganism identified in Unspecified specimen by Culture^LN^AFBC^AFB Culture^L^2.40||113858008^Mycobacterium tuberculosis complex (organism)^SCT^^^^07/31/2012^^Mycobacterium tuberculosis complex||||||F|||20120315|||||20120415||||Vandermeer University Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^42D7654321|2 Vandermeer Drive^^Nashville^TN^37211
OBR|2||R-783274-5^LIS^2.16.840.1.113883.3.32.1.11^ISO|29579-0^Mycobacterial susceptibility panel in Isolate^LN^SIRE^MTB Susceptibility Panel (SIRE)^L^2.40|||20120315|||||||||455701^One^T^B^^Dr.^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI|^WPN^PH^^^555^7771234|||||20120422000000-0600|||F|11475-1&Microorganism identified in Unspecified specimen by Culture&LN&AFBC&AFB Culture&L^^Mycobacterium tuberculosis complex (organism)|||^R-783274&LIS&2.16.840.1.113883.3.32.1.11&ISO
OBX|1|SN|48177-0^Streptomycin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria^LN^STRP^Streptomycin 1.0 ug/mL^L^2.40||<^100|[arb'U]^arbitrary unit^UCUM^growth units^growth units^L||S^Susceptible^HL70078^^^^2.5.1|||F|||20120315|||||20120422||||Vandermeer University Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^42D7654321|2 Vandermeer Drive^^Nashville^TN^37211
OBX|2|SN|25217-1^Isoniazid 0.1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria^LN^ISON^Isoniazid 0.1 ug/mL^L^2.40||>^100|[arb'U]^arbitrary unit^UCUM^growth units^growth units^L||R^Resistant^HL70078^^^^2.5.1|||F|||20120315|||||20120422||||Vandermeer University Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^42D7654321|2 Vandermeer Drive^^Nashville^TN^37211
OBX|3|SN|25202-3^Rifampin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria^LN^RIFA^Rifampin 1.0 ug/mL^L^2.40||<^100|[arb'U]^arbitrary unit^UCUM^growth units^growth units^L||S^Susceptible^HL70078^^^^2.5.1|||F|||20120315|||||20120422||||Vandermeer University Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^42D7654321|2 Vandermeer Drive^^Nashville^TN^37211
OBX|4|SN|25194-2^Ethambutol 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria^LN^ETHA^Ethambutol 5.0 ug/mL^L^2.40||<^100|[arb'U]^arbitrary unit^UCUM^growth units^growth units^L||S^Susceptible^HL70078^^^^2.5.1|||F|||20120315|||||20120422||||Vandermeer University Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^42D7654321|2 Vandermeer Drive^^Nashville^TN^37211


MSH|^~\&#|NIST^2.16.840.1.113883.3.72.5.20^ISO|NIST^2.16.840.1.113883.3.72.5.21^ISO|NIST^2.16.840.1.113883.3.72.5.22^ISO|NIST^2.16.840.1.113883.3.72.5.23^ISO|20120821140551-0500||ORU^R01^ORU_R01|NIST-ELR-004.03|T|2.5.1|||NE|NE|||||PHLabReport-NoAck^HL7^2.16.840.1.113883.9.11^ISO
SFT|NIST Lab, Inc.^L^^^^NIST&2.16.840.1.113883.3.987.1&ISO^XX^^^123544|3.6.23|A-1 Lab System|6742873-12||20100617
PID|1||P12345887^^^EHRSy&2.16.840.1.113883.3.62.5.27&ISO^MR||Hisan^Toyoto^^^^^L||19870517|M||2028-9^Asian^CDCREC^A^Asian^L|1201 Bears Ave^^Tampa^FL^33606^USA^H^^12057||^PRN^PH^^^407^2444554|||||||||N^Not Hispanic or Latino^HL70189
ORC|RE|ORD2113586-3^^2.16.840.1.113883.3.62.5.27^ISO|TEST0001^LIS^2.16.840.1.113883.3.72.6.27^ISO|||||||||125627^Bucci^Tampa^^^Dr.^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI||^WPN^PH^^^407^3031200|||||||Tampa General Hospital|1 Tampa General Circle^^Tampa^FL^33606^USA^L|^WPN^PH^^^407^3031200|555 Orange Ave^^Maitland^FL^33606^^O
OBR|1|ORD2113586-3^^2.16.840.1.113883.3.62.5.27^ISO|TEST0001^LIS^2.16.840.1.113883.3.72.6.27^ISO|6463-4^Bacteria identified in Unspecified specimen by Culture^LN^75400008^CULTURE, BLOOD^L^2.40|||20120612|||||||||125627^Bucci^Tampa^^^Dr.^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI|^WPN^PH^^^407^3031200|||||201206170842-0500|||F
OBX|1|CWE|6463-4^Bacteria identified in Unspecified specimen by Culture^LN^75400008^CULTURE, BLOOD^L^2.40||9861002^Streptococcus pneumoniae (organism)^SCT^^^^07/31/2012^^Streptococcus pneumoniae||||||F|||20120612|||||20120616||||Tampa General Hospital Clinical Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^04D0290071|1 Tampa General Circle^^Tampa^FL^33606^^L|234568^Ray^Devil^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^MD
OBR|2||TEST000123B^LIS^2.16.840.1.113883.3.72.6.27^ISO|50545-3^Bacterial Susceptibility Panel in Isolate by Minimum Inhibitory Concentration (MIC)^LN^85400007^SUSCEPTIBILITY PANEL, MIC^L^2.40|||20120612|||||||||125627^Bucci^Tampa^^^Dr.^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI|^WPN^PH^^^407^3031200|||||201206170842-0500|||F|6463-4&Bacteria identified in Unspecified specimen by Culture&LN&75400008&CULTURE, BLOOD&L^^Streptococcus pneumoniae (organism)|||^TEST0001&LIS&2.16.840.1.113883.3.72.6.27&ISO
OBX|1|SN|20-8^Amoxicillin + Clavulanate [Susceptibility] by Minimum Inhibitory concentration (MIC)^LN^AUG^AMOX/CLAVULANATE^L^2.40||<^2|ug/mL^micrograms per milliliter^UCUM^mcg/ml^^L||S^Susceptible^HL70078^^^^2.7|||F|||20120612|||||201206170842-0500||||Tampa General Hospital Clinical Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^04D0290071|1 Tampa General Circle^^Tampa^FL^33606^^L|234568^Ray^Devil^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^MD
OBX|2|SN|141-2^Ceftriaxone [Susceptibility] by Minimum Inhibitory concentration (MIC)^LN^CAX^CEFTRIAXONE^L^2.40||^2|ug/mL^micrograms per milliliter^UCUM^mcg/ml^^L||S^Susceptible^HL70078^^^^2.7|||F|||20120612|||||201206170842-0500||||Tampa General Hospital Clinical Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^04D0290071|1 Tampa General Circle^^Tampa^FL^33606^^L|234568^Ray^Devil^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^MD
OBX|3|SN|193-3^Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^CC^CLINDAMYCIN^L^2.40||^4|ug/mL^micrograms per milliliter^UCUM^mcg/ml^^L||S^Susceptible^HL70078^^^^2.7|||F|||20120612|||||201206170842-0500||||Tampa General Hospital Clinical Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^04D0290071|1 Tampa General Circle^^Tampa^FL^33606^^L|234568^Ray^Devil^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^MD
OBX|4|SN|108-1^Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^CTX^CEFOTAXIME^L^2.40||^2|ug/mL^micrograms per milliliter^UCUM^mcg/ml^^L||S^Susceptible^HL70078^^^^2.7|||F|||20120612|||||201206170842-0500||||Tampa General Hospital Clinical Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^04D0290071|1 Tampa General Circle^^Tampa^FL^33606^^L|234568^Ray^Devil^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^MD
OBX|5|SN|145-3^Cefuroxime Parenteral [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^CXMP^CEFUROXIME, SODIUM^L^2.40||>^32|ug/mL^micrograms per milliliter^UCUM^mcg/ml^^L||R^Resistant^HL70078^^^^2.7|||F|||20120612|||||201206170842-0500||||Tampa General Hospital Clinical Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^04D0290071|1 Tampa General Circle^^Tampa^FL^33606^^L|234568^Ray^Devil^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^MD
OBX|6|SN|233-7^Erythromycin  [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^E^RYTHROMYCIN^L^2.40||>^32|ug/mL^micrograms per milliliter^UCUM^mcg/ml^^L||R^Resistant^HL70078^^^^2.7|||F|||20120612|||||201206170842-0500||||Tampa General Hospital Clinical Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^04D0290071|1 Tampa General Circle^^Tampa^FL^33606^^L|234568^Ray^Devil^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^MD
OBX|7|SN|6644-9^Cefepime [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^FEP^CEFEPIME^L^2.40||^4|ug/mL^micrograms per milliliter^UCUM^mcg/ml^^L||S^Susceptible^HL70078^^^^2.7|||F|||20120612|||||201206170842-0500||||Tampa General Hospital Clinical Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^04D0290071|1 Tampa General Circle^^Tampa^FL^33606^^L|234568^Ray^Devil^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^MD
OBX|8|SN|20396-8^Levofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^LVX^LEVOFLOXACIN^L^2.40||<^2|ug/mL^micrograms per milliliter^UCUM^mcg/ml^^L||S^Susceptible^HL70078^^^^2.7|||F|||20120612|||||201206170842-0500||||Tampa General Hospital Clinical Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^04D0290071|1 Tampa General Circle^^Tampa^FL^33606^^L|234568^Ray^Devil^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^MD
OBX|9|SN|6652-2^Meropenem [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^MEM^MEROPENEM^L^2.40||^4|ug/mL^micrograms per milliliter^UCUM^mcg/ml^^L||S^Susceptible^HL70078^^^^2.7|||F|||20120612|||||201206170842-0500||||Tampa General Hospital Clinical Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^04D0290071|1 Tampa General Circle^^Tampa^FL^33606^^L|234568^Ray^Devil^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^MD
OBX|10|SN|6932-8^Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^PEN^Penicillin^L^2.40||>^32|ug/mL^micrograms per milliliter^UCUM^mcg/ml^^L||R^Resistant^HL70078^^^^2.7|||F|||20120612|||||201206170842-0500||||Tampa General Hospital Clinical Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^04D0290071|1 Tampa General Circle^^Tampa^FL^33606^^L|234568^Ray^Devil^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^MD
OBX|11|SN|524-9^Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^VA^VANCOMYCIN^L^2.40||^2|ug/mL^micrograms per milliliter^UCUM^mcg/ml^^L||S^Susceptible^HL70078^^^^2.7|||F|||20120612|||||201206170842-0500||||Tampa General Hospital Clinical Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^04D0290071|1 Tampa General Circle^^Tampa^FL^33606^^L|234568^Ray^Devil^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^MD


MSH|^~\&#|NIST^2.16.840.1.113883.3.72.5.20^ISO|NIST^2.16.840.1.113883.3.72.5.21^ISO|NIST^2.16.840.1.113883.3.72.5.22^ISO|NIST^2.16.840.1.113883.3.72.5.23^ISO|20120821140551-0500||ORU^R01^ORU_R01|NIST-ELR-005A.01|T|2.5.1|||NE|NE|||||PHLabReport-NoAck^HL7^2.16.840.1.113883.9.11^ISO
SFT|NIST Lab, Inc.^L^^^^NIST&2.16.840.1.113883.3.987.1&ISO^XX^^^123544|3.6.23|A-1 Lab System|6742873-12||20100617
PID|1||PATID1234^^^MPI&2.16.840.1.113883.3.0.0.0.3&ISO^MR^Princeton Hospital&2.16.840.1.113883.3.0&ISO||Smirnoff^Peggy^^^^^L||19750401|F||2106-3^White^CDCREC^wh^white^L|135 State St^Apt#5^Trenton^NJ^08625^USA^H^^34021||^PRN^CP^^1^609^1234567^^Patient has a home phone, but prefers this for contact~^NET^Internet^psmir@bogus.bogus|||||||||N^Not Hispanic or Latino^HL70189^NH^^L
ORC|RE|ORD723222^EHR System^2.16.840.1.113883.3.0.0.0.1^ISO|R-511^LIS^2.16.840.1.113883.3.0.1.0.2^ISO|||||||||1234567890^Fine^Larry^^^Dr.^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^Princeton Hospital&2.16.840.1.113883.3.0&ISO||^WPN^PH^^^609^9876543^1|||||||Princeton Hospital|123 High Street^^Princeton^NJ^08540|^WPN^PH^^^609^9876543^1|123 High Street^^Princeton^NJ^08540
OBR|1|ORD723222^EHR System^2.16.840.1.113883.3.0.0.0.1^ISO|R-511^LIS^2.16.840.1.113883.3.0.1.0.2^ISO|AHEPR^Acute Hepatititis Panel with Reflex^L|||20120628070100|||||||||1234567890^Fine^Larry^^^Dr.^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^Princeton Hospital&2.16.840.1.113883.3.0&ISO|^WPN^PH^^^609^9876543^1|||||20120629132900-0500|||F
OBX|1|CWE|22314-9^Hepatitis A virus IgM Ab [Presence] in Serum^LN^HAVM^Hepatitis A IgM antibodies (IgM anti-HAV)^L||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L||Negative||||F|||20120628070100|||||20120628080500||||Princeton Hospital laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
OBX|2|CWE|16933-4^Hepatitis B virus core Ab [Presence] in Serum^LN^HBVcAB^Hepatitis B core antibodies (anti-HBVc)^L||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L||Negative||||F|||20120628070100|||||20120628080500||||Princeton Hospital laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
OBX|3|CWE|5195-3^Hepatitis B virus surface Ag [Presence] in Serum^LN^HBVsAG^Hepatitis B surface antigen (HBsAg)^L||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L||Negative||||F|||20120628070100|||||20120628080500||||Princeton Hospital laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
OBX|4|CWE|13955-0^Hepatitis C virus Ab [Presence] in Serum by Immunoassay^LN^HCVAB^Hepatitis C antibody screen  (anti-HCV)^L||10828004^Positive (qualifier value)^SCT^POS^POSITIVE^L||Negative|A^Abnormal^HL70078|||F|||20120628070100|||||20120628080500||||Princeton Hospital laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
OBX|5|SN|48159-8^Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay^LN^HCVSCO^Hepatitis C antibodies Signal to Cut-off Ratio^L||^10.8|{s_co_ratio}^Signal to cutoff ratio^UCUM^s/co^^L|0.0-0.9 s/co|H^Above high normal^HL70078|||F|||20120628070100|||||20120628080500||||Princeton Hospital laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
NTE|1||In order to reduce the incidence of a false positive result, the CDC recommends that all s/co ratios between 1.0 and 10.9 be confirmed with additional Hepatitis C quantitative PCR testing. Quantification range of the PCR assay is 43-69,000,000 IU/mL .
OBX|6|SN|11011-4^Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method^LN^HCVRNA^Hepatitis C RNA PCR^L||^7611200|[IU]/mL^international unit per milliliter^UCUM^IU/ml^^L|<43 IU/mL|H^Above high normal^HL70078|||F|||20120628070100|||||20120628092700||||Princeton Hospital laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.


MSH|^~\&#|NIST^2.16.840.1.113883.3.72.5.20^ISO|NIST^2.16.840.1.113883.3.72.5.21^ISO|NIST^2.16.840.1.113883.3.72.5.22^ISO|NIST^2.16.840.1.113883.3.72.5.23^ISO|20120821140551-0500||ORU^R01^ORU_R01|NIST-ELR-005A.03|T|2.5.1|||NE|NE|||||PHLabReport-NoAck^HL7^2.16.840.1.113883.9.11^ISO
SFT|NIST Lab, Inc.^L^^^^NIST&2.16.840.1.113883.3.987.1&ISO^XX^^^123544|3.6.23|A-1 Lab System|6742873-12||20100617
PID|1||SMB3948814^^^MPI&2.16.840.1.113883.3.0.0.0.3&ISO^MR^Clark Mem Hosp&2.16.840.1.113883.3.0&ISO||Smith^Beatrice||19650501|F||2054-5^Black or African American^CDCREC^B^Black^L|335 Ash Street^^Jeffersonville^IN^47130^^H||^PRN^PH^^^812^1235540~^NET^Internet^SSMITH86@email.com|||||||||N^Not Hispanic or Latino^HL70189^NL^^L
ORC|RE|OR723222980^EHR System^2.16.840.1.113883.3.0.0.0.1^ISO|SP531^LIS^2.16.840.1.113883.3.0.1.0.2^ISO|||||||||5608888^Terrell^Fred^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^MD||^WPN^PH^^^812^4456256|||||||Clark Memorial Hospital|1220 Missouri Avenue^^Jeffersonville^IN^47130|^WPN^PH^^^812^2826631|1 Professional Way^^Jeffersonville^IN^47131
OBR|1|OR723222980^EHR System^2.16.840.1.113883.3.0.0.0.1^ISO|SP531^LIS^2.16.840.1.113883.3.0.1.0.2^ISO|51657-5^Hepatitis C Virus Ab[Presence] in Body Fluid^LN^137^HCV Profile^L^2.40|||201206010701|||||||||5608888^Terrell^Fred^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^MD|^WPN^PH^^^812^4456256|||||20120603132900-0500|||F
OBX|1|CWE|13955-0^Hepatitis C virus Ab [Presence] in Serum by Immunoassay^LN^138C^Hepatitis C Antibody QL^L^2.40||11214006^Reactive^SCT^R^Reactive^L||non-reactive|A^Abnormal^HL70078|||F|||201206010701|||||201206011316||||Clark Memorial Hospital Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^22D4560000|1220 Missouri Avenue^^Jeffersonville^IN^47130|^Lee^H^^^Dr.
OBX|2|SN|48159-8^Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay^LN^137C^Hepatitis C Antibody^L^2.40||^8.0|{s_co_ratio}^Signal to cutoff ratio^UCUM|<1.0 S/CO|H^Above high normal^HL70078|||F|||201206010701|||||201206011316||||Clark Memorial Hospital Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^22D4560000|1220 Missouri Avenue^^Jeffersonville^IN^47130|^Lee^H^^^Dr.
OBX|3|SN|11011-4^Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method^LN^919A^Heptimax (R) HCV RNA^L^2.40||^1111100|[IU]/mL^international unit per milliliter^UCUM^IU/mL^^L|<43 IU/mL|H^Above high normal^HL70078|||F|||201206010701|||||201206020927||||Clark Memorial Hospital Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^22D4560000|1220 Missouri Avenue^^Jeffersonville^IN^47130|^Lee^H^^^Dr.
NTE|1||In order to reduce the incidence of a false positive result, the CDC recommends that all s/co ratios between 1.0 and 10.9 be confirmed with additional Hepatitis C quantitative PCR testing. Quantification range of the PCR assay is 43-69,000,000 IU/mL .


MSH|^~\&#|NIST^2.16.840.1.113883.3.72.5.20^ISO|NIST^2.16.840.1.113883.3.72.5.21^ISO|NIST^2.16.840.1.113883.3.72.5.22^ISO|NIST^2.16.840.1.113883.3.72.5.23^ISO|20120821140551-0500||ORU^R01^ORU_R01|NIST-ELR-005B.01|T|2.5.1|||NE|NE|||||PHLabReport-NoAck^HL7^2.16.840.1.113883.9.11^ISO
SFT|NIST Lab, Inc.^L^^^^NIST&2.16.840.1.113883.3.987.1&ISO^XX^^^123544|3.6.23|A-1 Lab System|6742873-12||20100617
PID|1||PATID1234^^^MPI&2.16.840.1.113883.3.0.0.0.3&ISO^MR^Princeton Hospital&2.16.840.1.113883.3.0&ISO||Smirnoff^Peggy^^^^^L||19750401|F||2106-3^White^CDCREC^wh^white^L|135 State St^Apt#5^Trenton^NJ^08625^USA^H^^34021||^PRN^CP^^1^609^1234567^^Patient has a home phone, but prefers this for contact~^NET^Internet^psmir@bogus.bogus|||||||||N^Not Hispanic or Latino^HL70189^NH^^L
ORC|RE|ORD723222^EHR System^2.16.840.1.113883.3.0.0.0.1^ISO|R-511^LIS^2.16.840.1.113883.3.0.1.0.2^ISO|||||||||1234567890^Fine^Larry^^^Dr.^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^Princeton Hospital&2.16.840.1.113883.3.0&ISO||^WPN^PH^^^609^9876543^1|||||||Princeton Hospital|123 High Street^^Princeton^NJ^08540|^WPN^PH^^^609^9876543^1|123 High Street^^Princeton^NJ^08540
OBR|1|ORD723222^EHR System^2.16.840.1.113883.3.0.0.0.1^ISO|R-511^LIS^2.16.840.1.113883.3.0.1.0.2^ISO|AHEPR^Acute Hepatititis Panel with Reflex^L|||20120628070100|||||||||1234567890^Fine^Larry^^^Dr.^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^Princeton Hospital&2.16.840.1.113883.3.0&ISO|^WPN^PH^^^609^9876543^1|||||20120629132900-0500|||F
OBX|1|CWE|22314-9^Hepatitis A virus IgM Ab [Presence] in Serum^LN^HAVM^Hepatitis A IgM antibodies (IgM anti-HAV)^L||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L||Negative||||F|||20120628070100|||||20120628080500||||Princeton Hospital laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
OBX|2|CWE|16933-4^Hepatitis B virus core Ab [Presence] in Serum^LN^HBVcAB^Hepatitis B core antibodies (anti-HBVc)^L||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L||Negative||||F|||20120628070100|||||20120628080500||||Princeton Hospital laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
OBX|3|CWE|5195-3^Hepatitis B virus surface Ag [Presence] in Serum^LN^HBVsAG^Hepatitis B surface antigen (HBsAg)^L||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L||Negative||||F|||20120628070100|||||20120628080500||||Princeton Hospital laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
OBX|4|CWE|13955-0^Hepatitis C virus Ab [Presence] in Serum by Immunoassay^LN^HCVAB^Hepatitis C antibody screen  (anti-HCV)^L||10828004^Positive (qualifier value)^SCT^POS^POSITIVE^L||Negative|A^Abnormal^HL70078|||F|||20120628070100|||||20120628080500||||Princeton Hospital laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
OBX|5|SN|48159-8^Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay^LN^HCVSCO^Hepatitis C antibodies Signal to Cut-off Ratio^L||^10.8|{s_co_ratio}^Signal to cutoff ratio^UCUM^s/co^^L|0.0-0.9 s/co|H^Above high normal^HL70078|||F|||20120628070100|||||20120628080500||||Princeton Hospital laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
NTE|1||In order to reduce the incidence of a false positive result, the CDC recommends that all s/co ratios between 1.0 and 10.9 be confirmed with additional Hepatitis C quantitative PCR testing. Quantification range of the PCR assay is 43-69,000,000 IU/mL .
OBR|2||R-512^LIS^2.16.840.1.113883.3.0.1.0.2^ISO|11011-4^Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method^LN^HCVRNA^Hepatitis C RNA PCR^L|||20120628070100|||||||||1234567890^Fine^Larry^^^Dr.^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^Princeton Hospital&2.16.840.1.113883.3.0&ISO|^WPN^PH^^^609^9876543^1|||||20120629132900-0500|||F|13955-0&Hepatitis C virus Ab [Presence] in Serum by Immunoassay&LN&HCVAB&Hepatitis C antibody screen  (anti-HCV)&L^^Positive|||^R-511&LIS&2.16.840.1.113883.3.0.1.0.2&ISO
OBX|1|SN|11011-4^Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method^LN^HCVRNA^Hepatitis C RNA PCR^L||^7611200|[IU]/mL^international unit per milliliter^UCUM^IU/ml^^L|<43 IU/mL|H^Above high normal^HL70078|||F|||20120628070100|||||20120628092700||||Princeton Hospital laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.


MSH|^~\&#|NIST^2.16.840.1.113883.3.72.5.20^ISO|NIST^2.16.840.1.113883.3.72.5.21^ISO|NIST^2.16.840.1.113883.3.72.5.22^ISO|NIST^2.16.840.1.113883.3.72.5.23^ISO|20120821140551-0500||ORU^R01^ORU_R01|NIST-ELR-005B.03|T|2.5.1|||NE|NE|||||PHLabReport-NoAck^HL7^2.16.840.1.113883.9.11^ISO
SFT|NIST Lab, Inc.^L^^^^NIST&2.16.840.1.113883.3.987.1&ISO^XX^^^123544|3.6.23|A-1 Lab System|6742873-12||20100617
PID|1||SMB3948814^^^MPI&2.16.840.1.113883.3.0.0.0.3&ISO^MR^Clark Mem Hosp&2.16.840.1.113883.3.0&ISO||Smith^Beatrice||19650501|F||2054-5^Black or African American^CDCREC^B^Black^L|335 Ash Street^^Jeffersonville^IN^47130^^H||^PRN^PH^^^812^1235540~^NET^Internet^SSMITH86@email.com|||||||||N^Not Hispanic or Latino^HL70189^NL^^L
ORC|RE|OR723222980^EHR System^2.16.840.1.113883.3.0.0.0.1^ISO|SP531^LIS^2.16.840.1.113883.3.0.1.0.2^ISO|||||||||5608888^Terrell^Fred^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^MD||^WPN^PH^^^812^4456256|||||||Clark Memorial Hospital|1220 Missouri Avenue^^Jeffersonville^IN^47130|^WPN^PH^^^812^2826631|1 Professional Way^^Jeffersonville^IN^47131
OBR|1|OR723222980^EHR System^2.16.840.1.113883.3.0.0.0.1^ISO|SP531^LIS^2.16.840.1.113883.3.0.1.0.2^ISO|51657-5^Hepatitis C Virus Ab[Presence] in Body Fluid^LN^137^HCV Profile^L^2.40|||201206010701|||||||||5608888^Terrell^Fred^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^MD|^WPN^PH^^^812^4456256|||||20120603132900-0500|||F
OBX|1|CWE|13955-0^Hepatitis C virus Ab [Presence] in Serum by Immunoassay^LN^138C^Hepatitis C Antibody QL^L^2.40||11214006^Reactive^SCT^R^Reactive^L||non-reactive|A^Abnormal^HL70078|||F|||201206010701|||||201206011316||||Clark Memorial Hospital Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^22D4560000|1220 Missouri Avenue^^Jeffersonville^IN^47130|^Lee^H^^^Dr.
OBX|2|SN|48159-8^Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay^LN^137C^Hepatitis C Antibody^L^2.40||^8.0|{s_co_ratio}^Signal to cutoff ratio^UCUM|<1.0 S/CO|H^Above high normal^HL70078|||F|||201206010701|||||201206011316||||Clark Memorial Hospital Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^22D4560000|1220 Missouri Avenue^^Jeffersonville^IN^47130|^Lee^H^^^Dr.
NTE|1||In order to reduce the incidence of a false positive result, the CDC recommends that all s/co ratios between 1.0 and 10.9 be confirmed with additional Hepatitis C quantitative PCR testing. Quantification range of the PCR assay is 43-69,000,000 IU/mL .
OBR|2||SP532^LIS^2.16.840.1.113883.3.0.1.0.2^ISO|11011-4^Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method^LN^919A^Heptimax (R) HCV RNA^L^2.40|||201206010701|||||||||5608888^Terrell^Fred^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^MD|^WPN^PH^^^812^4456256|||||20120603132900-0500|||F|48159-8&HCV Ab s/co SerPl EIA&LN&137C&Hepatitis C Antibody&L^^8.0|||^SP531&LIS&2.16.840.1.113883.3.0.1.0.2&ISO
OBX|1|SN|11011-4^Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method^LN^919A^Heptimax (R) HCV RNA^L^2.40||^1111100|[IU]/mL^international unit per milliliter^UCUM^IU/mL^^L|<43 IU/mL|H^Above high normal^HL70078|||F|||201206010701|||||201206020927||||Clark Memorial Hospital Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^22D4560000|1220 Missouri Avenue^^Jeffersonville^IN^47130|^Lee^H^^^Dr.


MSH|^~\&#|NIST^2.16.840.1.113883.3.72.5.20^ISO|NIST^2.16.840.1.113883.3.72.5.21^ISO|NIST^2.16.840.1.113883.3.72.5.22^ISO|NIST^2.16.840.1.113883.3.72.5.23^ISO|20120821140551-0500||ORU^R01^ORU_R01|NIST-ELR-006.01|T|2.5.1|||NE|NE|||||PHLabReport-NoAck^HL7^2.16.840.1.113883.9.11^ISO
SFT|NIST Lab, Inc.^L^^^^NIST&2.16.840.1.113883.3.987.1&ISO^XX^^^123544|3.6.23|A-1 Lab System|6742873-12||20100617
PID|1||PATID1234^^^&2.16.840.1.113883.3.72.5.30.2&ISO^MR^&2.16.840.1.113883.3.0&ISO||Skeeto^Maurice^^^^^L||19471101|M||2106-3^White^CDCREC^Wh^White^L|531 NW 125th Street^^Chuluota^FL^32766^USA^H||^PRN^PH^^^407^8675309~^ORN^CP^^^251^7271919|||||||||H^Hispanic or Latino^HL70189^L^Latino^L^2.5.1
ORC|RE|OR980768901-1^^2.16.840.1.113883.3.72.5.30.2^ISO|O2012987006172-1^DPHFL-Seminole^2.16.840.1.114222.4.1.908.283^ISO|||||||||^ONCALL^JOHN||^WPN^PH^^^407^2341212|||||||Seminole County Health Clinic|555 Orange Ave^^Oveido^FL^32765^^L|^WPN^PH^^^407^2341212|555 Orange Ave^^Oveido^FL^32765
OBR|1|OR980768901-1^^2.16.840.1.113883.3.72.5.30.2^ISO|O2012987006172-1^DPHFL-Seminole^2.16.840.1.114222.4.1.908.283^ISO|6812-2^Dengue virus IgM Ab [Titer] in Serum^LN^3752^Dengue Fever - IGM AB EIA^L^2.40^v1|||20120601095300|||||||||^ONCALL^JOHN|^WPN^PH^^^407^2341212|||||20120602133506-0500|||F
OBX|1|SN|6812-2^Dengue virus IgM Ab [Titer] in Serum^LN^3752^Dengue Fever - IGM AB EIA^L^2.40^v1||^1^:^256|{titer}^titer^UCUM^titer^titer^L^1.8.2|<1:64|H^Above High Normal^HL70078|||F|||20120601095300|||||20120602133006||||Seminole County Health Department Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^66D6116116|555 Orange Ave^^Oveido^FL^32765^USA^L^^12059


MSH|^~\&#|NIST^2.16.840.1.113883.3.72.5.20^ISO|NIST^2.16.840.1.113883.3.72.5.21^ISO|NIST^2.16.840.1.113883.3.72.5.22^ISO|NIST^2.16.840.1.113883.3.72.5.23^ISO|20120821140551-0500||ORU^R01^ORU_R01|NIST-ELR-006.02|T|2.5.1|||NE|NE|||||PHLabReport-NoAck^HL7^2.16.840.1.113883.9.11^ISO
SFT|NIST Lab, Inc.^L^^^^NIST&2.16.840.1.113883.3.987.1&ISO^XX^^^123544|3.6.23|A-1 Lab System|6742873-12||20100617
PID|1||PATID125789^^^&2.16.840.1.113883.3.72.5.670.22&ISO^MR||Smiley^Horace^T^^^^L||19841101|M||2106-3^White^CDCREC^W^White^L|125 Third Ave^Apt C^West Memphis^AR^72301^USA^H||^PRN^CP^^^501^2278610~^ORN^PH^^^501^2281218|||||||||N^Not Hispanic or Latino^HL70189^^^^2.5.1
ORC|RE|2012-0987890001^^2.16.840.1.113883.3.72.5.670.22^ISO|8907659-ORD-3^PHL.AR^2.16.840.1.114222.4.1.20083^ISO|||||||||^Riddell^Rita^^^Dr.||^WPN^PH^^^501^5551234^119|||||||Crittenden County Health Unit|901 North 7th Street^^West Memphis^AR^72301^^L|^WPN^PH^^^501^6612220|901 North 7th Street^^West Memphis^AR^72301^^B
OBR|1|2012-0987890001^^2.16.840.1.113883.3.72.5.670.22^ISO|8907659-ORD-3^PHL.AR^2.16.840.1.114222.4.1.20083^ISO|31147-2^Reagin Ab [Titer] in Serum by RPR^LN^2059^Syphilis RPR^L^2.40^v45|||20111105143000-0600|||||||||^Riddell^Rita^^^Dr.|^WPN^PH^^^501^5551234^119|||||20111106101500-0600|||F
OBX|1|SN|31147-2^Reagin Ab [Titer] in Serum by RPR^LN^2059^Syphilis RPR^L^2.40^v45||^1^:^4|{titer}^titer^UCUM^titer^titer^L^1.8.2|<1:1|H^Above High Normal^HL70078|||F|||20111105143000-0600|||||20111106100000-0600||||Arkansas Public Health laboratories^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^04D1044168|201 South Monroe^^Little Rock^AR^72205^^L


MSH|^~\&#|NIST^2.16.840.1.113883.3.72.5.20^ISO|NIST^2.16.840.1.113883.3.72.5.21^ISO|NIST^2.16.840.1.113883.3.72.5.22^ISO|NIST^2.16.840.1.113883.3.72.5.23^ISO|20120821140551-0500||ORU^R01^ORU_R01|NIST-ELR-006.03|T|2.5.1|||NE|NE|||||PHLabReport-NoAck^HL7^2.16.840.1.113883.9.11^ISO
SFT|NIST Lab, Inc.^L^^^^NIST&2.16.840.1.113883.3.987.1&ISO^XX^^^123544|3.6.23|A-1 Lab System|6742873-12||20100617
PID|1||PATID139948312^^^&2.16.840.1.113883.3.72.5.310.4&ISO^MR||Hogg^Jimbo^Skeeter^^^^L||19870215|M||2106-3^White^CDCREC^W^White^L|4292 Tram Road^^Tallahassee^FL^32311^USA^H||^PRN^PH^^^850^2455309~^ORN^CP^^^850^4561125|||||||||N^Not Hispanic or Latino^HL70189^NL^Not latino^L^2.5.1
ORC|RE|ord12-0987066712^^2.16.840.1.113883.3.72.5.310.4^ISO|ord12-90879958-9851^Tallahasse MHL^2.16.840.1.114222.4.1.928.3^ISO|||||||||1412941681^Seminole^Bobby^^^^^^NPI&2.16.840.1.113883.4.6&ISO^U^^^NPI^^^^^^^^DO||^WPN^PH^^^850^2341888|||||||Tallahassee Family Medical^^^^^NPI&2.16.840.1.113883.4.6&ISO^NPI^^^1376647230|555 Tennessee Ave^^Tallahassee^FL^23212^^L|^WPN^PH^^^850^2348050|510 Tennessee Ave^Suite 230^Tallahassee^FL^23212^^B
OBR|1|ord12-0987066712^^2.16.840.1.113883.3.72.5.310.4^ISO|ord12-90879958-9851^Tallahasse MHL^2.16.840.1.114222.4.1.928.3^ISO|33331-0^West Nile virus IgM Ab [Titer] in Serum^LN^1522^West Nile virus AB IgM, ELISA, Serum^L^2.40|||20120801|||||||||1412941681^Seminole^Bobby^^^^^^NPI&2.16.840.1.113883.4.6&ISO^U^^^NPI^^^^^^^^DO|^WPN^PH^^^850^2341888|||||20120802111345-0500|||F
OBX|1|SN|33331-0^West Nile virus IgM Ab [Titer] in Serum^LN^1522^West Nile virus AB IgM, ELISA, Serum^L^2.40||^1^:^32|{titer}^titer^UCUM^titer^titer^L^1.8.2|<1:8|H^Above High Normal^HL70078^H^High^L^2.5.1|||F|||20120801|||||20120802||||Tallahasse Memorial Hospital^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^10D0270216|1300 Miccosukee Road^^Tallahassee^FL^32308^^L


MSH|^~\&#|NIST^2.16.840.1.113883.3.72.5.20^ISO|NIST^2.16.840.1.113883.3.72.5.21^ISO|NIST^2.16.840.1.113883.3.72.5.22^ISO|NIST^2.16.840.1.113883.3.72.5.23^ISO|20120821140551-0500||ORU^R01^ORU_R01|NIST-ELR-007.01|T|2.5.1|||NE|NE|||||PHLabReport-NoAck^HL7^2.16.840.1.113883.9.11^ISO
SFT|NIST Lab, Inc.^L^^^^NIST&2.16.840.1.113883.3.987.1&ISO^XX^^^123544|3.6.23|A-1 Lab System|6742873-12||20100617
PID|1||PATID1234^^^QOV_MPI&2.16.840.1.114222.4.10.3&ISO^PI^Queen of the Valley&2.16.840.1.114222.4.10.3&ISO||Lopez^Luiz^^^^^L||20081101|M||2106-3^WHITE^CDCREC^W^White^L|P.O. Box 42^^Oakville^CA^94582|||||||||||H^Hispanic or Latino^HL70189^L^Latino^L^2.5.1|||||||201207100423|Y
NK1|1||||||||||||Oakville Orphanage^L^^^^QOV_MPI&2.16.840.1.114222.4.10.3&ISO^XX^^^OID711|||||||||||||||||Ramos^Hector^L^Jr^Fr^^L^^^^^^^D.D.|^WPN^PH^^01^707^3637740^71^call between 8 and 5 PST|P.O. Box 42^Suite 71^Oakville^CA^94582^USA^M^^06055
ORC|RE|O12-897451-23^^2.16.840.1.114222.4.10.3^ISO|T098145-2012-jul^^2.16.840.1.114222.4.45.76.2^ISO|||||||||987654312^Artze^Johanna^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^MD||^WPN^PH^^^707^2643378|||||||Queen of the Valley Hospital|1000 Trancas Street^^Napa^CA^94558|^WPN^PH^^^707^2524411|115 Trancas Street^^Napa^CA^94558
OBR|1|O12-897451-23^^2.16.840.1.114222.4.10.3^ISO|T098145-2012-jul^^2.16.840.1.114222.4.45.76.2^ISO|23826-1^Bordetella pertussis DNA [Presence] in Unspecified specimen by Probe and target amplification method^LN^BPRP^Bordetella pertussis PCR^L^2.40|||20120710|||||||||987654312^Artze^Johanna^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^MD|^WPN^PH^^^707^2643378|||||201207120800-0800|||F
OBX|1|CWE|23826-1^Bordetella pertussis DNA [Presence] in Unspecified specimen by Probe and target amplification method^LN^BPRP^Bordetella pertussis PCR^L^2.40||10828004^Positive (qualifier value)^SCT^BPPOS^Positive^L^20120131^^Positive||||||F|||20120710|||||201207110800||||Queen of the Valley Hospital Clinical Laboratory^L^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^05D0599855|1000 Trancas Street^^Napa^CA^94558^^B
NTE|1|L|This test was validated and its performance measures were determined to meet all local and federal requirements.|RE^Remark^HL70364^^^^2.5.1


MSH|^~\&#|NIST^2.16.840.1.113883.3.72.5.20^ISO|NIST^2.16.840.1.113883.3.72.5.21^ISO|NIST^2.16.840.1.113883.3.72.5.22^ISO|NIST^2.16.840.1.113883.3.72.5.23^ISO|20120821140551-0500||ORU^R01^ORU_R01|NIST-ELR-007.02|T|2.5.1|||NE|NE|||||PHLabReport-NoAck^HL7^2.16.840.1.113883.9.11^ISO
SFT|NIST Lab, Inc.^L^^^^NIST&2.16.840.1.113883.3.987.1&ISO^XX^^^123544|3.6.23|A-1 Lab System|6742873-12||20100617
PID|1||NJ2012-08556^^^ECMH&2.16.840.1.114222.4.16.37&ISO^PI||Nguyen^Jessie^^^^^L||19161016|F||2028-9^Asian^CDCREC^A^Asian^L|1563 Bloomquist Way^^El Campo^TX^77437||^PRN^PH^^^979^5435475|||||||||N^Not Hispanic or Latino^HL70189^NL^Not latino^L|||||||201208081415|Y
NK1|1||||||||||||Wharton County Nursing Home^L^^^^ECMH&2.16.840.1.114222.4.16.37&ISO^XX^^^OID721|||||||||||||||||Jameson^Jana^J^II^DR^^L^^^^^^^PHD|^WPN^PH^^01^979^2341115^72^call between 8 and 5 CST|1563 Bloomquist Way^Suite 72^El Campo^TX^77437^USA^L^^48481
ORC|RE|TR09820981-2012^^2.16.840.1.114222.4.16.37^ISO|ELML2012-09567889132^^2.16.840.1.114222.4.137.9^ISO|||||||||1417887211^Feelbetter^Joe^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^MD||^WPN^PH^^^979^5436244|||||||El Campo Memorial Hospital|303 Sandy Corner Rd^^El Campo^TX^77437|^WPN^PH^^^979^5436200|303 Sandy Corner Rd^^El Campo^TX^77437
OBR|1|TR09820981-2012^^2.16.840.1.114222.4.16.37^ISO|ELML2012-09567889132^^2.16.840.1.114222.4.137.9^ISO|40982-1^Influenza virus B RNA [Presence] in Unspecified specimen by Probe and target amplification method^LN^FBPCR^Flu B PCR^L^2.40|||20120808|||||||||1417887211^Feelbetter^Joe^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^MD|^WPN^PH^^^979^5436244|||||201208082151-0600|||F
OBX|1|CWE|40982-1^Influenza virus B RNA [Presence] in Unspecified specimen by Probe and target amplification method^LN^FBPCR^Flu B PCR^L^2.40||260373001^Detected^SCT^Det^detected^L^20120131^^detected||||||F|||20120808|||||201208082151||||El Campo Memorial Hospital Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^07D7217217|341 Sandy Corner Rd^^El Campo^TX^77437
NTE|1|L|This test was validated and its performance measures were determined to meet all local and federal requirements.|RE^Remark^HL70364^^^^2.5.1


MSH|^~\&#|NIST^2.16.840.1.113883.3.72.5.20^ISO|NIST^2.16.840.1.113883.3.72.5.21^ISO|NIST^2.16.840.1.113883.3.72.5.22^ISO|NIST^2.16.840.1.113883.3.72.5.23^ISO|20120821140551-0500||ORU^R01^ORU_R01|NIST-ELR-007.04|T|2.5.1|||NE|NE|||||PHLabReport-NoAck^HL7^2.16.840.1.113883.9.11^ISO
SFT|NIST Lab, Inc.^L^^^^NIST&2.16.840.1.113883.3.987.1&ISO^XX^^^123544|3.6.23|A-1 Lab System|6742873-12||20100617
PID|1||PATID5678^^^VanderU&2.16.840.1.114222.4.50.12.4&ISO^MR||Lung^Neil^^^^^L||19480802|M||2028-9^Asian^CDCREC^A^Asian^L|550 8th Avenue South^Apt 10^Goodlettsville^TN^34209||^PRN^PH^^^615^5558585|||||||||N^Not Hispanic or Latino^HL70189^NTL^Not Latino^L|||||||201203162130|Y
NK1|1||||||||||||Charles B. Bass Correctional Complex^L^^^^VanderU&2.16.840.1.114222.4.50.12.4&ISO^XX^^^OID721|||||||||||||||||Miller^J^R^III^DR^^L^^^^^^^PHD|^WPN^PH^^01^615^3503361^73^call between 8 and 5 CST|7177 Cockrill Bend Boulevard^Suite 73^Nashville^TN^37243-0470^USA^B^^47037
ORC|RE|Ord2012-568798-1^^2.16.840.1.114222.4.50.12.4^ISO|VUL2012-0987631^^2.16.840.1.114222.4.90.76^ISO|||||||||455701^One^T^B^^Dr.^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI||^WPN^PH^^^555^7771234^123|||||||Vandermeer University Medical Center|Vandermeer Drive^^Nashville^TN^37211|^WPN^PH^^^555^7771234^123|Vandermeer Drive^^Nashville^TN^37211
OBR|1|Ord2012-568798-1^^2.16.840.1.114222.4.50.12.4^ISO|VUL2012-0987631^^2.16.840.1.114222.4.90.76^ISO|48174-7^Mycobacterium tuberculosis complex rRNA [Presence] in Unspecified specimen by Probe and target amplification method^LN^MTBN^MTB complex NAAT^L^2.40|||20120316|||||||||455701^One^T^B^^Dr.^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI|^WPN^PH^^^555^7771234^123|||||201203170930-0600|||F
OBX|1|CWE|48174-7^Mycobacterium tuberculosis complex rRNA [Presence] in Unspecified specimen by Probe and target amplification method^LN^MTBN^MTB complex NAAT^L^2.40||11214006^Reactive (qualifier value)^SCT^REACT^Reactive^L^20120131^^Reactive||||||F|||20120316|||||20120317||||Vandermeer University Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^07D7317317|2 Vandermeer Drive^^Nashville^TN^37211
NTE|1|L|Includes M. tuberculosis, M. bovis, M microti, M. africanumare|RE^Remark^HL70364^^^^2.5.1


MSH|^~\&#|NIST^2.16.840.1.113883.3.72.5.20^ISO|NIST^2.16.840.1.113883.3.72.5.21^ISO|NIST^2.16.840.1.113883.3.72.5.22^ISO|NIST^2.16.840.1.113883.3.72.5.23^ISO|20120821140551-0500||ORU^R01^ORU_R01|NIST-ELR-008.01|T|2.5.1|||NE|NE|||||PHLabReport-NoAck^HL7^2.16.840.1.113883.9.11^ISO
SFT|NIST Lab, Inc.^L^^^^NIST&2.16.840.1.113883.3.987.1&ISO^XX^^^123544|3.6.23|A-1 Lab System|6742873-12||20100617
PID|1||WILJ2012-979952^^^Sunnyside&2.16.840.1.113883.48.73&ISO^PI||Jones^William^T^^^^L||19930619|M||2054-5^Black or African American^CDCREC^B^Black or African American^L|1156 Ash Streeet^^Houston^TX^77501^^H||^PRN^CP^^^713^5555555|||||||||N^Not Hispanic or Latino^HL70189
ORC|RE|Ord89017782^Sunnyside^2.16.840.1.113883.48.73^ISO|201207-58080-1^HDHHS Bureau of Lab^2.16.840.1.114222.4.1.9951^ISO|||||||||412941681^Davis^Daniel^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^MD||^WPN^PH^^^713^7325000^113|||||||Sunnyside Health Center|9314 Cullen^^Houston^TX^77501^^L|^WPN^PH^^^713^7325000|9314 Cullen^^Houston^TX^77501^^O
OBR|1|Ord89017782^Sunnyside^2.16.840.1.113883.48.73^ISO|201207-58080-1^HDHHS Bureau of Lab^2.16.840.1.114222.4.1.9951^ISO|64017-7^Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel in Unspecified specimen by Probe and target amplification method^LN^2332^APTIMA GC/CT Panel^L^2.40|||20120731140000|||||||||412941681^Davis^Daniel^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^MD|^WPN^PH^^^713^7325000^113|||||201208021000-0600|||F
OBX|1|CWE|43305-2^Neisseria gonorrhoeae rRNA [Presence] in Unspecified specimen by Probe and target amplification method^LN^2334^APTIMA GC^L^2.40||10828004^Positive (qualifier value)^SCT^POS^Positive^L^07/31/2012^^Positive||||||F|||20120731140000|||||201208021000||||HDHHS Bureau of Laboratory Services^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^45D1086886|1115 S. Braeswood Blvd.^^Houston^TX^77030^USA^O
OBX|2|CWE|43304-5^Chlamydia trachomatis rRNA [Presence] in Unspecified specimen by Probe and target amplification method^LN^2336^APTIMA CT^L^2.40||10828004^Positive (qualifier value)^SCT^POS^Positive^L^07/31/2012^^Positive||||||F|||20120731140000|||||201208021000||||HDHHS Bureau of Laboratory Services^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^45D1086886|1115 S. Braeswood Blvd.^^Houston^TX^77030^USA^O


MSH|^~\&#|NIST^2.16.840.1.113883.3.72.5.20^ISO|NIST^2.16.840.1.113883.3.72.5.21^ISO|NIST^2.16.840.1.113883.3.72.5.22^ISO|NIST^2.16.840.1.113883.3.72.5.23^ISO|20120821140551-0500||ORU^R01^ORU_R01|NIST-ELR-008.02|T|2.5.1|||NE|NE|||||PHLabReport-NoAck^HL7^2.16.840.1.113883.9.11^ISO
SFT|NIST Lab, Inc.^L^^^^NIST&2.16.840.1.113883.3.987.1&ISO^XX^^^123544|3.6.23|A-1 Lab System|6742873-12||20100617
PID|1||P2008-706781-2^^^El Campo MH&2.16.840.1.113883.87.1.73&ISO^PI||Yee^Sue^^^^^L||19161019|F||2028-9^Asian^CDCREC^A^Asian^L|116 Elderberry Way^^El Campo^TX^77437^^H||^PRN^PH^^^979^5435555|||||||||N^Not Hispanic or Latino^HL70189
ORC|RE|O2012-8711-12^El Campo MH^2.16.840.1.113883.87.1.73^ISO|T2012-8975098711^El Campo MH Lab^2.16.840.1.114222.4.6.1232^ISO|||||||||1412948211^Jones^Micheala^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^MD||^WPN^PH^^^979^5436244|||||||El Campo Memorial Hospital|303 Sandy Corner Rd^^El Campo^TX^77437^^L|^WPN^PH^^^797^5436244|303 Sandy Corner Rd^^El Campo^TX^77437^^O
OBR|1|O2012-8711-12^El Campo MH^2.16.840.1.113883.87.1.73^ISO|T2012-8975098711^El Campo MH Lab^2.16.840.1.114222.4.6.1232^ISO|60566-7^Respiratory virus DNA and RNA 12 panel in Unspecified specimen by Probe and target amplification method^LN^2007^Luminex Multiplex Respiratory Virus PCR^L^2.40|||20120108-0600|||||||||1412948211^Jones^Micheala^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^MD|^WPN^PH^^^979^5436244|||||20120108215100-0600|||F
OBX|1|CWE|39528-5^Adenovirus DNA [Presence] in Unspecified specimen by Probe and target^LN^Adenovirus (NAT)^Adenovirus (NAT)^L^2.40||260415000^Not detected (qualifier value)^SCT^Not Detected^Not Detected^L^07/31/2012^^Not Detected||||||F|||20120108-0600|||||20120108215100-0600||||El Campo Memorial Hospital Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^08D8218218|341 Sandy Corner Rd^^El Campo^TX^77437
OBX|2|CWE|34487-9^Influenza virus A RNA [Presence] in Unspecified specimen by Probe and target^LN^Influenza A (NAT)^Influenza A (NAT)^L^2.40||260415000^Not detected (qualifier value)^SCT^Not Detected^Not Detected^L^07/31/2012^^Not Detected||||||F|||20120108-0600|||||20120108215100-0600||||El Campo Memorial Hospital Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^08D8218218|341 Sandy Corner Rd^^El Campo^TX^77437
OBX|3|CWE|49521-8^Influenza virus A H1 RNA [Presence] in Unspecified specimen by Probe and target amplification method^LN^Influenza A/H1 (NAT)^Influenza A/H1 (NAT)^L^2.40||260415000^Not detected (qualifier value)^SCT^Not Detected^Not Detected^L^07/31/2012^^Not Detected||||||F|||20120108-0600|||||20120108215100-0600||||El Campo Memorial Hospital Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^08D8218218|341 Sandy Corner Rd^^El Campo^TX^77437
OBX|4|CWE|49524-2^Influenza virus A H3 RNA [Presence] in Unspecified specimen by Probe and target amplification method^LN^Influenza A/H3 (NAT)^Influenza A/H3 (NAT)^L^2.40||260415000^Not detected (qualifier value)^SCT^Not Detected^Not Detected^L^07/31/2012^^Not Detected||||||F|||20120108-0600|||||20120108215100-0600||||El Campo Memorial Hospital Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^08D8218218|341 Sandy Corner Rd^^El Campo^TX^77437
OBX|5|CWE|40982-1^Influenza virus B RNA [Presence] in Unspecified specimen by Probe and target amplification method^LN^Influenza B (NAT)^Influenza B (NAT)^L^2.40||260415000^Not detected (qualifier value)^SCT^Not Detected^Not Detected^L^07/31/2012^^Not Detected||||||F|||20120108-0600|||||20120108215100-0600||||El Campo Memorial Hospital Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^08D8218218|341 Sandy Corner Rd^^El Campo^TX^77437
OBX|6|CWE|29908-1^Parainfluenza virus 1 RNA [Presence] in Unspecified specimen by Probe and target amplification method^LN^Para 1 (NAT)^Para Influenza Virus 1 (NAT)^L^2.40||260415000^Not detected (qualifier value)^SCT^Not Detected^Not Detected^L^07/31/2012^^Not Detected||||||F|||20120108-0600|||||20120108215100-0600||||El Campo Memorial Hospital Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^08D8218218|341 Sandy Corner Rd^^El Campo^TX^77437
OBX|7|CWE|29909-9^Parainfluenza virus 2 RNA [Presence] in Unspecified specimen by Probe and target amplification method^LN^Para 2 (NAT)^Para Influenza Virus 2 (NAT)^L^2.40||260415000^Not detected (qualifier value)^SCT^Not Detected^Not Detected^L^07/31/2012^^Not Detected||||||F|||20120108-0600|||||20120108215100-0600||||El Campo Memorial Hospital Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^08D8218218|341 Sandy Corner Rd^^El Campo^TX^77437
OBX|8|CWE|29910-7^Parainfluenza virus 3 RNA [Presence] in Unspecified specimen by Probe and target amplification method^LN^Para 3 (NAT)^Para Influenza Virus 3 (NAT)^L^2.40||260415000^Not detected (qualifier value)^SCT^Not Detected^Not Detected^L^07/31/2012^^Not Detected||||||F|||20120108-0600|||||20120108215100-0600||||El Campo Memorial Hospital Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^08D8218218|341 Sandy Corner Rd^^El Campo^TX^77437
OBX|9|CWE|30075-6^Respiratory syncytial virus A RNA [Presence] in Unspecified specimen by Probe and target amplification method^LN^RSV A (NAT)^RSV A (NAT)^L^2.40||260415000^Not detected (qualifier value)^SCT^Not Detected^Not Detected^L^07/31/2012^^Not Detected||||||F|||20120108-0600|||||20120108215100-0600||||El Campo Memorial Hospital Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^08D8218218|341 Sandy Corner Rd^^El Campo^TX^77437
OBX|10|CWE|30076-4^Respiratory syncytial virus B RNA [Presence] in Unspecified specimen by Probe and target amplification method^LN^RSV B (NAT)^RSV B (NAT)^L^2.40||260373001^Detected (qualifier value)^SCT^Detected^Detected^L^07/31/2012^^Detected||||||F|||20120108-0600|||||20120108215100-0600||||El Campo Memorial Hospital Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^08D8218218|341 Sandy Corner Rd^^El Campo^TX^77437
OBX|11|CWE|7993-9^Rhinovirus RNA [Presence] in Unspecified specimen by Probe and target amplification method^LN^RhinoVirus (NAT)^RhinoVirus (NAT)^L^2.40||260415000^Not detected (qualifier value)^SCT^Not Detected^Not Detected^L^07/31/2012^^Not Detected||||||F|||20120108-0600|||||20120108215100-0600||||El Campo Memorial Hospital Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^08D8218218|341 Sandy Corner Rd^^El Campo^TX^77437
OBX|12|CWE|38917-1^Human metapneumovirus RNA [Presence] in Unspecified specimen by Probe and target amplification method^LN^Metapneumo (NAT)^Metapneumovirus (NAT)^L^2.40||260415000^Not detected (qualifier value)^SCT^Not Detected^Not Detected^L^07/31/2012^^Not Detected||||||F|||20120108-0600|||||201201082151-0600||||El Campo Memorial Hospital Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^08D8218218|341 Sandy Corner Rd^^El Campo^TX^77437


MSH|^~\&#|NIST^2.16.840.1.113883.3.72.5.20^ISO|NIST^2.16.840.1.113883.3.72.5.21^ISO|NIST^2.16.840.1.113883.3.72.5.22^ISO|NIST^2.16.840.1.113883.3.72.5.23^ISO|20120821140551-0500||ORU^R01^ORU_R01|NIST-ELR-008.03|T|2.5.1|||NE|NE|||||PHLabReport-NoAck^HL7^2.16.840.1.113883.9.11^ISO
SFT|NIST Lab, Inc.^L^^^^NIST&2.16.840.1.113883.3.987.1&ISO^XX^^^123544|3.6.23|A-1 Lab System|6742873-12||20100617
PID|1||MJ200978990544^^^&2.16.840.1.113883.475.45.3&ISO^MR||Montoro^Jovelyn^^^^^L||19920923|F||2028-9^Asian^CDCREC^A^Asian^L|115 Springs Street^Apt 30^Vallejo^CA^94591^^H||^PRN^CP^^^707^2908343|||||||||N^Not Hispanic or Latino^HL70189
ORC|RE|TPMG097865^^2.16.840.1.113883.475.45.3^ISO|20120631-078^TPMG^2.16.840.1.114222.4.78.23.1^ISO|||||||||1225292253^Huang^Karen^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^MD||^WPN^PH^^^510^4901222|||||||Kaiser Permanente Vallejo Medical Center|975 Sereno Drive^^Vallejo^CA^94589^^L|^WPN^PH^^^707^6511000|3200 KEARNEY STREET^^Fremont^CA^94538^^O
OBR|1|TPMG097865^^2.16.840.1.113883.475.45.3^ISO|20120631-078^TPMG^2.16.840.1.114222.4.78.23.1^ISO|46197-0^Measles virus Ab [Presence] in Serum^LN^ROP^Rubeola (Measles) Antibodies, IgG and IgM (Separate Determinations), Serum^L^2.40|||20120630114000-0800|||||||||1225292253^Huang^Karen^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^MD|^WPN^PH^^^510^4901222|||||20120630210400-0800|||F
OBX|1|CWE|20479-2^Measles virus IgG Ab [Presence] in Serum^LN^ROG^Rubeola (Measles) Ab, IgG, S^L^2.40||10828004^Positive (qualifier value)^SCT^POS^Positive^L^07/31/2012^^Positive||||||F|||20120630114000-0800|||||20120630210400-0800||||TPMG Regional Laboratory^L^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^45D1086886|Marina Way South Campus^914 Marina Way South^Richmond^CA^94804^USA^L
OBX|2|CWE|21503-8^Measles virus IgM Ab [Presence] in Serum^LN^ROM^Rubeola (Measles) Ab, IgM, S^L^2.40||10828004^Positive (qualifier value)^SCT^POS^Positive^L^07/31/2012^^Positive||||||F|||20120630114000-0800|||||20120630210400-0800||||TPMG Regional Laboratory^L^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^45D1086886|Marina Way South Campus^914 Marina Way South^Richmond^CA^94804^USA^L


MSH|^~\&#|NIST^2.16.840.1.113883.3.72.5.20^ISO|NIST^2.16.840.1.113883.3.72.5.21^ISO|NIST^2.16.840.1.113883.3.72.5.22^ISO|NIST^2.16.840.1.113883.3.72.5.23^ISO|20120821140551-0500||ORU^R01^ORU_R01|NIST-ELR-009.01|T|2.5.1|||NE|NE|||||PHLabReport-NoAck^HL7^2.16.840.1.113883.9.11^ISO
SFT|NIST Lab, Inc.^L^^^^NIST&2.16.840.1.113883.3.987.1&ISO^XX^^^123544|3.6.23|A-1 Lab System|6742873-12||20100617
PID|1||ShuA20120618-1^^^Valley Hospital&2.16.840.1.113883.58.99&ISO^PI||Shultz^Anna^A^Jr^DR^^L^^^^^^^PhD||19461115|F||2106-3^White^CDCREC^w^White^L|P.O. Box 5342^^Rancho Cordova^CA^95607||^PRN^CP^^^916^8387740|||||||||N^Not Hispanic or Latino^HL70189^NH^Not Hispanic or Latino^L
ORC|RE|Ord123499^^2.16.840.1.113883.58.99^ISO|VC2012061801^^2.16.840.1.113883.43.19^ISO|||||||||455678^Lam^Manuel^^^Dr.^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI||^WPN^CP^^^916^8384747|||||||Valley Hospital|2521 Stockton Blvd^^Sacramento^CA^95817|^WPN^PH^^^916^2524411|4150 V Street^^Sacramento^CA^95817
OBR|1|Ord123499^^2.16.840.1.113883.58.99^ISO|VC2012061801^^2.16.840.1.113883.43.19^ISO|6463-4^Bacteria identified in Unspecified specimen by Culture^LN^TCX^Throat Culture^L^2.40|||20120618|||||||||455678^Lam^Manuel^^^Dr.^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI|^WPN^CP^^^916^8384747|||||201206211015-0800|||F
OBX|1|CWE|6463-4^Bacteria identified in Unspecified specimen by Culture^LN^TCX^Throat Culture^L^2.40||5851001^Corynebacterium diphtheriae^SCT^^^^^^Corynebacterium diphtheriae isolated||||||F|||20120618|||||201206211015-0800||||Valley Hospital^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^09D9119119|2521 Stockton Blvd^^Sacramento^CA^95817
NTE|1|L|An isolate cultured from this specimen has been submitted to the local Public Health Laboratory.|RE^Remark^HL70364^^^^2.5.1


MSH|^~\&#|NIST^2.16.840.1.113883.3.72.5.20^ISO|NIST^2.16.840.1.113883.3.72.5.21^ISO|NIST^2.16.840.1.113883.3.72.5.22^ISO|NIST^2.16.840.1.113883.3.72.5.23^ISO|20120821140551-0500||ORU^R01^ORU_R01|NIST-ELR-009.02|T|2.5.1|||NE|NE|||||PHLabReport-NoAck^HL7^2.16.840.1.113883.9.11^ISO
SFT|NIST Lab, Inc.^L^^^^NIST&2.16.840.1.113883.3.987.1&ISO^XX^^^123544|3.6.23|A-1 Lab System|6742873-12||20100617
PID|1||BB20120315-351^^^&2.16.840.1.113883.69.3.4&ISO^MR||Bird^Barry^A^III^DR^^L^^^^^^^DVM||19881031|M||2106-3^White^CDCREC^wh^White^L|550 8th Avenue South^Apt 10^Petersburg^VA^23801^^^^51149||^PRN^CP^^^804^5558585|||||||||N^Not Hispanic or Latino^HL70189^NH^Not Hispanic or Latino^L
ORC|RE|Ord68034987^^2.16.840.1.113883.69.3.4^ISO|MBC20120315091^^2.16.840.1.113883.46.169^ISO|||||||||455701^One^T^B^^Dr.^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI||^WPN^PH^^^804^7771234^123|||||||Vandermeer University Medical Center|Vandermeer Drive^^Petersburg^VA^23801|^WPN^PH^^^804^7771234|Vandermeer Drive^^Petersburg^VA^23801
OBR|1|Ord68034987^^2.16.840.1.113883.69.3.4^ISO|MBC20120315091^^2.16.840.1.113883.46.169^ISO|543-9^Mycobacterium sp identified in Unspecified specimen by Organism specific culture^LN^AFBC^AFB Culture^L^2.40|||20120315|||||||||455701^One^T^B^^Dr.^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI|^WPN^PH^^^804^7771234^123|||||201204221630-0700|||F
OBX|1|CWE|543-9^Mycobacterium sp identified in Unspecified specimen by Organism specific culture^LN^AFBC^AFB Culture^L^2.40||83723009^Mycobacterium avium^SCT^Mycobacterium avium^Mycobacterium avium^L^07/31/2012^^Mycobacterium avium||||||F|||20120315|||||20120422||||Vandermeer University Laboratory^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^09D9219219|2 Vandermeer Drive^^Petersburg^VA^23801
NTE|1|L|An isolate cultured from this specimen has been submitted to the local Public Health Laboratory.|RE^Remark^HL70364^^^^2.5.1


MSH|^~\&#|NIST^2.16.840.1.113883.3.72.5.20^ISO|NIST^2.16.840.1.113883.3.72.5.21^ISO|NIST^2.16.840.1.113883.3.72.5.22^ISO|NIST^2.16.840.1.113883.3.72.5.23^ISO|20120821140551-0500||ORU^R01^ORU_R01|NIST-ELR-009.03|T|2.5.1|||NE|NE|||||PHLabReport-NoAck^HL7^2.16.840.1.113883.9.11^ISO
SFT|NIST Lab, Inc.^L^^^^NIST&2.16.840.1.113883.3.987.1&ISO^XX^^^123544|3.6.23|A-1 Lab System|6742873-12||20100617
PID|1||NECS2012080-2^^^&2.16.840.1.113883.65.4.678&ISO^MR||Neck^Steve^L^Sr^DR^^L^^^^^^^DDS||19630626|M||2106-3^White^CDCREC^cauc^Caucasian^L|1125 Third Ave^^San Diego^CA^92037^USA^H||^PRN^PH^^^858^6551025|||||||||N^Not Hispanic or Latino^HL70189^NL^Not latino^L
ORC|RE|Ord12389600762^^2.16.840.1.113883.65.4.678^ISO|MI201208080918^^2.16.840.1.113883.56.913^ISO|||||||||^Bansai^Vishai^^^^^^^^^^^^^^^^^^MD||^WPN^PH^^^858^2225555|||||||UC San Diego Medical Center (Hillcrest)|200 West Arbor Dr.^^San Diego^CA^92103|^WPN^PH^^1^619^5436222|Perlman Medical Office^9350 Campus Point Drive^La Jolla^CA^92037^^O
OBR|1|Ord12389600762^^2.16.840.1.113883.65.4.678^ISO|MI201208080918^^2.16.840.1.113883.56.913^ISO|11475-1^Microorganism identified in Unspecified specimen by Culture^LN^CXCSF^Cerebrospinal Fluid (CSF) Culture^L^2.40|||201208081500-0800|||||||||^Bansai^Vishai^^^^^^^^^^^^^^^^^^MD|^WPN^PH^^^858^2225555|||||201208101330-0800|||F
OBX|1|CWE|11475-1^Microorganism identified in Unspecified specimen by Culture^LN^CXCSF^Cerebrospinal Fluid (CSF) Culture^L^2.40||17872004^Neisseria meningitidis^SCT^Neisseria meningitid^Neisseria meningitidis^L^07/31/2012^^Neisseria meningitidis||||||F|||201208081500-0800|||||201208101330-0800||||UCSD CLINICAL LABORATORIES - HILLCREST^^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^05D0643085|200 West Arbor Dr.^^San Diego^CA^92103^USA^L
NTE|1|L|An isolate cultured from this specimen has been submitted to the local Public Health Laboratory.|RE^Remark^HL70364^^^^2.5.1


MSH|^~\&|Test EHR Application|X68||NIST Test Iz Reg|201207010822||VXU^V04^VXU_V04|NIST-IZ-001.00|P|2.5.1|||AL|ER
PID|1||D26376273^^^NIST MPI^MR||Snow^Madelynn^Ainsley^^^^L|Lam^Morgan|20070706|F||2076-8^Native Hawaiian or Other Pacific Islander^CDCREC|32 Prescott Street Ave^^Warwick^MA^02452^USA^L||^PRN^PH^^^657^5558563|||||||||2186-5^non Hispanic or Latino^CDCREC
PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20120701|20120701
NK1|1|Lam^Morgan^^^^^L|MTH^Mother^HL70063|32 Prescott Street Ave^^Warwick^MA^02452^USA^L|^PRN^PH^^^657^5558563
ORC|RE||IZ-783274^NDA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L
RXA|0|1|20120814||140^Influenza, seasonal, injectable, preservative free^CVX|0.5|mL^MilliLiter [SI Volume Units]^UCUM||00^New immunization record^NIP001|7832-1^Lemon^Mike^A^^^^^NIST-AA-1|^^^X68||||Z0860BB|20121104|CSL^CSL Behring^MVX|||CP|A
RXR|C28161^Intramuscular^NCIT|LD^Left Arm^HL70163
OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20120701|||VXC40^Eligibility captured at the immunization level^CDCPHINVS
OBX|2|CE|30956-7^vaccine type^LN|2|88^Influenza, unspecified formulation^CVX||||||F
OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F
OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120814||||||F


MSH|^~\&|Test EHR Application|X68||NIST Test Iz Reg|201207010822||VXU^V04^VXU_V04|NIST-IZ-002.00|P|2.5.1|||AL|ER
PID|1||D26376281^^^NIST MPI^MR||Marsh^Tierney^Beacher^^^^L|Lucas^Morgan|20100814|M||2076-8^Native Hawaiian or Other Pacific Islander^HL70005|10 Huntington Rd^^Brockton^MA^16080^USA^L||^PRN^PH^^^379^5559369|||||||||2186-5^non Hispanic or Latino^CDCREC
PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20120701|20120701
NK1|1|Lucas^Morgan^^^^^L|MTH^Mother^HL70063|32 Prescott Street Ave^^Warwick^MA^02452^USA^L|^PRN^PH^^^657^5558563
ORC|RE||IZ-783274^NDA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L
RXA|0|1|20120815||140^Influenza^CVX|0.25|mL^MilliLiter [SI Volume Units]^UCUM||00^New immunization record^NIP001|7832-1^Lemon^Mike^A^^^^^NIST-AA-1|^^^B31||||Y9789ZR|20121215|PMC^sanofi pasteur^MVX|||CP|A
RXR|C28161^Intramuscular^NCIT|RA^Right Arm^HL70163
OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20120701|||VXC40^Eligibility captured at the immunization level^CDCPHINVS
OBX|2|CE|30956-7^vaccine type^LN|2|88^Influenza, unspecified formulation^CVX||||||F
OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F
OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120814||||||F


MSH|^~\&|Test EHR Application|X68||NIST Test Iz Reg|201207010822||VXU^V04^VXU_V04|NIST-IZ-003.00|P|2.5.1|||AL|ER
PID|1||D26376301^^^MAA^MR||Deschutes^Brooklyn^Dolly^^^^L|Dewey^Dona|20100826|F||2076-8^Native Hawaiian or Other Pacific Islander^HL70005|902 Pacific St^^Orleans^MA^20540^USA^L||^PRN^PH^^^790^5553151|||||||||2186-5^non Hispanic or Latino^CDCREC
PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20120701|20120701
NK1|1|Dewey^Dona^^^^^L|MTH^Mother^HL70063|32 Prescott Street Ave^^Warwick^MA^02452^USA^L|^PRN^PH^^^657^5558563
ORC|RE||IZ-783274^NDA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L
RXA|0|1|20120816||140^Influenza^CVX|0.25|mL^MilliLiter [SI Volume Units]^UCUM||00^New immunization record^NIP001|7832-1^Lemon^Mike^A^^^^^NIST-AA-1|^^^B31||||J6702KP|20121216|PMC^sanofi pasteur^MVX|||CP|A
RXR|C28161^Intramuscular^NCIT|LA^Left Arm^HL70163
OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20120814|||VXC40^Eligibility captured at the immunization level^CDCPHINVS
OBX|2|CE|30956-7^vaccine type^LN|2|88^Influenza, unspecified formulation^CVX||||||F
OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F
OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120816||||||F


MSH|^~\&|Test EHR Application|X68||NIST Test Iz Reg|201207010822||VXU^V04^VXU_V04|NIST-IZ-004.00|P|2.5.1|||AL|ER
PID|1||MR-76732^^^NIST MPI^MR~184-36-9200^^^MAA^SS||Vally^Nitika^^^^^L||19410813|F|||||^~^NET^^nvally@fastmail.com
ORC|RE||IZ-783275^NDA|||||||||57422^RADON^NICHOLAS^^^^^^NDA^L
RXA|0|1|20120814||52^Hep A^CVX|1|mL^MilliLiter [SI Volume Units]^UCUM||00^New immunization record^NIP001||^^^F28||||I90FV|20121214|MSD^Merck and Co^MVX|||CP|A
RXR|C28161^Intramuscular^NCIT|RD^Right Arm^HL70163
OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20120814|||VXC40^Eligibility captured at the immunization level^CDCPHINVS
OBX|2|TS|29768-9^Date vaccine information statement published^LN|2|20111025||||||F
OBX|3|CE|30956-7^vaccine type^LN|2|85^Hepatitis A^CVX||||||F
OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120814||||||F


MSH|^~\&|Test EHR Application|X68||NIST Test Iz Reg|201207010822||VXU^V04^VXU_V04|NIST-IZ-005.00|P|2.5.1|||AL|ER
PID|1||MR-1789^^^MAA^MR~184-15-3421^^^MAA^SS||Cimarron^Ottoline^^^^^L||19410717|F|||||^~^NET^^Ottoline@hotmail.com
ORC|RE||IZ-783275^NDA|||||||||57422^RADON^NICHOLAS^^^^^^NDA^L
RXA|0|1|20120814||52^Hep A^CVX|1|mL^MilliLiter [SI Volume Units]^UCUM||00^New immunization record^NIP001||^^^F28||||I90FV|20121214|MSD^Merck and Co^MVX|||CP|A
RXR|C28161^Intramuscular^NCIT|RD^Right Arm^HL70163
OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20120814|||VXC40^Eligibility captured at the immunization level^CDCPHINVS
OBX|2|CE|30956-7^vaccine type^LN|2|85^Hepatitis A^CVX||||||F
OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20111025||||||F
OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120814||||||F


MSH|^~\&|Test EHR Application|X68||NIST Test Iz Reg|201207010822||VXU^V04^VXU_V04|NIST-IZ-006.00|P|2.5.1|||AL|ER
PID|1||MR-356^^^MAA^MR~184-25-4562^^^MAA^SS||Quinla^Eisig^^^^^L||19410714|M|||||^~^NET^^Eisig@hotmail.com
ORC|RE||IZ-783275^NDA|||||||||57422^RADON^NICHOLAS^^^^^^NDA^L
RXA|0|1|20120816||115^Tdap^CVX|0.5|mL^MilliLiter [SI Volume Units]^UCUM||00^New immunization record^NIP001||^^^0||||Z79YG|20121216|SKB^GlaxoSmithKline^MVX|||CP|A
RXR|C28161^Intramuscular^NCIT|RD^Right Arm^HL70163
OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20120814|||VXC40^Eligibility captured at the immunization level^CDCPHINVS
OBX|2|CE|30956-7^vaccine type^LN|2|139^Td(adult) unspecified formulation^CVX||||||F
OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20130509||||||F
OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120816||||||F


MSH|^~\&|Test EHR Application|X68||NIST Test Iz Reg|201207010822||VXU^V04^VXU_V04|NIST-IZ-007.00|P|2.5.1|||AL|ER
PID|1||MR-99922^^^NIST MPI^MR||Montgomery^Lewis^^^^^L||20010821|M
ORC|RE||IZ-783276^NDA
RXA|0|1|20110215||118^HPV^CVX|999|||01^Historical information - source unspecified^NIP001


MSH|^~\&|Test EHR Application|X68||NIST Test Iz Reg|201207010822||VXU^V04^VXU_V04|NIST-IZ-008.00|P|2.5.1|||AL|ER
PID|1||456^^^MAA^MR||Denton^Blakeley^^^^^L||20010824|M
ORC|RE||IZ-783276^NDA
RXA|0|1|20110214||115^Tdap^CVX|999|||01^Historical information - source unspecified^NIP001


MSH|^~\&|Test EHR Application|X68||NIST Test Iz Reg|201207010822||VXU^V04^VXU_V04|NIST-IZ-009.00|P|2.5.1|||AL|ER
PID|1||656^^^MAA^MR||Lubbock^Wyuna^^^^^L||20010831|F
ORC|RE||IZ-783276^NDA
RXA|0|1|20110215||83^Hep A^CVX|999|||01^Historical information - source unspecified^NIP001


MSH|^~\&|Test EHR Application|X68||NIST Test Iz Reg|201207010822||VXU^V04^VXU_V04|NIST-IZ-010.00|P|2.5.1|||AL|ER
PID|1||X-6523^^^NIST MPI^MR||Newton^Lea^^^^^L||20010905|F
PD1||||||||||||N|20120701
ORC|RE||IZ-783277^NDA
RXA|0|1|20110214||115^Tdap^CVX|999|||01^Historical information - source unspecified^NIP001


MSH|^~\&|Test EHR Application|X68||NIST Test Iz Reg|201207010822||VXU^V04^VXU_V04|NIST-IZ-011.00|P|2.5.1|||AL|ER
PID|1||5678^^^MAA^MR||Larsen^Hilzarie^^^^^L||20010823|F
PD1||||||||||||N|20120701
ORC|RE||IZ-783277^NDA
RXA|0|1|20110214||115^Tdap^CVX|999|||01^Historical information - source unspecified^NIP001


MSH|^~\&|Test EHR Application|X68||NIST Test Iz Reg|201207010822||VXU^V04^VXU_V04|NIST-IZ-012.00|P|2.5.1|||AL|ER
PID|1||45335^^^MAA^MR||Pierce^Rianna^^^^^L||20010813|F
PD1||||||||||||N|20120701
ORC|RE||IZ-783277^NDA
RXA|0|1|20110214||118^HPV^CVX|999|||01^Historical information - source unspecified^NIP001


MSH|^~\&|Test EHR Application|X68||NIST Test Iz Reg|201207010822||VXU^V04^VXU_V04|NIST-IZ-013.00|P|2.5.1|||AL|ER
PID|1||MR-67323^^^NIST MPI^MR||Fleming^Chad^^^^^L||20100830|M
ORC|RE||9999^CDC
RXA|0|1|20120815||03^MMR^CVX|999||||||||||||00^Parental Refusal^NIP002||RE


MSH|^~\&|Test EHR Application|X68||NIST Test Iz Reg|201207010822||VXU^V04^VXU_V04|NIST-IZ-014.00|P|2.5.1|||AL|ER
PID|1||24572457^^^MAA^MR||Santa Barbara^Naretha^^^^^L||20100831|F
ORC|RE||9999^CDC
RXA|0|1|20120815||03^MMR^CVX|999||||||||||||00^Parental Refusal^NIP002||RE


MSH|^~\&|Test EHR Application|X68||NIST Test Iz Reg|201207010822||VXU^V04^VXU_V04|NIST-IZ-015.00|P|2.5.1|||AL|ER
PID|1||23546138^^^MAA^MR||Jones^Braz^^^^^L||20100907|M
ORC|RE||9999^CDC
RXA|0|1|20120815||03^MMR^CVX|999||||||||||||00^Parental Refusal^NIP002||RE


MSH|^~\&|Test EHR Application|X68||NIST Test Iz Reg|201207010822||VXU^V04^VXU_V04|NIST-IZ-016.00|P|2.5.1|||AL|ER
PID|1||MR-11891^^^NIST MPI^MR||Wolfe^Aron^^^^^L||20010907|M
ORC|RE||9999^CDC
RXA|0|1|20110215||998^No vaccine administered^CVX|999||||||||||||||NA
OBX|1|CE|59784-9^Disease with presumed immunity^LN|1|38907003^Varicella infection^SCT||||||F


MSH|^~\&|Test EHR Application|X68||NIST Test Iz Reg|201207010822||VXU^V04^VXU_V04|NIST-IZ-017.00|P|2.5.1|||AL|ER
PID|1||MR-10791^^^NIST MPI^MR||Riverside^Jezebel^^^^^L||20110901|F
ORC|RE||9999^CDC
RXA|0|1|20120216||998^No vaccine administered^CVX|999||||||||||||||NA
OBX|1|CE|59784-9^Disease with presumed immunity^LN|1|38907003^Varicella infection^SCT||||||F


MSH|^~\&|Test EHR Application|X68||NIST Test Iz Reg|201207010822||VXU^V04^VXU_V04|NIST-IZ-018.00|P|2.5.1|||AL|ER
PID|1||MR-10581^^^NIST MPI^MR||Buckshorn^Ankita^^^^^L||20010829|F
ORC|RE||9999^CDC
RXA|0|1|20110215||998^No vaccine administered^CVX|999||||||||||||||NA
OBX|1|CE|59784-9^Disease with presumed immunity^LN|1|38907003^Varicella infection^SCT||||||F


MSH|^~\&|Test EHR Application|X68||NIST Test Iz Reg|201207010822||VXU^V04^VXU_V04|NIST-IZ-019.00|P|2.5.1|||AL|ER
PID|1||Q-73221^^^NIST MPI^MR||Mercer^Jirra^Emmanuelle^^^^L||20100907|F
ORC|RE||IZ-783278^NDA|||||||||57422^RADON^NICHOLAS^^^^^^NDA^L
RXA|0|1|20120816||141^Influenza^CVX|0.25|mL^MilliLiter [SI Volume Units]^UCUM||00^New immunization record^NIP001||||||K5094SC|20121216|PMC^sanofi pasteur^MVX|||CP|A
RXR|C28161^Intramuscular^NCIT|RA^Right Arm^HL70163
OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20120701|||VXC40^Eligibility captured at the immunization level^CDCPHINVS
OBX|2|CE|30956-7^vaccine type^LN|2|88^Influenza, unspecified formulation^CVX||||||F
OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F
OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120814||||||F
ORC|RE||IZ-783276^NDA
RXA|0|1|20110216||10^IPV^CVX|999|||01^Historical information - source unspecified^NIP001
ORC|RE||IZ-783282^NDA|||||||||57422^RADON^NICHOLAS^^^^^^NDA^L
RXA|0|1|20120816||120^DTaP-Hib-IPV^CVX|0.5|mL^MilliLiter [SI Volume Units]^UCUM||00^New immunization record^NIP001||||||568AHK11|20121216|PMC^sanofi pasteur^MVX|||CP|A
RXR|C28161^Intramuscular^NCIT|RA^Right Arm^HL70163
OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20120701|||VXC40^Eligibility captured at the immunization level^CDCPHINVS
OBX|2|CE|30956-7^vaccine type^LN|2|107^DTaP^CVX||||||F
OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20070517||||||F
OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120816||||||F
OBX|5|CE|30956-7^vaccine type^LN|3|89^Polio^CVX||||||F
OBX|6|TS|29768-9^Date vaccine information statement published^LN|3|20111108||||||F
OBX|7|TS|29769-7^Date vaccine information statement presented^LN|3|20120816||||||F
OBX|8|CE|30956-7^vaccine type^LN|4|17^Hib^CVX||||||F
OBX|9|TS|29768-9^Date vaccine information statement published^LN|4|19981216||||||F
OBX|10|TS|29769-7^Date vaccine information statement presented^LN|4|20120816||||||F


MSH|^~\&|Test EHR Application|X68||NIST Test Iz Reg|201207010822||VXU^V04^VXU_V04|NIST-IZ-020.00|P|2.5.1|||AL|ER
PID|1||262627^^^MAA^MR||Umatilla^Salima^Kailyn^^^^L||20100824|F
ORC|RE||IZ-783278^NDA|||||||||57422^RADON^NICHOLAS^^^^^^NDA^L
RXA|0|1|20120814||140^Influenza^CVX|0.25|mL^MilliLiter [SI Volume Units]^UCUM||00^New immunization record^NIP001||||||D6992FF|20121214|PMC^sanofi pasteur^MVX|||CP|A
RXR|C28161^Intramuscular^NCIT|RA^Right Arm^HL70163
OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20120701|||VXC40^Eligibility captured at the immunization level^CDCPHINVS
OBX|2|CE|30956-7^vaccine type^LN|2|88^Influenza, unspecified formulation^CVX||||||F
OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F
OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120814||||||F
ORC|RE||IZ-783276^NDA
RXA|0|1|20110214||20^DTaP^CVX|999|||01^Historical information - source unspecified^NIP001
ORC|RE||IZ-783282^NDA|||||||||57422^RADON^NICHOLAS^^^^^^NDA^L
RXA|0|1|20120814||120^DTaP-Hib-IPV^CVX|0.5|mL^MilliLiter [SI Volume Units]^UCUM||00^New immunization record^NIP001||||||568AHK11|20121214|PMC^sanofi pasteur^MVX|||CP|A
RXR|C28161^Intramuscular^NCIT|RA^Right Arm^HL70163
OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20120701|||VXC40^Eligibility captured at the immunization level^CDCPHINVS
OBX|2|CE|30956-7^vaccine type^LN|2|107^DTaP^CVX||||||F
OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20070517||||||F
OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120814||||||F
OBX|5|CE|30956-7^vaccine type^LN|3|89^Polio^CVX||||||F
OBX|6|TS|29768-9^Date vaccine information statement published^LN|3|20111108||||||F
OBX|7|TS|29769-7^Date vaccine information statement presented^LN|3|20120814||||||F
OBX|8|CE|30956-7^vaccine type^LN|4|17^Hib^CVX||||||F
OBX|9|TS|29768-9^Date vaccine information statement published^LN|4|19981216||||||F
OBX|10|TS|29769-7^Date vaccine information statement presented^LN|4|20120814||||||F


MSH|^~\&|Test EHR Application|X68||NIST Test Iz Reg|201207010822||VXU^V04^VXU_V04|NIST-IZ-020.00|P|2.5.1|||AL|ER
PID|1||252430^^^MAA^MR||Curry^Qiang^Trystan^^^^L||20090819|M
ORC|RE||IZ-783278^NDA|||||||||57422^RADON^NICHOLAS^^^^^^NDA^L
RXA|0|1|20120814||140^Influenza^CVX|0.5|mL^MilliLiter [SI Volume Units]^UCUM||00^New immunization record^NIP001||||||W1356FE|20121214|SKB^GlaxoSmithKline^MVX|||CP|A
RXR|C28161^Intramuscular^NCIT|RA^Right Arm^HL70163
OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20120701|||VXC40^Eligibility captured at the immunization level^CDCPHINVS
OBX|2|CE|30956-7^vaccine type^LN|2|88^Influenza, unspecified formulation^CVX||||||F
OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F
OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120814||||||F
ORC|RE||IZ-783276^NDA
RXA|0|1|20110214||133^PCV 13^CVX|999|||01^Historical information - source unspecified^NIP001
ORC|RE||IZ-783282^NDA|||||||||57422^RADON^NICHOLAS^^^^^^NDA^L
RXA|0|1|20120814||110^DTaP-Hep B-IPV^CVX|0.5|mL^MilliLiter [SI Volume Units]^UCUM||00^New immunization record^NIP001||||||78HH34I|20121214|SKB^GlaxoSmithKline^MVX|||CP|A
RXR|C28161^Intramuscular^NCIT|LA^Left Arm^HL70163
OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20120701|||VXC40^Eligibility captured at the immunization level^CDCPHINVS
OBX|2|CE|30956-7^vaccine type^LN|2|107^DTaP^CVX||||||F
OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20070517||||||F
OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120814||||||F
OBX|5|CE|30956-7^vaccine type^LN|3|89^Polio^CVX||||||F
OBX|6|TS|29768-9^Date vaccine information statement published^LN|3|20111108||||||F
OBX|7|TS|29769-7^Date vaccine information statement presented^LN|3|20120814||||||F
OBX|8|CE|30956-7^vaccine type^LN|4|45^Hep B, unspecified formulation^CVX||||||F
OBX|9|TS|29768-9^Date vaccine information statement published^LN|4|20120202||||||F
OBX|10|TS|29769-7^Date vaccine information statement presented^LN|4|20120814||||||F


MSH|^~\&#|NIST Test Lab APP^2.16.840.1.113883.3.72.5.20^ISO|NIST Lab Facility^2.16.840.1.113883.3.72.5.21^ISO||NIST EHR Facility^2.16.840.1.113883.3.72.5.23^ISO|20110531140551-0500||ORU^R01^ORU_R01|NIST-LRI-GU-001.00|T|2.5.1|||AL|NE|||||LRI_Common_Component^Profile Component^2.16.840.1.113883.9.16^ISO~LRI_GU_Component^Profile Component^2.16.840.1.113883.9.12^ISO~LRI_RU_Component^Profile Component^2.16.840.1.113883.9.14^ISO
PID|1||PATID1234^^^NIST MPI&2.16.840.1.113883.3.72.5.30.2&ISO^MR||Jones^William^A^JR^^^L||19610615|M||2106-3^White^HL70005^CAUC^Caucasian^L
ORC|RE|ORD723222^NIST EHR^2.16.840.1.113883.3.72.5.24^ISO|R-783274^NIST Lab Filler^2.16.840.1.113883.3.72.5.25^ISO|GORD874211^NIST EHR^2.16.840.1.113883.3.72.5.24^ISO||||||||57422^Radon^Nicholas^M^JR^DR^^^NIST-AA-1&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
OBR|1|ORD723222^NIST EHR^2.16.840.1.113883.3.72.5.24^ISO|R-783274^NIST Lab Filler^2.16.840.1.113883.3.72.5.25^ISO|30341-2^Erythrocyte sedimentation rate^LN^815115^Erythrocyte sedimentation rate^99USI^^^Erythrocyte sedimentation rate|||20110331140551-0800||||L||7520000^fever of unknown origin^SCT^22546000^fever, origin unknown^99USI^^^Fever of unknown origin|||57422^Radon^Nicholas^M^JR^DR^^^NIST-AA-1&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI||||||20110331160428-0800|||F|||10092^Hamlin^Pafford^M^Sr.^Dr.^^^NIST-AA-1&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI|||||||||||||||||||||CC^Carbon Copy^HL70507^C^Send Copy^L^^^Copied Requested
NTE|1||Patient is extremely anxious about needles used for drawing blood.
TQ1|1||||||20110331150028-0800|20110331152028-0800
OBX|1|NM|30341-2^Erythrocyte sedimentation rate^LN^815117^ESR^99USI^^^Erythrocyte sedimentation rate||10|mm/h^millimeter per hour^UCUM|0 to 17|N|||F|||20110331140551-0800|||||20110331150551-0800||||Century Hospital^^^^^NIST-AA-1&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^USA^B^^06037|2343242^Knowsalot^Phil^J.^III^Dr.^^^NIST-AA-1&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
MSH|^~\&#|NIST Test Lab APP|NIST Lab Facility||NIST EHR Facility|20110531140551-0500||ORU^R01^ORU_R01|NIST-LRI-NG-001.00|T|2.5.1|||AL|NE|||||LRI_Common_Component^Profile Component^2.16.840.1.113883.9.16^ISO~LRI_NG_Component^Profile Component^2.16.840.1.113883.9.13^ISO~LRI_RU_Component^Profile Component^2.16.840.1.113883.9.14^ISO
PID|1||PATID1234^^^NIST MPI^MR||Jones^William^A^JR^^^L||19610615|M||2106-3^White^HL70005^CAUC^Caucasian^L
ORC|RE|ORD723222^NIST EHR|R-783274^NIST Lab Filler|GORD874211^NIST EHR||||||||57422^Radon^Nicholas^M^JR^DR^^^NIST-AA-1^L^^^NPI
OBR|1|ORD723222^NIST EHR|R-783274^NIST Lab Filler|30341-2^Erythrocyte sedimentation rate^LN^815115^Erythrocyte sedimentation rate^99USI^^^Erythrocyte sedimentation rate|||20110331140551-0800||||L||7520000^fever of unknown origin^SCT^22546000^fever, origin unknown^99USI^^^Fever of unknown origin|||57422^Radon^Nicholas^M^JR^DR^^^NIST-AA-1^L^^^NPI||||||20110331160428-0800|||F|||10092^Hamlin^Pafford^M^Sr.^Dr.^^^NIST-AA-1^L^^^NPI|||||||||||||||||||||CC^Carbon Copy^HL70507^C^Send Copy^L^^^Copied Requested
NTE|1||Patient is extremely anxious about needles used for drawing blood.
TQ1|1||||||20110331150028-0800|20110331152028-0800
OBX|1|NM|30341-2^Erythrocyte sedimentation rate^LN^815117^ESR^99USI^^^Erythrocyte sedimentation rate||10|mm/h^millimeter per hour^UCUM|0 to 17|N|||F|||20110331140551-0800|||||20110331150551-0800||||Century Hospital^^^^^NIST-AA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^USA^B^^06037|2343242^Knowsalot^Phil^J.^III^Dr.^^^NIST-AA-1^L^^^DN
MSH|^~\&#|NIST Test Lab APP^2.16.840.1.113883.3.72.5.20^ISO|NIST Lab Facility^2.16.840.1.113883.3.72.5.21^ISO||NIST EHR Facility^2.16.840.1.113883.3.72.5.23^ISO|20110531140551-0500||ORU^R01^ORU_R01|NIST-LRI-GU-001.01|T|2.5.1|||AL|NE|||||LRI_Common_Component^Profile Component^2.16.840.1.113883.9.16^ISO~LRI_GU_Component^Profile Component^2.16.840.1.113883.9.12^ISO~LRI_RU_Component^Profile Component^2.16.840.1.113883.9.14^ISO
PID|1||PATID1234^^^NIST MPI&2.16.840.1.113883.3.72.5.30.2&ISO^MR||Jones^William^A^JR^^^L||19610615|M||2106-3^White^HL70005^CAUC^Caucasian^L
ORC|RE|ORD723222^NIST EHR^2.16.840.1.113883.3.72.5.24^ISO|R-783274^NIST Lab Filler^2.16.840.1.113883.3.72.5.25^ISO|GORD874211^NIST EHR^2.16.840.1.113883.3.72.5.24^ISO||||||||57422^Radon^Nicholas^M^JR^DR^^^NIST-AA-1&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
OBR|1|ORD723222^NIST EHR^2.16.840.1.113883.3.72.5.24^ISO|R-783274^NIST Lab Filler^2.16.840.1.113883.3.72.5.25^ISO|30341-2^Erythrocyte sedimentation rate^LN^815115^Erythrocyte sedimentation rate^99USI^^^Erythrocyte sedimentation rate|||20110331140551-0800||||L||7520000^fever of unknown origin^SCT^22546000^fever, origin unknown^99USI^^^Fever of unknown origin|||57422^Radon^Nicholas^M^JR^DR^^^NIST-AA-1&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI||||||20110331160428-0800|||C|||10092^Hamlin^Pafford^M^Sr.^Dr.^^^NIST-AA-1&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI|||||||||||||||||||||CC^Carbon Copy^HL70507^C^Send Copy^L^^^Copied Requested
NTE|1||Patient is extremely anxious about needles used for drawing blood.
TQ1|1||||||20110331150028-0800|20110331152028-0800
OBX|1|NM|30341-2^Erythrocyte sedimentation rate^LN^815117^ESR^99USI^^^Erythrocyte sedimentation rate||20|mm/h^millimeter per hour^UCUM|0 to 17|H|||C|||20110331140551-0800|||||20110331150551-0800||||Century Hospital^^^^^NIST-AA-1&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^USA^B^^06037|2343242^Knowsalot^Phil^J.^III^Dr.^^^NIST-AA-1&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
NTE|1||Specimen re-analyzed per request of ordering provider.
MSH|^~\&#|NIST Test Lab APP|NIST Lab Facility||NIST EHR Facility|20110531140551-0500||ORU^R01^ORU_R01|NIST-LRI-NG-001.01|T|2.5.1|||AL|NE|||||LRI_Common_Component^Profile Component^2.16.840.1.113883.9.16^ISO~LRI_NG_Component^Profile Component^2.16.840.1.113883.9.13^ISO~LRI_RU_Component^Profile Component^2.16.840.1.113883.9.14^ISO
PID|1||PATID1234^^^NIST MPI^MR||Jones^William^A^JR^^^L||19610615|M||2106-3^White^HL70005^CAUC^Caucasian^L
ORC|RE|ORD723222^NIST EHR|R-783274^NIST Lab Filler|GORD874211^NIST EHR||||||||57422^Radon^Nicholas^M^JR^DR^^^NIST-AA-1^L^^^NPI
OBR|1|ORD723222^NIST EHR|R-783274^NIST Lab Filler|30341-2^Erythrocyte sedimentation rate^LN^815115^Erythrocyte sedimentation rate^99USI^^^Erythrocyte sedimentation rate|||20110331140551-0800||||L||7520000^fever of unknown origin^SCT^22546000^fever, origin unknown^99USI^^^Fever of unknown origin|||57422^Radon^Nicholas^M^JR^DR^^^NIST-AA-1^L^^^NPI||||||20110331160428-0800|||C|||10092^Hamlin^Pafford^M^Sr.^Dr.^^^NIST-AA-1^L^^^NPI|||||||||||||||||||||CC^Carbon Copy^HL70507^C^Send Copy^L^^^Copied Requested
NTE|1||Patient is extremely anxious about needles used for drawing blood.
TQ1|1||||||20110331150028-0800|20110331152028-0800
OBX|1|NM|30341-2^Erythrocyte sedimentation rate^LN^815117^ESR^99USI^^^Erythrocyte sedimentation rate||20|mm/h^millimeter per hour^UCUM|0 to 17|H|||C|||20110331140551-0800|||||20110331150551-0800||||Century Hospital^^^^^NIST-AA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^USA^B^^06037|2343242^Knowsalot^Phil^J.^III^Dr.^^^NIST-AA-1^L^^^DN
NTE|1||Specimen re-analyzed per request of ordering provider.
MSH|^~\&|^2.16.840.1.113883.3.72.5.20^ISO|^2.16.840.1.113883.3.72.5.21^ISO||^2.16.840.1.113883.3.72.5.23^ISO|20110531140551-0500||ORU^R01^ORU_R01|NIST-LRI-GU-001.04|T|2.5.1|||AL|NE|||||LRI_Common_Component^^2.16.840.1.113883.9.16^ISO~LRI_GU_Component^^2.16.840.1.113883.9.12^ISO~LRI_RU_Component^^2.16.840.1.113883.9.14^ISO
PID|1||PATID1236^^^&2.16.840.1.113883.3.72.5.30.2&ISO^MR||Anderson^Janet||19860930|F||2106-3^White^HL70005
ORC|RE|ORD723222-1^^2.16.840.1.113883.3.72.5.24^ISO|R-783274-1^^2.16.840.1.113883.3.72.5.25^ISO|GORD874222^^2.16.840.1.113883.3.72.5.24^ISO||||||||57422^Radon^Nicholas^^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
OBR|1|ORD723222-1^^2.16.840.1.113883.3.72.5.24^ISO|R-783274-1^^2.16.840.1.113883.3.72.5.25^ISO|30341-2^Erythrocyte sedimentation rate^LN^815115^Erythrocyte sedimentation rate^99USI^^^Erythrocyte sedimentation rate|||20110331140551-0800|||||||||57422^Radon^Nicholas^^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI||||||20110331160428-0800|||X
MSH|^~\&|NIST Test Lab APP|NIST Lab Facility||NIST EHR Facility|20110531140551-0500||ORU^R01^ORU_R01|NIST-LRI-NG-001.04|T|2.5.1|||AL|NE|||||LRI_Common_Component^^2.16.840.1.113883.9.16^ISO~LRI_NG_Component^^2.16.840.1.113883.9.13^ISO~LRI_RU_Component^^2.16.840.1.113883.9.14^ISO
PID|1||PATID1236^^^NIST MPI^MR||Anderson^Janet||19860930|F||2106-3^White^HL70005
ORC|RE|ORD723222-1^NIST EHR|R-783274-1^NIST Lab Filler|GORD874222^NIST EHR||||||||57422^Radon^Nicholas^^^^^^NIST-AA-1^L^^^NPI
OBR|1|ORD723222-1^NIST EHR|R-783274-1^NIST Lab Filler|30341-2^Erythrocyte sedimentation rate^LN^815115^Erythrocyte sedimentation rate^99USI^^^Erythrocyte sedimentation rate|||20110331140551-0800|||||||||57422^Radon^Nicholas^^^^^^NIST-AA-1^L^^^NPI||||||20110331160428-0800|||X
MSH|^~\&|^2.16.840.1.113883.3.72.5.20^ISO|^2.16.840.1.113883.3.72.5.21^ISO||^2.16.840.1.113883.3.72.5.23^ISO|20110531140551-0500||ORU^R01^ORU_R01|NIST-LRI-GU-002.00|T|2.5.1|||AL|NE|||||LRI_Common_Component^^2.16.840.1.113883.9.16^ISO~LRI_GU_Component^^2.16.840.1.113883.9.12^ISO~LRI_RU_Component^^2.16.840.1.113883.9.14^ISO
PID|1||PATID1234^^^&2.16.840.1.113883.3.72.5.30.2&ISO^MR||Jones^William^A||19610615|M||2106-3^White^HL70005
ORC|RE|ORD666555^^2.16.840.1.113883.3.72.5.24^ISO|R-991133^^2.16.840.1.113883.3.72.5.25^ISO|GORD874233^^2.16.840.1.113883.3.72.5.24^ISO||||||||57422^Radon^Nicholas^^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
OBR|1|ORD666555^^2.16.840.1.113883.3.72.5.24^ISO|R-991133^^2.16.840.1.113883.3.72.5.25^ISO|57021-8^CBC W Auto Differential panel in Blood^LN^4456544^CBC^99USI^^^CBC W Auto Differential panel in Blood|||20110103143428-0800|||||||||57422^Radon^Nicholas^^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI||||||20110104170028-0800|||F|||10093^Deluca^Naddy^^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI|||||||||||||||||||||CC^Carbon Copy^HL70507
OBX|1|NM|26453-1^Erythrocytes [#/volume] in Blood^LN^^^^^^Erythrocytes [#/volume] in Blood||4.41|10*6/uL^million per microliter^UCUM|4.3 to 6.2|N|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
OBX|2|NM|718-7^Hemoglobin [Mass/volume] in Blood^LN^^^^^^Hemoglobin [Mass/volume] in Blood||12.5|g/mL^grams per milliliter^UCUM|13 to 18|L|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
OBX|3|NM|20570-8^Hematocrit [Volume Fraction] of Blood^LN^^^^^^Hematocrit [Volume Fraction] of Blood||41|%^percent^UCUM|40 to 52|N|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
OBX|4|NM|26464-8^Leukocytes [#/volume] in Blood^LN^^^^^^Leukocytes [#/volume] in Blood||105600|{cells}/uL^cells per microliter^UCUM|4300 to 10800|HH|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
OBX|5|NM|26515-7^Platelets [#/volume] in Blood^LN^^^^^^Platelets [#/volume] in Blood||210000|{cells}/uL^cells per microliter^UCUM|150000 to 350000|N|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
OBX|6|NM|30428-7^Erythrocyte mean corpuscular volume [Entitic volume]^LN^^^^^^Erythrocyte mean corpuscular volume [Entitic volume]||91|fL^femtoliter^UCUM|80 to 95|N|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
OBX|7|NM|28539-5^Erythrocyte mean corpuscular hemoglobin [Entitic mass]^LN^^^^^^Erythrocyte mean corpuscular hemoglobin [Entitic mass]||29|pg/{cell}^picograms per cell^UCUM|27 to 31|N|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
OBX|8|NM|28540-3^Erythrocyte mean corpuscular hemoglobin concentration [Mass/volume]^LN^^^^^^Erythrocyte mean corpuscular hemoglobin concentration [Mass/volume]||32.4|g/dL^grams per deciliter^UCUM|32 to 36|N|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
OBX|9|NM|30385-9^Erythrocyte distribution width [Ratio]^LN^^^^^^Erythrocyte distribution width [Ratio]||10.5|%^percent^UCUM|10.2 to 14.5|N|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
OBX|10|NM|26444-0^Basophils [#/volume] in Blood^LN^^^^^^Basophils [#/volume] in Blood||0.1|10*3/uL^thousand per microliter^UCUM|0 to 0.3|N|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
OBX|11|NM|30180-4^Basophils/100 leukocytes in Blood^LN^^^^^^Basophils/100 leukocytes in Blood||0.1|%^percent^UCUM|0 to 2|N|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
OBX|12|NM|26484-6^Monocytes [#/volume] in Blood^LN^^^^^^Monocytes [#/volume] in Blood||3|10*3/uL^thousand per microliter^UCUM|0.0 to 13.0|N|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
OBX|13|NM|26485-3^Monocytes/100 leukocytes in Blood^LN^^^^^^Monocytes/100 leukocytes in Blood||3|%^percent^UCUM|0 to 10|N|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
OBX|14|NM|26449-9^Eosinophils [#/volume] in Blood^LN^^^^^^Eosinophils [#/volume] in Blood||2.1|10*3/uL^thousand per microliter^UCUM|0.0 to 0.45|HH|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
OBX|15|NM|26450-7^Eosinophils/100 leukocytes in Blood^LN^^^^^^Eosinophils/100 leukocytes in Blood||2|%^percent^UCUM|0 to 6|N|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
OBX|16|NM|26474-7^Lymphocytes [#/volume] in Blood^LN^^^^^^Lymphocytes [#/volume] in Blood||41.2|10*3/uL^thousand per microliter^UCUM|1.0 to 4.8|HH|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
OBX|17|NM|26478-8^Lymphocytes/100 leukocytes in Blood^LN^^^^^^Lymphocytes/100 leukocytes in Blood||39|%^percent^UCUM|15.0 to 45.0|N|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
OBX|18|NM|26499-4^Neutrophils [#/volume] in Blood^LN^^^^^^Neutrophils [#/volume] in Blood||58|10*3/uL^thousand per microliter^UCUM|1.5 to 7.0|HH|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
OBX|19|NM|26511-6^Neutrophils/100 leukocytes in Blood^LN^^^^^^Neutrophils/100 leukocytes in Blood||55|%^percent^UCUM|50 to 73|N|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
OBX|20|CWE|38892-6^Anisocytosis [Presence] in Blood^LN^^^^^^Anisocytosis [Presence] in Blood||260348001^Present ++ out of ++++^SCT^^^^^^Moderate Anisocytosis|||A|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
OBX|21|CWE|30400-6^Hypochromia [Presence] in Blood^LN^^^^^^Hypochromia [Presence] in Blood||260415000^not detected^SCT^^^^^^None seen|||N|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
OBX|22|CWE|30424-6^Macrocytes [Presence] in Blood^LN^^^^^^Macrocytes [Presence] in Blood||260415000^not detected^SCT^^^^^^None seen|||N|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
OBX|23|CWE|30434-5^Microcytes [Presence] in Blood^LN^^^^^^Microcytes [Presence] in Blood||260415000^not detected^SCT^^^^^^None seen|||N|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
OBX|24|CWE|779-9^Poikilocytosis [Presence] in Blood by Light microscopy^LN^^^^^^Poikilocytosis [Presence] in Blood by Light microscopy||260415000^not detected^SCT^^^^^^None seen|||N|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
OBX|25|CWE|10378-8^Polychromasia [Presence] in Blood by Light microscopy^LN^^^^^^Polychromasia [Presence] in Blood by Light microscopy||260415000^not detected^SCT^^^^^^None seen|||N|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
OBX|26|TX|6742-1^Erythrocyte morphology finding [Identifier] in Blood^LN^^^^^^Erythrocyte morphology finding [Identifier] in Blood||Many spherocytes present.|||A|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
OBX|27|TX|11156-7^Leukocyte morphology finding [Identifier] in Blood^LN^^^^^^Leukocyte morphology finding [Identifier] in Blood||Reactive morphology in lymphoid cells.|||A|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
OBX|28|TX|11125-2^Platelet morphology finding [Identifier] in Blood^LN^^^^^^Platelet morphology finding [Identifier] in Blood||Platelets show defective granulation.|||A|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
MSH|^~\&|NIST Test Lab APP|NIST Lab Facility||NIST EHR Facility|20110531140551-0500||ORU^R01^ORU_R01|NIST-LRI-NG-002.00|T|2.5.1|||AL|NE|||||LRI_Common_Component^^2.16.840.1.113883.9.16^ISO~LRI_NG_Component^^2.16.840.1.113883.9.13^ISO~LRI_RU_Component^^2.16.840.1.113883.9.14^ISO
PID|1||PATID1234^^^NIST MPI^MR||Jones^William^A||19610615|M||2106-3^White^HL70005
ORC|RE|ORD666555^NIST EHR|R-991133^NIST Lab Filler|GORD874233^NIST EHR||||||||57422^Radon^Nicholas^^^^^^NIST-AA-1^L^^^NPI
OBR|1|ORD666555^NIST EHR|R-991133^NIST Lab Filler|57021-8^CBC W Auto Differential panel in Blood^LN^4456544^CBC^99USI^^^CBC W Auto Differential panel in Blood|||20110103143428-0800|||||||||57422^Radon^Nicholas^^^^^^NIST-AA-1^L^^^NPI||||||20110104170028-0800|||F|||10093^Deluca^Naddy^^^^^^NIST-AA-1^L^^^NPI|||||||||||||||||||||CC^Carbon Copy^HL70507
OBX|1|NM|26453-1^Erythrocytes [#/volume] in Blood^LN^^^^^^Erythrocytes [#/volume] in Blood||4.41|10*6/uL^million per microliter^UCUM|4.3 to 6.2|N|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^NIST-AA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^NIST-AA-1^L^^^DN
OBX|2|NM|718-7^Hemoglobin [Mass/volume] in Blood^LN^^^^^^Hemoglobin [Mass/volume] in Blood||12.5|g/mL^grams per milliliter^UCUM|13 to 18|L|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^NIST-AA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^NIST-AA-1^L^^^DN
OBX|3|NM|20570-8^Hematocrit [Volume Fraction] of Blood^LN^^^^^^Hematocrit [Volume Fraction] of Blood||41|%^percent^UCUM|40 to 52|N|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^NIST-AA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^NIST-AA-1^L^^^DN
OBX|4|NM|26464-8^Leukocytes [#/volume] in Blood^LN^^^^^^Leukocytes [#/volume] in Blood||105600|{cells}/uL^cells per microliter^UCUM|4300 to 10800|HH|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^NIST-AA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^NIST-AA-1^L^^^DN
OBX|5|NM|26515-7^Platelets [#/volume] in Blood^LN^^^^^^Platelets [#/volume] in Blood||210000|{cells}/uL^cells per microliter^UCUM|150000 to 350000|N|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^NIST-AA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^NIST-AA-1^L^^^DN
OBX|6|NM|30428-7^Erythrocyte mean corpuscular volume [Entitic volume]^LN^^^^^^Erythrocyte mean corpuscular volume [Entitic volume]||91|fL^femtoliter^UCUM|80 to 95|N|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^NIST-AA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^NIST-AA-1^L^^^DN
OBX|7|NM|28539-5^Erythrocyte mean corpuscular hemoglobin [Entitic mass]^LN^^^^^^Erythrocyte mean corpuscular hemoglobin [Entitic mass]||29|pg/{cell}^picograms per cell^UCUM|27 to 31|N|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^NIST-AA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^NIST-AA-1^L^^^DN
OBX|8|NM|28540-3^Erythrocyte mean corpuscular hemoglobin concentration [Mass/volume]^LN^^^^^^Erythrocyte mean corpuscular hemoglobin concentration [Mass/volume]||32.4|g/dL^grams per deciliter^UCUM|32 to 36|N|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^NIST-AA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^NIST-AA-1^L^^^DN
OBX|9|NM|30385-9^Erythrocyte distribution width [Ratio]^LN^^^^^^Erythrocyte distribution width [Ratio]||10.5|%^percent^UCUM|10.2 to 14.5|N|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^NIST-AA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^NIST-AA-1^L^^^DN
OBX|10|NM|26444-0^Basophils [#/volume] in Blood^LN^^^^^^Basophils [#/volume] in Blood||0.1|10*3/uL^thousand per microliter^UCUM|0 to 0.3|N|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^NIST-AA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^NIST-AA-1^L^^^DN
OBX|11|NM|30180-4^Basophils/100 leukocytes in Blood^LN^^^^^^Basophils/100 leukocytes in Blood||0.1|%^percent^UCUM|0 to 2|N|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^NIST-AA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^NIST-AA-1^L^^^DN
OBX|12|NM|26484-6^Monocytes [#/volume] in Blood^LN^^^^^^Monocytes [#/volume] in Blood||3|10*3/uL^thousand per microliter^UCUM|0.0 to 13.0|N|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^NIST-AA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^NIST-AA-1^L^^^DN
OBX|13|NM|26485-3^Monocytes/100 leukocytes in Blood^LN^^^^^^Monocytes/100 leukocytes in Blood||3|%^percent^UCUM|0 to 10|N|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^NIST-AA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^NIST-AA-1^L^^^DN
OBX|14|NM|26449-9^Eosinophils [#/volume] in Blood^LN^^^^^^Eosinophils [#/volume] in Blood||2.1|10*3/uL^thousand per microliter^UCUM|0.0 to 0.45|HH|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^NIST-AA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^NIST-AA-1^L^^^DN
OBX|15|NM|26450-7^Eosinophils/100 leukocytes in Blood^LN^^^^^^Eosinophils/100 leukocytes in Blood||2|%^percent^UCUM|0 to 6|N|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^NIST-AA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^NIST-AA-1^L^^^DN
OBX|16|NM|26474-7^Lymphocytes [#/volume] in Blood^LN^^^^^^Lymphocytes [#/volume] in Blood||41.2|10*3/uL^thousand per microliter^UCUM|1.0 to 4.8|HH|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^NIST-AA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^NIST-AA-1^L^^^DN
OBX|17|NM|26478-8^Lymphocytes/100 leukocytes in Blood^LN^^^^^^Lymphocytes/100 leukocytes in Blood||39|%^percent^UCUM|15.0 to 45.0|N|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^NIST-AA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^NIST-AA-1^L^^^DN
OBX|18|NM|26499-4^Neutrophils [#/volume] in Blood^LN^^^^^^Neutrophils [#/volume] in Blood||58|10*3/uL^thousand per microliter^UCUM|1.5 to 7.0|HH|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^NIST-AA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^NIST-AA-1^L^^^DN
OBX|19|NM|26511-6^Neutrophils/100 leukocytes in Blood^LN^^^^^^Neutrophils/100 leukocytes in Blood||55|%^percent^UCUM|50 to 73|N|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^NIST-AA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^NIST-AA-1^L^^^DN
OBX|20|CWE|38892-6^Anisocytosis [Presence] in Blood^LN^^^^^^Anisocytosis [Presence] in Blood||260348001^Present ++ out of ++++^SCT^^^^^^Moderate Anisocytosis|||A|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^NIST-AA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^NIST-AA-1^L^^^DN
OBX|21|CWE|30400-6^Hypochromia [Presence] in Blood^LN^^^^^^Hypochromia [Presence] in Blood||260415000^not detected^SCT^^^^^^None seen|||N|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^NIST-AA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^NIST-AA-1^L^^^DN
OBX|22|CWE|30424-6^Macrocytes [Presence] in Blood^LN^^^^^^Macrocytes [Presence] in Blood||260415000^not detected^SCT^^^^^^None seen|||N|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^NIST-AA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^NIST-AA-1^L^^^DN
OBX|23|CWE|30434-5^Microcytes [Presence] in Blood^LN^^^^^^Microcytes [Presence] in Blood||260415000^not detected^SCT^^^^^^None seen|||N|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^NIST-AA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^NIST-AA-1^L^^^DN
OBX|24|CWE|779-9^Poikilocytosis [Presence] in Blood by Light microscopy^LN^^^^^^Poikilocytosis [Presence] in Blood by Light microscopy||260415000^not detected^SCT^^^^^^None seen|||N|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^NIST-AA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^NIST-AA-1^L^^^DN
OBX|25|CWE|10378-8^Polychromasia [Presence] in Blood by Light microscopy^LN^^^^^^Polychromasia [Presence] in Blood by Light microscopy||260415000^not detected^SCT^^^^^^None seen|||N|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^NIST-AA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^NIST-AA-1^L^^^DN
OBX|26|TX|6742-1^Erythrocyte morphology finding [Identifier] in Blood^LN^^^^^^Erythrocyte morphology finding [Identifier] in Blood||Many spherocytes present.|||A|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^NIST-AA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^NIST-AA-1^L^^^DN
OBX|27|TX|11156-7^Leukocyte morphology finding [Identifier] in Blood^LN^^^^^^Leukocyte morphology finding [Identifier] in Blood||Reactive morphology in lymphoid cells.|||A|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^NIST-AA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^NIST-AA-1^L^^^DN
OBX|28|TX|11125-2^Platelet morphology finding [Identifier] in Blood^LN^^^^^^Platelet morphology finding [Identifier] in Blood||Platelets show defective granulation.|||A|||F|||20110103143428-0800|||||20110103163428-0800||||Century Hospital^^^^^NIST-AA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^NIST-AA-1^L^^^DN
MSH|^~\&|^2.16.840.1.113883.3.72.5.20^ISO|^2.16.840.1.113883.3.72.5.21^ISO||^2.16.840.1.113883.3.72.5.23^ISO|20110531140551-0500||ORU^R01^ORU_R01|NIST-LRI-GU-003.00|T|2.5.1|||AL|NE|||||LRI_Common_Component^^2.16.840.1.113883.9.16^ISO~LRI_GU_Component^^2.16.840.1.113883.9.12^ISO~LRI_RU_Component^^2.16.840.1.113883.9.14^ISO
PID|1||PATID1234^^^&2.16.840.1.113883.3.72.5.30.2&ISO^MR||Jones^William^A||19610615|M||2106-3^White^HL70005
ORC|RE|ORD777888^^2.16.840.1.113883.3.72.5.24^ISO|R-220713^^2.16.840.1.113883.3.72.5.25^ISO|GORD874244^^2.16.840.1.113883.3.72.5.24^ISO||||||||57422^Radon^Nicholas^^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
OBR|1|ORD777888^^2.16.840.1.113883.3.72.5.24^ISO|R-220713^^2.16.840.1.113883.3.72.5.25^ISO|24331-1^Lipid 1996 panel in Serum or Plasma^LN^345789^Lipid Panel^99USI^^^Lipid 1996 panel in Serum or Plasma|||20110531123551-0800||||||56388000^hyperlipidemia^99USI^3744001^hyperlipoproteinemia^SCT^^^hyperlipoproteinemia|||57422^Radon^Nicholas^^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI||||||20110611140428-0800|||F|||10092^Hamlin^Pafford^^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI|||||||||||||||||||||BCC^Blind Copy^HL70507
OBX|1|NM|2093-3^Cholesterol [Mass/volume] in Serum or Plasma^LN^^^^^^Cholesterol [Mass/volume] in Serum or Plasma||196|mg/dL^milligrams per deciliter^UCUM|Recommended: <200; Moderate Risk: 200-239 ; High Risk: >240|N|||F|||20110531123551-0800|||||20110601130551-0800||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
OBX|2|NM|2571-8^Triglyceride [Mass/volume] in Serum or Plasma^LN^^^^^^Triglyceride [Mass/volume] in Serum or Plasma||100|mg/dL^milligrams per deciliter^UCUM|40 to 160|N|||F|||20110531123551-0800|||||20110601130551-0800||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
OBX|3|NM|2085-9^Cholesterol in HDL [Mass/volume] in Serum or Plasma^LN^^^^^^Cholesterol in HDL [Mass/volume] in Serum or Plasma||60|mg/dL^milligrams per deciliter^UCUM|29 to 72|N|||F|||20110531123551-0800|||||20110601130551-0800||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
OBX|4|NM|2089-1^Cholesterol in LDL [Mass/volume] in Serum or Plasma^LN^^^^^^Cholesterol in LDL [Mass/volume] in Serum or Plasma||116|mg/dL^milligrams per deciliter^UCUM|Recommended: <130; Moderate Risk: 130-159; High Risk: >160|N|||F|||20110531123551-0800|||||20110601130551-0800||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
MSH|^~\&|NIST Test Lab APP|NIST Lab Facility||NIST EHR Facility|20110531140551-0500||ORU^R01^ORU_R01|NIST-LRI-NG-003.00|T|2.5.1|||AL|NE|||||LRI_Common_Component^^2.16.840.1.113883.9.16^ISO~LRI_NG_Component^^2.16.840.1.113883.9.13^ISO~LRI_RU_Component^^2.16.840.1.113883.9.14^ISO
PID|1||PATID1234^^^NIST MPI^MR||Jones^William^A||19610615|M||2106-3^White^HL70005
ORC|RE|ORD777888^NIST EHR|R-220713^NIST Lab Filler|GORD874244^NIST EHR||||||||57422^Radon^Nicholas^^^^^^NIST-AA-1^L^^^NPI
OBR|1|ORD777888^NIST EHR|R-220713^NIST Lab Filler|24331-1^Lipid 1996 panel in Serum or Plasma^LN^345789^Lipid Panel^99USI^^^Lipid 1996 panel in Serum or Plasma|||20110531123551-0800||||||56388000^hyperlipidemia^99USI^3744001^hyperlipoproteinemia^SCT^^^hyperlipoproteinemia|||57422^Radon^Nicholas^^^^^^NIST-AA-1^L^^^NPI||||||20110611140428-0800|||F|||10092^Hamlin^Pafford^^^^^^NIST-AA-1^L^^^NPI|||||||||||||||||||||CC^Carbon Copy^HL70507
OBX|1|NM|2093-3^Cholesterol [Mass/volume] in Serum or Plasma^LN^^^^^^Cholesterol [Mass/volume] in Serum or Plasma||196|mg/dL^milligrams per deciliter^UCUM|Recommended: <200; Moderate Risk: 200-239 ; High Risk: >240|N|||F|||20110531123551-0800|||||20110601130551-0800||||Century Hospital^^^^^NIST HCAA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^NIST HCAA-1^L^^^DN
OBX|2|NM|2571-8^Triglyceride [Mass/volume] in Serum or Plasma^LN^^^^^^Triglyceride [Mass/volume] in Serum or Plasma||100|mg/dL^milligrams per deciliter^UCUM|40 to 160|N|||F|||20110531123551-0800|||||20110601130551-0800||||Century Hospital^^^^^NIST HCAA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^NIST HCAA-1^L^^^DN
OBX|3|NM|2085-9^Cholesterol in HDL [Mass/volume] in Serum or Plasma^LN^^^^^^Cholesterol in HDL [Mass/volume] in Serum or Plasma||60|mg/dL^milligrams per deciliter^UCUM|29 to 72|N|||F|||20110531123551-0800|||||20110601130551-0800||||Century Hospital^^^^^NIST HCAA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^NIST HCAA-1^L^^^DN
OBX|4|NM|2089-1^Cholesterol in LDL [Mass/volume] in Serum or Plasma^LN^^^^^^Cholesterol in LDL [Mass/volume] in Serum or Plasma||116|mg/dL^milligrams per deciliter^UCUM|Recommended: <130; Moderate Risk: 130-159; High Risk: >160|N|||F|||20110531123551-0800|||||20110601130551-0800||||Century Hospital^^^^^NIST HCAA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Knowsalot^Phil^^^Dr.^^^NIST HCAA-1^L^^^DN
MSH|^~\&|^2.16.840.1.113883.3.72.5.20^ISO|^2.16.840.1.113883.3.72.5.21^ISO||^2.16.840.1.113883.3.72.5.23^ISO|20110531140551-0500||ORU^R01^ORU_R01|NIST-LRI-GU-004.00|T|2.5.1|||AL|NE|||||LRI_Common_Component^^2.16.840.1.113883.9.16^ISO~LRI_GU_Component^^2.16.840.1.113883.9.12^ISO~LRI_RU_Component^^2.16.840.1.113883.9.14^ISO
PID|1||PATID1234^^^&2.16.840.1.113883.3.72.5.30.2&ISO^MR||Jones^William^A||19610615|M||2106-3^White^HL70005
ORC|RE|ORD723222-4^^2.16.840.1.113883.3.72.5.24^ISO|R-783274-4^^2.16.840.1.113883.3.72.5.25^ISO|GORD874211^^2.16.840.1.113883.3.72.5.24^ISO||||||||57422^Radon^Nicholas^^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
OBR|1|ORD723222-4^^2.16.840.1.113883.3.72.5.24^ISO|R-783274-4^^2.16.840.1.113883.3.72.5.25^ISO|625-4^Bacteria identified in Stool by Culture^LN^3456543^CULTURE STOOL^99USI^^^Stool Culture|||20110530123551-0500||||||787.91^DIARRHEA^I9CDX^^^^^^DIARRHEA|||57422^Radon^Nicholas^^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI||||||20110531140428-0500|||P
OBX|1|CWE|625-4^Bacteria identified in Stool by Culture^LN^^^^^^Stool Culture|1|103429008^Enterohemorrhagic Escherichia coli, serotype O157:H7^SCT^^^^^^Shiga toxin producing E. coli O157:H7 isolated|||A|||P|||20110530123551-0500|||||20110531130655-0500||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
OBX|2|CWE|625-4^Bacteria identified in Stool by Culture^LN^^^^^^Stool Culture|2|398567006^Salmonella I, group O:4^SCT^^^^^^Salmonella I, group O:4 isolated|||A|||P|||20110530123551-0500|||||20110531130655-0500||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
OBX|3|CWE|625-4^Bacteria identified in Stool by Culture^LN^^^^^^Stool Culture|3|85729005^Shigella flexneri^SCT^^^^^^Shigella flexneri isolated|||A|||P|||20110530123551-0500|||||20110531130655-0500||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
MSH|^~\&|NIST Test Lab APP|NIST Lab Facility||NIST EHR Facility|20110531140551-0500||ORU^R01^ORU_R01|NIST-LRI-NG-004.00|T|2.5.1|||AL|NE|||||LRI_Common_Component^^2.16.840.1.113883.9.16^ISO~LRI_NG_Component^^2.16.840.1.113883.9.13^ISO~LRI_RU_Component^^2.16.840.1.113883.9.14^ISO
PID|1||PATID1234^^^NIST MPI^MR||Jones^William^A||19610615|M||2106-3^White^HL70005
ORC|RE|ORD723222-4^NIST EHR|R-783274-4^NIST Lab Filler|GORD874211^NIST EHR||||||||57422^Radon^Nicholas^^^^^^NIST-AA-1^L^^^NPI
OBR|1|ORD723222-4^NIST EHR|R-783274-4^NIST Lab Filler|625-4^Bacteria identified in Stool by Culture^LN^3456543^CULTURE STOOL^99USI^^^Stool Culture|||20110530123551-0500||||||787.91^DIARRHEA^I9CDX^^^^^^DIARRHEA|||57422^Radon^Nicholas^^^^^^NIST-AA-1^L^^^NPI||||||20110531140428-0500|||P
OBX|1|CWE|625-4^Bacteria identified in Stool by Culture^LN^^^^^^Stool Culture|1|103429008^Enterohemorrhagic Escherichia coli, serotype O157:H7^SCT^^^^^^Shiga toxin producing E. coli O157:H7 isolated|||A|||P|||20110530123551-0500|||||20110531130655-0500||||Century Hospital^^^^^NIST HCAA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^NIST HCAA-1^L^^^NPI
OBX|2|CWE|625-4^Bacteria identified in Stool by Culture^LN^^^^^^Stool Culture|2|398567006^Salmonella I, group O:4^SCT^^^^^^Salmonella I, group O:4 isolated|||A|||P|||20110530123551-0500|||||20110531130655-0500||||Century Hospital^^^^^NIST HCAA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^NIST HCAA-1^L^^^NPI
OBX|3|CWE|625-4^Bacteria identified in Stool by Culture^LN^^^^^^Stool Culture|3|85729005^Shigella flexneri^SCT^^^^^^Shigella flexneri isolated|||A|||P|||20110530123551-0500|||||20110531130655-0500||||Century Hospital^^^^^NIST HCAA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^NIST HCAA-1^L^^^NPI
MSH|^~\&|^2.16.840.1.113883.3.72.5.20^ISO|^2.16.840.1.113883.3.72.5.21^ISO||^2.16.840.1.113883.3.72.5.23^ISO|20110531140551-0500||ORU^R01^ORU_R01|NIST-LRI-GU-RU-004.01|T|2.5.1|||AL|NE|||||LRI_Common_Component^^2.16.840.1.113883.9.16^ISO~LRI_GU_Component^^2.16.840.1.113883.9.12^ISO~LRI_RU_Component^^2.16.840.1.113883.9.14^ISO
PID|1||PATID1234^^^&2.16.840.1.113883.3.72.5.30.2&ISO^MR||Jones^William^A||19610615|M||2106-3^White^HL70005
ORC|RE|ORD723222-4^^2.16.840.1.113883.3.72.5.24^ISO|R-783274-4^^2.16.840.1.113883.3.72.5.25^ISO|GORD874211^^2.16.840.1.113883.3.72.5.24^ISO||||||||57422^Radon^Nicholas^^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
OBR|1|ORD723222-4^^2.16.840.1.113883.3.72.5.24^ISO|R-783274-4^^2.16.840.1.113883.3.72.5.25^ISO|625-4^Bacteria identified in Stool by Culture^LN^3456543^CULTURE STOOL^99USI^^^Stool Culture|||20110530123551-0500||||||787.91^DIARRHEA^I9CDX^^^^^^DIARRHEA|||57422^Radon^Nicholas^^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI||||||20110531140428-0500|||F
OBX|1|CWE|625-4^Bacteria identified in Stool by Culture^LN^^^^^^Stool Culture|1|103429008^Enterohemorrhagic Escherichia coli, serotype O157:H7^SCT^^^^^^Shiga toxin producing E. coli O157:H7 isolated|||A|||F|||20110530123551-0500|||||20110531130655-0500||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
OBX|2|CWE|625-4^Bacteria identified in Stool by Culture^LN^^^^^^Stool Culture|2|398567006^Salmonella I, group O:4^SCT^^^^^^Salmonella I, group O:4 isolated|||A|||F|||20110530123551-0500|||||20110531130655-0500||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
OBX|3|CWE|625-4^Bacteria identified in Stool by Culture^LN^^^^^^Stool Culture|3|85729005^Shigella flexneri^SCT^^^^^^Shigella flexneri isolated|||A|||F|||20110530123551-0500|||||20110531130655-0500||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
ORC|RE||R-783274-5^^2.16.840.1.113883.3.72.5.25^ISO|GORD874211^^2.16.840.1.113883.3.72.5.24^ISO||||||||57422^Radon^Nicholas^^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
OBR|2||R-783274-5^^2.16.840.1.113883.3.72.5.25^ISO|50545-3^Bacterial susceptibility panel in Isolate by Minimum inhibitory concentration (MIC)^LN^^^^^^Bacteria susceptibility|||20110530123551-0500||||G|||||57422^Radon^Nicholas^^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI||||||20110601140428-0500|||F|625-4&Bacteria identified in Stool by Culture&LN&&&&&&Stool Culture^1|||ORD723222-4&&2.16.840.1.113883.3.72.5.24&ISO^R-783274-4&&2.16.840.1.113883.3.72.5.25&ISO
OBX|1|SN|28-1^Ampicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^^^^^^AMPICILLIN|1|<^0.06|ug/mL^^UCUM||S|||F|||20110530123551-0500|||||20110601130655-0500||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
OBX|2|SN|267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^^^^^^GENTAMICIN|1|^0.05|ug/mL^^UCUM||S|||F|||20110530123551-0500|||||20110601130655-0500||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
OBX|3|SN|185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^^^^^^CIPROFLOXACIN|1|^0.05|ug/mL^^UCUM||S|||F|||20110530123551-0500|||||20110601130655-0500||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
ORC|RE||R-783274-6^^2.16.840.1.113883.3.72.5.25^ISO|GORD874211^^2.16.840.1.113883.3.72.5.24^ISO||||||||57422^Radon^Nicholas^^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
OBR|3||R-783274-6^^2.16.840.1.113883.3.72.5.25^ISO|50545-3^Bacterial susceptibility panel in Isolate by Minimum inhibitory concentration (MIC)^LN^^^^^^Bacteria susceptibility|||20110530123551-0500||||G|||||57422^Radon^Nicholas^^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI||||||20110601140428-0500|||F|625-4&Bacteria identified in Stool by Culture&LN&&&&&&Stool Culture^2|||ORD723222-4&&2.16.840.1.113883.3.72.5.24&ISO^R-783274-4&&2.16.840.1.113883.3.72.5.25&ISO
OBX|1|SN|28-1^Ampicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^^^^^^AMPICILLIN|1|<^0.06|ug/mL^^UCUM||S|||F|||20110530123551-0500|||||20110601130655-0500||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
OBX|2|SN|267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^^^^^^GENTAMICIN|1|^0.05|ug/mL^^UCUM||S|||F|||20110530123551-0500|||||20110601130655-0500||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
OBX|3|SN|185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^^^^^^CIPROFLOXACIN|1|^0.05|ug/mL^^UCUM||S|||F|||20110530123551-0500|||||20110601130655-0500||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
ORC|RE||R-783274-7^^2.16.840.1.113883.3.72.5.25^ISO|GORD874211^^2.16.840.1.113883.3.72.5.24^ISO||||||||57422^Radon^Nicholas^^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
OBR|4||R-783274-7^^2.16.840.1.113883.3.72.5.25^ISO|50545-3^Bacterial susceptibility panel in Isolate by Minimum inhibitory concentration (MIC)^LN^^^^^^Bacteria susceptibility|||20110530123551-0500||||G|||||57422^Radon^Nicholas^^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI||||||20110601140428-0500|||F|625-4&Bacteria identified in Stool by Culture&LN&&&&&&Stool Culture^3|||ORD723222-4&&2.16.840.1.113883.3.72.5.24&ISO^R-783274-4&&2.16.840.1.113883.3.72.5.25&ISO
OBX|1|SN|28-1^Ampicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^^^^^^AMPICILLIN|1|<^0.06|ug/mL^^UCUM||S|||F|||20110530123551-0500|||||20110601130655-0500||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
OBX|2|SN|267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^^^^^^GENTAMICIN|1|^0.05|ug/mL^^UCUM||S|||F|||20110530123551-0500|||||20110601130655-0500||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
OBX|3|SN|185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^^^^^^CIPROFLOXACIN|1|^0.05|ug/mL^^UCUM||S|||F|||20110530123551-0500|||||20110601130655-0500||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
MSH|^~\&|NIST Test Lab APP|NIST Lab Facility||NIST EHR Facility|20110531140551-0500||ORU^R01^ORU_R01|NIST-LRI-NG-RU-004.01|T|2.5.1|||AL|NE|||||LRI_Common_Component^^2.16.840.1.113883.9.16^ISO~LRI_NG_Component^^2.16.840.1.113883.9.13^ISO~LRI_RU_Component^^2.16.840.1.113883.9.14^ISO
PID|1||PATID1234^^^NIST MPI^MR||Jones^William^A||19610615|M||2106-3^White^HL70005
ORC|RE|ORD723222-4^NIST EHR|R-783274-4^NIST Lab Filler|GORD874211^NIST EHR||||||||57422^Radon^Nicholas^^^^^^NIST-AA-1^L^^^NPI
OBR|1|ORD723222-4^NIST EHR|R-783274-4^NIST Lab Filler|625-4^Bacteria identified in Stool by Culture^LN^3456543^CULTURE STOOL^99USI^^^Stool Culture|||20110530123551-0500||||||787.91^DIARRHEA^I9CDX^^^^^^DIARRHEA|||57422^Radon^Nicholas^^^^^^NIST-AA-1^L^^^NPI||||||20110531140428-0500|||F
OBX|1|CWE|625-4^Bacteria identified in Stool by Culture^LN^^^^^^Stool Culture|1|103429008^Enterohemorrhagic Escherichia coli, serotype O157:H7^SCT^^^^^^Shiga toxin producing E. coli O157:H7 isolated|||A|||F|||20110530123551-0500|||||20110531130655-0500||||Century Hospital^^^^^NIST HCAA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^NIST HCAA-1^L^^^NPI
OBX|2|CWE|625-4^Bacteria identified in Stool by Culture^LN^^^^^^Stool Culture|2|398567006^Salmonella I, group O:4^SCT^^^^^^Salmonella I, group O:4 isolated|||A|||F|||20110530123551-0500|||||20110531130655-0500||||Century Hospital^^^^^NIST HCAA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^NIST HCAA-1^L^^^NPI
OBX|3|CWE|625-4^Bacteria identified in Stool by Culture^LN^^^^^^Stool Culture|3|85729005^Shigella flexneri^SCT^^^^^^Shigella flexneri isolated|||A|||F|||20110530123551-0500|||||20110531130655-0500||||Century Hospital^^^^^NIST HCAA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^NIST HCAA-1^L^^^NPI
ORC|RE||R-783274-5^NIST Lab Filler|GORD874211^NIST EHR||||||||57422^Radon^Nicholas^^^^^^NIST-AA-1^L^^^NPI
OBR|2||R-783274-5^NIST Lab Filler|50545-3^Bacterial susceptibility panel in Isolate by Minimum inhibitory concentration (MIC)^LN^^^^^^Bacteria susceptibility|||20110530123551-0500||||G|||||57422^Radon^Nicholas^^^^^^NIST-AA-1^L^^^NPI||||||20110601140428-0500|||F|625-4&Bacteria identified in Stool by Culture&LN&&&&&&Stool Culture^1|||ORD723222-4&NIST EHR^R-783274-4&NIST Lab Filler
OBX|1|SN|28-1^Ampicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^^^^^^AMPICILLIN|1|<^0.06|ug/mL^^UCUM||S|||F|||20110530123551-0500|||||20110601130655-0500||||Century Hospital^^^^^NIST HCAA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^NIST HCAA-1^L^^^NPI
OBX|2|SN|267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^^^^^^GENTAMICIN|1|^0.05|ug/mL^^UCUM||S|||F|||20110530123551-0500|||||20110601130655-0500||||Century Hospital^^^^^NIST HCAA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^NIST HCAA-1^L^^^NPI
OBX|3|SN|185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^^^^^^CIPROFLOXACIN|1|^0.05|ug/mL^^UCUM||S|||F|||20110530123551-0500|||||20110601130655-0500||||Century Hospital^^^^^NIST HCAA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^NIST HCAA-1^L^^^NPI
ORC|RE||R-783274-6^NIST Lab Filler|GORD874211^NIST EHR||||||||57422^Radon^Nicholas^^^^^^NIST-AA-1^L^^^NPI
OBR|3||R-783274-6^NIST Lab Filler|50545-3^Bacterial susceptibility panel in Isolate by Minimum inhibitory concentration (MIC)^LN^^^^^^Bacteria susceptibility|||20110530123551-0500||||G|||||57422^Radon^Nicholas^^^^^^NIST-AA-1^L^^^NPI||||||20110601140428-0500|||F|625-4&Bacteria identified in Stool by Culture&LN&&&&&&Stool Culture^2|||ORD723222-4&NIST EHR^R-783274-4&NIST Lab Filler
OBX|1|SN|28-1^Ampicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^^^^^^AMPICILLIN|1|<^0.06|ug/mL^^UCUM||S|||F|||20110530123551-0500|||||20110601130655-0500||||Century Hospital^^^^^NIST HCAA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^NIST HCAA-1^L^^^NPI
OBX|2|SN|267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^^^^^^GENTAMICIN|1|^0.05|ug/mL^^UCUM||S|||F|||20110530123551-0500|||||20110601130655-0500||||Century Hospital^^^^^NIST HCAA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^NIST HCAA-1^L^^^NPI
OBX|3|SN|185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^^^^^^CIPROFLOXACIN|1|^0.05|ug/mL^^UCUM||S|||F|||20110530123551-0500|||||20110601130655-0500||||Century Hospital^^^^^NIST HCAA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^NIST HCAA-1^L^^^NPI
ORC|RE||R-783274-7^NIST Lab Filler|GORD874211^NIST EHR||||||||57422^Radon^Nicholas^^^^^^NIST-AA-1^L^^^NPI
OBR|4||R-783274-7^NIST Lab Filler|50545-3^Bacterial susceptibility panel in Isolate by Minimum inhibitory concentration (MIC)^LN^^^^^^Bacteria susceptibility|||20110530123551-0500||||G|||||57422^Radon^Nicholas^^^^^^NIST-AA-1^L^^^NPI||||||20110601140428-0500|||F|625-4&Bacteria identified in Stool by Culture&LN&&&&&&Stool Culture^3|||ORD723222-4&NIST EHR^R-783274-4&NIST Lab Filler
OBX|1|SN|28-1^Ampicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^^^^^^AMPICILLIN|1|<^0.06|ug/mL^^UCUM||S|||F|||20110530123551-0500|||||20110601130655-0500||||Century Hospital^^^^^NIST HCAA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^NIST HCAA-1^L^^^NPI
OBX|2|SN|267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^^^^^^GENTAMICIN|1|^0.05|ug/mL^^UCUM||S|||F|||20110530123551-0500|||||20110601130655-0500||||Century Hospital^^^^^NIST HCAA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^NIST HCAA-1^L^^^NPI
OBX|3|SN|185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^^^^^^CIPROFLOXACIN|1|^0.05|ug/mL^^UCUM||S|||F|||20110530123551-0500|||||20110601130655-0500||||Century Hospital^^^^^NIST HCAA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^NIST HCAA-1^L^^^NPI
MSH|^~\&|^2.16.840.1.113883.3.72.5.20^ISO|^2.16.840.1.113883.3.72.5.21^ISO||^2.16.840.1.113883.3.72.5.23^ISO|20110531140551-0500||ORU^R01^ORU_R01|NIST-LRI-GU-RN-004.02|T|2.5.1|||AL|NE|||||LRI_Common_Component^^2.16.840.1.113883.9.16^ISO~LRI_GU_Component^^2.16.840.1.113883.9.12^ISO~LRI_RN_Component^^2.16.840.1.113883.9.15^ISO
PID|1||PATID1234^^^&2.16.840.1.113883.3.72.5.30.2&ISO^MR||Jones^William^A||19610615|M||2106-3^White^HL70005
ORC|RE|ORD723222-4^^2.16.840.1.113883.3.72.5.24^ISO|R-783274-4^^2.16.840.1.113883.3.72.5.25^ISO|GORD874255^^2.16.840.1.113883.3.72.5.24^ISO||||||||57422^Radon^Nicholas^^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
OBR|1|ORD723222-4^^2.16.840.1.113883.3.72.5.24^ISO|R-783274-4^^2.16.840.1.113883.3.72.5.25^ISO|625-4^Bacteria identified in Stool by Culture^LN^3456543^CULTURE STOOL^99USI^^^Stool Culture|||20110530123551-0500||||||787.91^DIARRHEA^I9CDX^^^^^^DIARRHEA|||57422^Radon^Nicholas^^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI||||||20110531140428-0500|||F
OBX|1|CWE|625-4^Bacteria identified in Stool by Culture^LN^^^^^^Stool Culture|1|103429008^Enterohemorrhagic Escherichia coli, serotype O157:H7^SCT^^^^^^Shiga toxin producing E. coli O157:H7 isolated|||A|||F|||20110530123551-0500|||||20110531130655-0500||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
OBX|2|CWE|625-4^Bacteria identified in Stool by Culture^LN^^^^^^Stool Culture|2|398567006^Salmonella I, group O:4^SCT^^^^^^Salmonella I, group O:4 isolated|||A|||F|||20110530123551-0500|||||20110531130655-0500||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
OBX|3|CWE|625-4^Bacteria identified in Stool by Culture^LN^^^^^^Stool Culture|3|85729005^Shigella flexneri^SCT^^^^^^Shigella flexneri isolated|||A|||F|||20110530123551-0500|||||20110531130655-0500||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
ORC|RE||R-783274-4^^2.16.840.1.113883.3.72.5.25^ISO|GORD874255^^2.16.840.1.113883.3.72.5.24^ISO||||||||57422^Radon^Nicholas^^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI|||||||||||||||||||625-4^Bacteria identified in Stool by Culture^LN^3456543^CULTURE STOOL^99USI^^^Stool Culture
OBR|2||R-783274-4^^2.16.840.1.113883.3.72.5.25^ISO|50545-3^Bacterial susceptibility panel in Isolate by Minimum inhibitory concentration (MIC)^LN^^^^^^Bacteria susceptibility|||20110530123551-0500||||G|||||57422^Radon^Nicholas^^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI||||||20110601140428-0500|||F|625-4&Bacteria identified in Stool by Culture&LN&&&&&&Stool Culture^1|||ORD723222-4&&2.16.840.1.113883.3.72.5.24&ISO^R-783274-4&&2.16.840.1.113883.3.72.5.25&ISO|||||||||||||||||||||625-4^Bacteria identified in Stool by Culture^LN^3456543^CULTURE STOOL^99USI^^^Stool Culture
OBX|1|SN|28-1^Ampicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^^^^^^AMPICILLIN|1|<^0.06|ug/mL^^UCUM||S|||F|||20110530123551-0500|||||20110601130655-0500||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
OBX|2|SN|267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^^^^^^GENTAMICIN|1|^0.05|ug/mL^^UCUM||S|||F|||20110530123551-0500|||||20110601130655-0500||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
OBX|3|SN|185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^^^^^^CIPROFLOXACIN|1|^0.05|ug/mL^^UCUM||S|||F|||20110530123551-0500|||||20110601130655-0500||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
ORC|RE||R-783274-4^^2.16.840.1.113883.3.72.5.25^ISO|GORD874255^^2.16.840.1.113883.3.72.5.24^ISO||||||||57422^Radon^Nicholas^^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI|||||||||||||||||||625-4^Bacteria identified in Stool by Culture^LN^3456543^CULTURE STOOL^99USI^^^Stool Culture
OBR|3||R-783274-4^^2.16.840.1.113883.3.72.5.25^ISO|50545-3^Bacterial susceptibility panel in Isolate by Minimum inhibitory concentration (MIC)^LN^^^^^^Bacteria susceptibility|||20110530123551-0500||||G|||||57422^Radon^Nicholas^^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI||||||20110601140428-0500|||F|625-4&Bacteria identified in Stool by Culture&LN&&&&&&Stool Culture^2|||ORD723222-4&&2.16.840.1.113883.3.72.5.24&ISO^R-783274-4&&2.16.840.1.113883.3.72.5.25&ISO|||||||||||||||||||||625-4^Bacteria identified in Stool by Culture^LN^3456543^CULTURE STOOL^99USI^^^Stool Culture
OBX|1|SN|28-1^Ampicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^^^^^^AMPICILLIN|1|<^0.06|ug/mL^^UCUM||S|||F|||20110530123551-0500|||||20110601130655-0500||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
OBX|2|SN|267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^^^^^^GENTAMICIN|1|^0.05|ug/mL^^UCUM||S|||F|||20110530123551-0500|||||20110601130655-0500||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
OBX|3|SN|185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^^^^^^CIPROFLOXACIN|1|^0.05|ug/mL^^UCUM||S|||F|||20110530123551-0500|||||20110601130655-0500||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
ORC|RE||R-783274-4^^2.16.840.1.113883.3.72.5.25^ISO|GORD874255^^2.16.840.1.113883.3.72.5.24^ISO||||||||57422^Radon^Nicholas^^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI|||||||||||||||||||625-4^Bacteria identified in Stool by Culture^LN^3456543^CULTURE STOOL^99USI^^^Stool Culture
OBR|4||R-783274-4^^2.16.840.1.113883.3.72.5.25^ISO|50545-3^Bacteria susceptibility^LN^^^^^^Bacteria susceptibility|||20110530123551-0500||||G|||||57422^Radon^Nicholas^^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI||||||20110601140428-0500|||F|625-4&Bacteria identified in Stool by Culture&LN&&&&&&Stool Culture^3|||ORD723222-4&&2.16.840.1.113883.3.72.5.24&ISO^R-783274-4&&2.16.840.1.113883.3.72.5.25&ISO|||||||||||||||||||||625-4^Bacteria identified in Stool by Culture^LN^3456543^CULTURE STOOL^99USI^^^Stool Culture
OBX|1|SN|28-1^Ampicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^^^^^^AMPICILLIN|1|<^0.06|ug/mL^^UCUM||S|||F|||20110530123551-0500|||||20110601130655-0500||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
OBX|2|SN|267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^^^^^^GENTAMICIN|1|^0.05|ug/mL^^UCUM||S|||F|||20110530123551-0500|||||20110601130655-0500||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
OBX|3|SN|185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^^^^^^CIPROFLOXACIN|1|^0.05|ug/mL^^UCUM||S|||F|||20110530123551-0500|||||20110601130655-0500||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
MSH|^~\&|NIST Test Lab APP|NIST Lab Facility||NIST EHR Facility|20110531140551-0500||ORU^R01^ORU_R01|NIST-LRI-NG-RN-004.02|T|2.5.1|||AL|NE|||||LRI_Common_Component^^2.16.840.1.113883.9.16^ISO~LRI_NG_Component^^2.16.840.1.113883.9.13^ISO~LRI_RN_Component^^2.16.840.1.113883.9.15^ISO
PID|1||PATID1234^^^NIST MPI^MR||Jones^William^A||19610615|M||2106-3^White^HL70005
ORC|RE|ORD723222-4^NIST EHR|R-783274-4^NIST Lab Filler|GORD874255^NIST EHR||||||||57422^Radon^Nicholas^^^^^^NIST-AA-1^L^^^NPI
OBR|1|ORD723222-4^NIST EHR|R-783274-4^NIST Lab Filler|625-4^Bacteria identified in Stool by Culture^LN^3456543^CULTURE STOOL^99USI^^^Stool Culture|||20110530123551-0500||||||787.91^DIARRHEA^I9CDX^^^^^^DIARRHEA|||57422^Radon^Nicholas^^^^^^NIST-AA-1^L^^^NPI||||||20110531140428-0500|||F
OBX|1|CWE|625-4^Bacteria identified in Stool by Culture^LN^^^^^^Stool Culture|1|103429008^Enterohemorrhagic Escherichia coli, serotype O157:H7^SCT^^^^^^Shiga toxin producing E. coli O157:H7 isolated|||A|||F|||20110530123551-0500|||||20110531130655-0500||||Century Hospital^^^^^NIST HCAA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^NIST HCAA-1^L^^^NPI
OBX|2|CWE|625-4^Bacteria identified in Stool by Culture^LN^^^^^^Stool Culture|2|398567006^Salmonella I, group O:4^SCT^^^^^^Salmonella I, group O:4 isolated|||A|||F|||20110530123551-0500|||||20110531130655-0500||||Century Hospital^^^^^NIST HCAA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^NIST HCAA-1^L^^^NPI
OBX|3|CWE|625-4^Bacteria identified in Stool by Culture^LN^^^^^^Stool Culture|3|85729005^Shigella flexneri^SCT^^^^^^Shigella flexneri isolated|||A|||F|||20110530123551-0500|||||20110531130655-0500||||Century Hospital^^^^^NIST HCAA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^NIST HCAA-1^L^^^NPI
ORC|RE||R-783274-4^NIST Lab Filler|GORD874255^NIST EHR||||||||57422^Radon^Nicholas^^^^^^NIST-AA-1^L^^^NPI|||||||||||||||||||625-4^Bacteria identified in Stool by Culture^LN^3456543^CULTURE STOOL^99USI^^^Stool Culture
OBR|2||R-783274-4^NIST Lab Filler|50545-3^Bacterial susceptibility panel in Isolate by Minimum inhibitory concentration (MIC)^LN^^^^^^Bacteria susceptibility|||20110530123551-0500||||G|||||57422^Radon^Nicholas^^^^^^NIST-AA-1^L^^^NPI||||||20110601140428-0500|||F|625-4&Bacteria identified in Stool by Culture&LN&&&&&&Stool Culture^1|||ORD723222-4&NIST EHR^R-783274-4&NIST Lab Filler|||||||||||||||||||||625-4^Bacteria identified in Stool by Culture^LN^3456543^CULTURE STOOL^99USI^^^Stool Culture
OBX|1|SN|28-1^Ampicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^^^^^^AMPICILLIN|1|<^0.06|ug/mL^^UCUM||S|||F|||20110530123551-0500|||||20110601130655-0500||||Century Hospital^^^^^NIST HCAA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^NIST HCAA-1^L^^^NPI
OBX|2|SN|267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^^^^^^GENTAMICIN|1|^0.05|ug/mL^^UCUM||S|||F|||20110530123551-0500|||||20110601130655-0500||||Century Hospital^^^^^NIST HCAA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^NIST HCAA-1^L^^^NPI
OBX|3|SN|185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^^^^^^CIPROFLOXACIN|1|^0.05|ug/mL^^UCUM||S|||F|||20110530123551-0500|||||20110601130655-0500||||Century Hospital^^^^^NIST HCAA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^NIST HCAA-1^L^^^NPI
ORC|RE||R-783274-4^NIST Lab Filler|GORD874255^NIST EHR||||||||57422^Radon^Nicholas^^^^^^NIST-AA-1^L^^^NPI|||||||||||||||||||625-4^Bacteria identified in Stool by Culture^LN^3456543^CULTURE STOOL^99USI^^^Stool Culture
OBR|3||R-783274-4^NIST Lab Filler|50545-3^Bacterial susceptibility panel in Isolate by Minimum inhibitory concentration (MIC)^LN^^^^^^Bacteria susceptibility|||20110530123551-0500||||G|||||57422^Radon^Nicholas^^^^^^NIST-AA-1^L^^^NPI||||||20110601140428-0500|||F|625-4&Bacteria identified in Stool by Culture&LN&&&&&&Stool Culture^2|||ORD723222-4&NIST EHR^R-783274-4&NIST Lab Filler|||||||||||||||||||||625-4^Bacteria identified in Stool by Culture^LN^3456543^CULTURE STOOL^99USI^^^Stool Culture
OBX|1|SN|28-1^Ampicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^^^^^^AMPICILLIN|1|<^0.06|ug/mL^^UCUM||S|||F|||20110530123551-0500|||||20110601130655-0500||||Century Hospital^^^^^NIST HCAA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^NIST HCAA-1^L^^^NPI
OBX|2|SN|267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^^^^^^GENTAMICIN|1|^0.05|ug/mL^^UCUM||S|||F|||20110530123551-0500|||||20110601130655-0500||||Century Hospital^^^^^NIST HCAA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^NIST HCAA-1^L^^^NPI
OBX|3|SN|185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^^^^^^CIPROFLOXACIN|1|^0.05|ug/mL^^UCUM||S|||F|||20110530123551-0500|||||20110601130655-0500||||Century Hospital^^^^^NIST HCAA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^NIST HCAA-1^L^^^NPI
ORC|RE||R-783274-4^NIST Lab Filler|GORD874255^NIST EHR||||||||57422^Radon^Nicholas^^^^^^NIST-AA-1^L^^^NPI|||||||||||||||||||625-4^Bacteria identified in Stool by Culture^LN^3456543^CULTURE STOOL^99USI^^^Stool Culture
OBR|4||R-783274-4^NIST Lab Filler|50545-3^Bacterial susceptibility panel in Isolate by Minimum inhibitory concentration (MIC)^LN^^^^^^Bacteria susceptibility|||20110530123551-0500||||G|||||57422^Radon^Nicholas^^^^^^NIST-AA-1^L^^^NPI||||||20110601140428-0500|||F|625-4&Bacteria identified in Stool by Culture&LN&&&&&&Stool Culture^3|||ORD723222-4&NIST EHR^R-783274-4&NIST Lab Filler|||||||||||||||||||||625-4^Bacteria identified in Stool by Culture^LN^3456543^CULTURE STOOL^99USI^^^Stool Culture
OBX|1|SN|28-1^Ampicillin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^^^^^^AMPICILLIN|1|<^0.06|ug/mL^^UCUM||S|||F|||20110530123551-0500|||||20110601130655-0500||||Century Hospital^^^^^NIST HCAA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^NIST HCAA-1^L^^^NPI
OBX|2|SN|267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^^^^^^GENTAMICIN|1|^0.05|ug/mL^^UCUM||S|||F|||20110530123551-0500|||||20110601130655-0500||||Century Hospital^^^^^NIST HCAA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^NIST HCAA-1^L^^^NPI
OBX|3|SN|185-9^Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN^^^^^^CIPROFLOXACIN|1|^0.05|ug/mL^^UCUM||S|||F|||20110530123551-0500|||||20110601130655-0500||||Century Hospital^^^^^NIST HCAA-1^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|9876543^Slide^Stan^S^^^^^NIST HCAA-1^L^^^NPI
MSH|^~\&|^2.16.840.1.113883.3.72.5.20^ISO|^2.16.840.1.113883.3.72.5.21^ISO||^2.16.840.1.113883.3.72.5.23^ISO|20110531140551-0500||ORU^R01^ORU_R01|NIST-LRI-GU-RU-005.00|T|2.5.1|||AL|NE|||||LRI_Common_Component^^2.16.840.1.113883.9.16^ISO~LRI_GU_Component^^2.16.840.1.113883.9.12^ISO~LRI_RU_Component^^2.16.840.1.113883.9.14^ISO
PID|1||PATID1239^^^&2.16.840.1.113883.3.72.5.30.2&ISO^MR||Smirnoff^Peggy^^^^^M||19750401|F||2106-3^White^HL70005^wh^white^L
ORC|RE|ORD448811^^2.16.840.1.113883.3.72.5.24^ISO|R-511^^2.16.840.1.113883.3.72.5.25^ISO|||||||||1234567890^Fine^Larry^^^Dr.^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
OBR|1|ORD448811^^2.16.840.1.113883.3.72.5.24^ISO|R-511^^2.16.840.1.113883.3.72.5.25^ISO|HepABC Panel^Hepatitis A B C Panel^L|||20120628070100|||||||||1234567890^Fine^Larry^^^Dr.^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI||||||20120629132900-0500|||F
OBX|1|CWE|22314-9^Hepatitis A virus IgM Ab [Presence] in Serum^LN^HAVM^Hepatitis A IgM antibodies (IgM anti-HAV)^L||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^^^Negative (qualifier value)||Negative|N|||F|||20120628070100|||||20120628100500||||Princeton Hospital Laboratory^^^^^NIST HCAA-1&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
OBX|2|CWE|20575-7^Hepatitis A virus Ab [Presence] in Serum^LN^HAVAB^Hepatitis A antibodies (anti-HAV)^L||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^^^Negative (qualifier value)||Negative|N|||F|||20120628070100|||||20120628100500||||Princeton Hospital Laboratory^^^^^NIST HCAA-1&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
OBX|3|CWE|16933-4^Hepatitis B virus core Ab [Presence] in Serum^LN^HBVcAB^Hepatitis B core antibodies (anti-HBVc)^L||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^^^Negative (qualifier value)||Negative|N|||F|||20120628070100|||||20120628100500||||Princeton Hospital Laboratory^^^^^NIST HCAA-1&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
OBX|4|SN|22316-4^Hepatitis B virus core Ab [Units/volume] in Serum^LN^HBcAbQ^Hepatitis B core antibodies (anti-HBVc) Quant^L||^0.40|[IU]/mL^international unit per milliliter^UCUM^IU/ml^^L|<0.50 IU/mL|N|||F|||20120628070100|||||20120628100500||||Princeton Hospital Laboratory^^^^^NIST HCAA-1&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
OBX|5|CWE|22320-6^Hepatitis B virus e Ab [Presence] in Serum^LN^HBVeAB^Hepatitis B e antibodies (anti-HBVe)^L||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^^^Negative (qualifier value)||Negative|N|||F|||20120628070100|||||20120628100500||||Princeton Hospital Laboratory^^^^^NIST HCAA-1&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
OBX|6|CWE|5195-3^Hepatitis B virus surface Ag [Presence] in Serum^LN^HBVsAG^Hepatitis B surface antigen (HBsAg)^L||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^^^Negative (qualifier value)||Negative|N|||F|||20120628070100|||||20120628100500||||Princeton Hospital Laboratory^^^^^NIST HCAA-1&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
OBX|7|CWE|22322-2^Hepatitis B virus surface Ab [Presence] in Serum^LN^HBVSAB^Hepatitis B surface antibody (anti-HBVs)^L||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^^^Negative (qualifier value)||Negative|N|||F|||20120628070100|||||20120628100500||||Princeton Hospital Laboratory^^^^^NIST HCAA-1&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
OBX|8|CWE|16128-1^Hepatitis C virus Ab [Presence] in Serum^LN^HCVAB^Hepatitis C antibody screen  (anti-HCV)^L||10828004^Positive (qualifier value)^SCT^POS^POSITIVE^L^^^Positive (qualifier value)||Negative|A|||F|||20120628070100|||||20120628100500||||Princeton Hospital Laboratory^^^^^NIST HCAA-1&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
OBX|9|SN|48159-8^Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay^LN^HCVSCO^Hepatitis C antibodies Signal to Cut-off Ratio^L||^10.8|{s_co_ratio}^Signal to cutoff ratio^UCUM^s/co^^L|0.0-0.9 s/co|H|||F|||20120628070100|||||20120628100500||||Princeton Hospital Laboratory^^^^^NIST HCAA-1&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
NTE|1||Negative:   < 0.8; Indeterminate 0.8 - 0.9; Positive:  > 0.9.  In order to reduce the incidence of a false positive result, the CDC recommends that all s/co ratios between 1.0 and 10.9 be confirmed with additional Verification or PCR testing.
ORC|RE||R-512^^2.16.840.1.113883.3.72.5.25^ISO|||||||||1234567890^Fine^Larry^^^Dr.^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
OBR|2||R-512^^2.16.840.1.113883.3.72.5.25^ISO|11011-4^Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method^LN^HCVRNA^Hepatitis C RNA PCR^L|||20120628070100||||G|||||1234567890^Fine^Larry^^^Dr.^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI||||||20120629132900-0500|||F|16128-1&Hepatitis C virus Ab [Presence] in Serum&LN&HCVAB&Hepatitis C antibody screen  (anti-HCV)&L|||ORD448811&&2.16.840.1.113883.3.72.5.24&ISO^R-511&&2.16.840.1.113883.3.72.5.25&ISO
OBX|1|SN|11011-4^Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method^LN^HCVRNA^Hepatitis C RNA PCR^L||^7611200|[IU]/mL^international unit per milliliter^UCUM^IU/ml^^L|<43 IU/mL|H|||F|||20120628070100|||||20120629092700||||Princeton Hospital Laboratory^^^^^NIST HCAA-1&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
MSH|^~\&|NIST Test Lab APP|NIST Lab Facility||NIST EHR Facility|20110531140551-0500||ORU^R01^ORU_R01|NIST-LRI-NG-RU-005.00|T|2.5.1|||AL|NE|||||LRI_Common_Component^^2.16.840.1.113883.9.16^ISO~LRI_NG_Component^^2.16.840.1.113883.9.13^ISO~LRI_RU_Component^^2.16.840.1.113883.9.14^ISO
PID|1||PATID1239^^^NIST MPI^MR||Smirnoff^Peggy^^^^^M||19750401|F||2106-3^White^HL70005^wh^white^L
ORC|RE|ORD448811^NIST EHR|R-511^NIST Lab Filler|||||||||1234567890^Fine^Larry^^^Dr.^^^NIST-AA-1^L^^^NPI
OBR|1|ORD448811^NIST EHR|R-511^NIST Lab Filler|HepABC Panel^Hepatitis A B C Panel^L|||20120628070100|||||||||1234567890^Fine^Larry^^^Dr.^^^NIST-AA-1^L^^^NPI||||||20120629132900-0500|||F
OBX|1|CWE|22314-9^Hepatitis A virus IgM Ab [Presence] in Serum^LN^HAVM^Hepatitis A IgM antibodies (IgM anti-HAV)^L||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^^^Negative (qualifier value)||Negative|N|||F|||20120628070100|||||20120628100500||||Princeton Hospital Laboratory^^^^^NIST HCAA-1^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
OBX|2|CWE|20575-7^Hepatitis A virus Ab [Presence] in Serum^LN^HAVAB^Hepatitis A antibodies (anti-HAV)^L||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^^^Negative (qualifier value)||Negative|N|||F|||20120628070100|||||20120628100500||||Princeton Hospital Laboratory^^^^^NIST HCAA-1^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
OBX|3|CWE|16933-4^Hepatitis B virus core Ab [Presence] in Serum^LN^HBVcAB^Hepatitis B core antibodies (anti-HBVc)^L||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^^^Negative (qualifier value)||Negative|N|||F|||20120628070100|||||20120628100500||||Princeton Hospital Laboratory^^^^^NIST HCAA-1^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
OBX|4|SN|22316-4^Hepatitis B virus core Ab [Units/volume] in Serum^LN^HBcAbQ^Hepatitis B core antibodies (anti-HBVc) Quant^L||^0.40|[IU]/mL^international unit per milliliter^UCUM^IU/ml^^L|<0.50 IU/mL|N|||F|||20120628070100|||||20120628100500||||Princeton Hospital Laboratory^^^^^NIST HCAA-1^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
OBX|5|CWE|22320-6^Hepatitis B virus e Ab [Presence] in Serum^LN^HBVeAB^Hepatitis B e antibodies (anti-HBVe)^L||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^^^Negative (qualifier value)||Negative|N|||F|||20120628070100|||||20120628100500||||Princeton Hospital Laboratory^^^^^NIST HCAA-1^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
OBX|6|CWE|5195-3^Hepatitis B virus surface Ag [Presence] in Serum^LN^HBVsAG^Hepatitis B surface antigen (HBsAg)^L||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^^^Negative (qualifier value)||Negative|N|||F|||20120628070100|||||20120628100500||||Princeton Hospital Laboratory^^^^^NIST HCAA-1^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
OBX|7|CWE|22322-2^Hepatitis B virus surface Ab [Presence] in Serum^LN^HBVSAB^Hepatitis B surface antibody (anti-HBVs)^L||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^^^Negative (qualifier value)||Negative|N|||F|||20120628070100|||||20120628100500||||Princeton Hospital Laboratory^^^^^NIST HCAA-1^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
OBX|8|CWE|16128-1^Hepatitis C virus Ab [Presence] in Serum^LN^HCVAB^Hepatitis C antibody screen  (anti-HCV)^L||10828004^Positive (qualifier value)^SCT^POS^POSITIVE^L^^^Positive (qualifier value)||Negative|A|||F|||20120628070100|||||20120628100500||||Princeton Hospital Laboratory^^^^^NIST HCAA-1^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
OBX|9|SN|48159-8^Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay^LN^HCVSCO^Hepatitis C antibodies Signal to Cut-off Ratio^L||^10.8|{s_co_ratio}^Signal to cutoff ratio^UCUM^s/co^^L|0.0-0.9 s/co|H|||F|||20120628070100|||||20120628100500||||Princeton Hospital Laboratory^^^^^NIST HCAA-1^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
NTE|1||Negative:   < 0.8; Indeterminate 0.8 - 0.9; Positive:  > 0.9.  In order to reduce the incidence of a false positive result, the CDC recommends that all s/co ratios between 1.0 and 10.9 be confirmed with additional Verification or PCR testing.
ORC|RE||R-512^NIST Lab Filler|||||||||1234567890^Fine^Larry^^^Dr.^^^NIST-AA-1^L^^^NPI
OBR|2||R-512^NIST Lab Filler|11011-4^Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method^LN^HCVRNA^Hepatitis C RNA PCR^L|||20120628070100||||G|||||1234567890^Fine^Larry^^^Dr.^^^NIST-AA-1^L^^^NPI||||||20120629132900-0500|||F|16128-1&Hepatitis C virus Ab [Presence] in Serum&LN&HCVAB&Hepatitis C antibody screen  (anti-HCV)&L|||ORD448811&NIST EHR^R-511&NIST Lab Filler
OBX|1|SN|11011-4^Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method^LN^HCVRNA^Hepatitis C RNA PCR^L||^7611200|[IU]/mL^international unit per milliliter^UCUM^IU/ml^^L|<43 IU/mL|H|||F|||20120628070100|||||20120629092700||||Princeton Hospital Laboratory^^^^^NIST HCAA-1^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
MSH|^~\&|^2.16.840.1.113883.3.72.5.20^ISO|^2.16.840.1.113883.3.72.5.21^ISO||^2.16.840.1.113883.3.72.5.23^ISO|20110531140551-0500||ORU^R01^ORU_R01|NIST-LRI-GU-RN-005.01|T|2.5.1|||AL|NE|||||LRI_Common_Component^^2.16.840.1.113883.9.16^ISO~LRI_GU_Component^^2.16.840.1.113883.9.12^ISO~LRI_RN_Component^^2.16.840.1.113883.9.15^ISO
PID|1||PATID1239^^^&2.16.840.1.113883.3.72.5.30.2&ISO^MR||Smirnoff^Peggy^^^^^M||19750401|F||2106-3^White^HL70005^wh^white^L
ORC|RE|ORD448811^^2.16.840.1.113883.3.72.5.24^ISO|R-511^^2.16.840.1.113883.3.72.5.25^ISO|||||||||1234567890^Fine^Larry^^^Dr.^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI
OBR|1|ORD448811^^2.16.840.1.113883.3.72.5.24^ISO|R-511^^2.16.840.1.113883.3.72.5.25^ISO|HepABC Panel^Hepatitis A B C Panel^L|||20120628070100|||||||||1234567890^Fine^Larry^^^Dr.^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI||||||20120629132900-0500|||F
OBX|1|CWE|22314-9^Hepatitis A virus IgM Ab [Presence] in Serum^LN^HAVM^Hepatitis A IgM antibodies (IgM anti-HAV)^L||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^^^Negative (qualifier value)||Negative|N|||F|||20120628070100|||||20120628100500||||Princeton Hospital Laboratory^^^^^NIST HCAA-1&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
OBX|2|CWE|20575-7^Hepatitis A virus Ab [Presence] in Serum^LN^HAVAB^Hepatitis A antibodies (anti-HAV)^L||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^^^Negative (qualifier value)||Negative|N|||F|||20120628070100|||||20120628100500||||Princeton Hospital Laboratory^^^^^NIST HCAA-1&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
OBX|3|CWE|16933-4^Hepatitis B virus core Ab [Presence] in Serum^LN^HBVcAB^Hepatitis B core antibodies (anti-HBVc)^L||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^^^Negative (qualifier value)||Negative|N|||F|||20120628070100|||||20120628100500||||Princeton Hospital Laboratory^^^^^NIST HCAA-1&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
OBX|4|SN|22316-4^Hepatitis B virus core Ab [Units/volume] in Serum^LN^HBcAbQ^Hepatitis B core antibodies (anti-HBVc) Quant^L||^0.40|[IU]/mL^international unit per milliliter^UCUM^IU/ml^^L|<0.50 IU/mL|N|||F|||20120628070100|||||20120628100500||||Princeton Hospital Laboratory^^^^^NIST HCAA-1&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
OBX|5|CWE|22320-6^Hepatitis B virus e Ab [Presence] in Serum^LN^HBVeAB^Hepatitis B e antibodies (anti-HBVe)^L||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^^^Negative (qualifier value)||Negative|N|||F|||20120628070100|||||20120628100500||||Princeton Hospital Laboratory^^^^^NIST HCAA-1&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
OBX|6|CWE|5195-3^Hepatitis B virus surface Ag [Presence] in Serum^LN^HBVsAG^Hepatitis B surface antigen (HBsAg)^L||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^^^Negative (qualifier value)||Negative|N|||F|||20120628070100|||||20120628100500||||Princeton Hospital Laboratory^^^^^NIST HCAA-1&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
OBX|7|CWE|22322-2^Hepatitis B virus surface Ab [Presence] in Serum^LN^HBVSAB^Hepatitis B surface antibody (anti-HBVs)^L||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^^^Negative (qualifier value)||Negative|N|||F|||20120628070100|||||20120628100500||||Princeton Hospital Laboratory^^^^^NIST HCAA-1&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
OBX|8|CWE|16128-1^Hepatitis C virus Ab [Presence] in Serum^LN^HCVAB^Hepatitis C antibody screen  (anti-HCV)^L||10828004^Positive (qualifier value)^SCT^POS^POSITIVE^L^^^Positive (qualifier value)||Negative|A|||F|||20120628070100|||||20120628100500||||Princeton Hospital Laboratory^^^^^NIST HCAA-1&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
OBX|9|SN|48159-8^Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay^LN^HCVSCO^Hepatitis C antibodies Signal to Cut-off Ratio^L||^10.8|{s_co_ratio}^Signal to cutoff ratio^UCUM^s/co^^L|0.0-0.9 s/co|H|||F|||20120628070100|||||20120628100500||||Princeton Hospital Laboratory^^^^^NIST HCAA-1&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
NTE|1||Negative:   < 0.8; Indeterminate 0.8 - 0.9; Positive:  > 0.9.  In order to reduce the incidence of a false positive result, the CDC recommends that all s/co ratios between 1.0 and 10.9 be confirmed with additional Verification or PCR testing.
ORC|RE||R-512^^2.16.840.1.113883.3.72.5.25^ISO|||||||||1234567890^Fine^Larry^^^Dr.^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI|||||||||||||||||||HepABC Panel^Hepatitis A B C Panel^L
OBR|2||R-512^^2.16.840.1.113883.3.72.5.25^ISO|11011-4^Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method^LN^HCVRNA^Hepatitis C RNA PCR^L|||20120628070100||||G|||||1234567890^Fine^Larry^^^Dr.^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^NPI||||||20120629132900-0500|||F|16128-1&Hepatitis C virus Ab [Presence] in Serum&LN&HCVAB&Hepatitis C antibody screen  (anti-HCV)&L|||ORD448811&&2.16.840.1.113883.3.72.5.24&ISO^R-511&&2.16.840.1.113883.3.72.5.25&ISO|||||||||||||||||||||HepABC Panel^Hepatitis A B C Panel^L
OBX|1|SN|11011-4^Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method^LN^HCVRNA^Hepatitis C RNA PCR^L||^7611200|[IU]/mL^international unit per milliliter^UCUM^IU/ml^^L|<43 IU/mL|H|||F|||20120628070100|||||20120629092700||||Princeton Hospital Laboratory^^^^^NIST HCAA-1&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
MSH|^~\&|NIST Test Lab APP|NIST Lab Facility||NIST EHR Facility|20110531140551-0500||ORU^R01^ORU_R01|NIST-LRI-NG-RN-005.01|T|2.5.1|||AL|NE|||||LRI_Common_Component^^2.16.840.1.113883.9.16^ISO~LRI_NG_Component^^2.16.840.1.113883.9.13^ISO~LRI_RN_Component^^2.16.840.1.113883.9.15^ISO
PID|1||PATID1239^^^NIST MPI^MR||Smirnoff^Peggy^^^^^M||19750401|F||2106-3^White^HL70005^wh^white^L
ORC|RE|ORD448811^NIST EHR|R-511^NIST Lab Filler|||||||||1234567890^Fine^Larry^^^Dr.^^^NIST-AA-1^L^^^NPI
OBR|1|ORD448811^NIST EHR|R-511^NIST Lab Filler|HepABC Panel^Hepatitis A B C Panel^L|||20120628070100|||||||||1234567890^Fine^Larry^^^Dr.^^^NIST-AA-1^L^^^NPI||||||20120629132900-0500|||F
OBX|1|CWE|22314-9^Hepatitis A virus IgM Ab [Presence] in Serum^LN^HAVM^Hepatitis A IgM antibodies (IgM anti-HAV)^L||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^^^Negative (qualifier value)||Negative|N|||F|||20120628070100|||||20120628100500||||Princeton Hospital Laboratory^^^^^NIST HCAA-1^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
OBX|2|CWE|20575-7^Hepatitis A virus Ab [Presence] in Serum^LN^HAVAB^Hepatitis A antibodies (anti-HAV)^L||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^^^Negative (qualifier value)||Negative|N|||F|||20120628070100|||||20120628100500||||Princeton Hospital Laboratory^^^^^NIST HCAA-1^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
OBX|3|CWE|16933-4^Hepatitis B virus core Ab [Presence] in Serum^LN^HBVcAB^Hepatitis B core antibodies (anti-HBVc)^L||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^^^Negative (qualifier value)||Negative|N|||F|||20120628070100|||||20120628100500||||Princeton Hospital Laboratory^^^^^NIST HCAA-1^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
OBX|4|SN|22316-4^Hepatitis B virus core Ab [Units/volume] in Serum^LN^HBcAbQ^Hepatitis B core antibodies (anti-HBVc) Quant^L||^0.40|[IU]/mL^international unit per milliliter^UCUM^IU/ml^^L|<0.50 IU/mL|N|||F|||20120628070100|||||20120628100500||||Princeton Hospital Laboratory^^^^^NIST HCAA-1^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
OBX|5|CWE|22320-6^Hepatitis B virus e Ab [Presence] in Serum^LN^HBVeAB^Hepatitis B e antibodies (anti-HBVe)^L||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^^^Negative (qualifier value)||Negative|N|||F|||20120628070100|||||20120628100500||||Princeton Hospital Laboratory^^^^^NIST HCAA-1^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
OBX|6|CWE|5195-3^Hepatitis B virus surface Ag [Presence] in Serum^LN^HBVsAG^Hepatitis B surface antigen (HBsAg)^L||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^^^Negative (qualifier value)||Negative|N|||F|||20120628070100|||||20120628100500||||Princeton Hospital Laboratory^^^^^NIST HCAA-1^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
OBX|7|CWE|22322-2^Hepatitis B virus surface Ab [Presence] in Serum^LN^HBVSAB^Hepatitis B surface antibody (anti-HBVs)^L||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^^^Negative (qualifier value)||Negative|N|||F|||20120628070100|||||20120628100500||||Princeton Hospital Laboratory^^^^^NIST HCAA-1^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
OBX|8|CWE|16128-1^Hepatitis C virus Ab [Presence] in Serum^LN^HCVAB^Hepatitis C antibody screen  (anti-HCV)^L||10828004^Positive (qualifier value)^SCT^POS^POSITIVE^L^^^Positive (qualifier value)||Negative|A|||F|||20120628070100|||||20120628100500||||Princeton Hospital Laboratory^^^^^NIST HCAA-1^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
OBX|9|SN|48159-8^Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay^LN^HCVSCO^Hepatitis C antibodies Signal to Cut-off Ratio^L||^10.8|{s_co_ratio}^Signal to cutoff ratio^UCUM^s/co^^L|0.0-0.9 s/co|H|||F|||20120628070100|||||20120628100500||||Princeton Hospital Laboratory^^^^^NIST HCAA-1^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
NTE|1||Negative:   < 0.8; Indeterminate 0.8 - 0.9; Positive:  > 0.9.  In order to reduce the incidence of a false positive result, the CDC recommends that all s/co ratios between 1.0 and 10.9 be confirmed with additional Verification or PCR testing.
ORC|RE||R-511^NIST Lab Filler|||||||||1234567890^Fine^Larry^^^Dr.^^^NIST-AA-1^L^^^NPI|||||||||||||||||||HepABC Panel^Hepatitis A B C Panel^L
OBR|2||R-511^NIST Lab Filler|11011-4^Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method^LN^HCVRNA^Hepatitis C RNA PCR^L|||20120628070100||||G|||||1234567890^Fine^Larry^^^Dr.^^^NIST-AA-1^L^^^NPI||||||20120629132900-0500|||F|16128-1&Hepatitis C virus Ab [Presence] in Serum&LN&HCVAB&Hepatitis C antibody screen  (anti-HCV)&L|||ORD448811&NIST EHR^R-511&NIST Lab Filler|||||||||||||||||||||HepABC Panel^Hepatitis A B C Panel^L
OBX|1|SN|11011-4^Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method^LN^HCVRNA^Hepatitis C RNA PCR^L||^7611200|[IU]/mL^international unit per milliliter^UCUM^IU/ml^^L|<43 IU/mL|H|||F|||20120628070100|||||20120629092700||||Princeton Hospital Laboratory^^^^^NIST HCAA-1^XX^^^34D4567890|123 High Street^^Princeton^NJ^08540^USA^O^^34021|^Martin^Steven^M^^Dr.
MSH|^~\&||BgCtyChldrnUrgntCar^1231231234^NPI|||201002201000||ADT^A04^ADT_A01|NIST-SS-001.11|P|2.5.1|||||||||PH_SS-NoAck^SS Sender^2.16.840.1.114222.4.10.3^ISO
EVN||201002200900|||||BgCtyChldrnUrgntCar^1231231234^NPI
PID|1||11111^^^^MR||^^^^^^~^^^^^^S|||M||2076-8^^CDCREC|^^^^02130^^^^25025|||||||||||2186-5^^CDCREC
PV1|1||||||||||||||||||1111_001^^^^VN|||||||||||||||||||||||||201002200830
OBX|1|CWE|SS003^^PHINQUESTION||261QU0200X^Urgent Care^NUCC||||||F
OBX|2|NM|21612-7^^LN||0|a^^UCUM|||||F
OBX|3|CWE|8661-1^^LN||^^^^^^^^Fever, cough||||||F
DG1|1||4871^Influenza with other respiratory manifestations^I9CDX|||W


MSH|^~\&||MidTwnUrgentC^2231231234^NPI|||201208171230||ADT^A04^ADT_A01|NIST-SS-001.12|P|2.5.1|||||||||PH_SS-NoAck^SS Sender^2.16.840.1.114222.4.10.3^ISO
EVN||201208171220|||||MidTwnUrgentC^2231231234^NPI
PID|1||2222^^^^MR||^^^^^^~^^^^^^S|||F||2106-3^^CDCREC|^^^^30303^^^^13121|||||||||||2135-2^^CDCREC
PV1|1||||||||||||||||||2222_001^^^^VN|||||||||||||||||||||||||201208171130
OBX|1|CWE|SS003^^PHINQUESTION||261QU0200X^Urgent Care^NUCC||||||F
OBX|2|NM|21612-7^^LN||35|a^^UCUM|||||F
OBX|3|CWE|8661-1^^LN||^^^^^^^^Fever, chills, smelly urine with burning during urination||||||F
DG1|1||5990^Urinary tract infection, site not specified^I9CDX|||W


MSH|^~\&||SmvUrgentC^3231231234^NPI|||201208251430||ADT^A04^ADT_A01|NIST-SS-001.13|P|2.5.1|||||||||PH_SS-NoAck^SS Sender^2.16.840.1.114222.4.10.3^ISO
EVN||201208251430|||||SmvUrgentC^3231231234^NPI
PID|1||3111^^^^MR||^^^^^^~^^^^^^S|||M||2106-3^^CDCREC|^^^^66733^^^^20133|||||||||||2186-5^^CDCREC
PV1|1||||||||||||||||||3111_001^^^^VN|||||||||||||||||||||||||201208251300
OBX|1|CWE|SS003^^PHINQUESTION||261QU0200X^Urgent Care^NUCC||||||F
OBX|2|NM|21612-7^^LN||27|a^^UCUM|||||F
OBX|3|CWE|8661-1^^LN||^^^^^^^^Skateboarding accident possible broken right arm, swelling and painful to move||||||F
DG1|1||81380^closed fracture of unspecified part of forearm^I9CDX|||W


MSH|^~\&||BgCtyChldrnUrgntCar^1231231234^NPI|||201002201800||ADT^A03^ADT_A03|NIST-SS-001.21|P|2.5.1|||||||||PH_SS-NoAck^SS Sender^2.16.840.1.114222.4.10.3^ISO
EVN||201002201800|||||BgCtyChldrnUrgntCar^1231231234^NPI
PID|1||11111^^^^MR||^^^^^^~^^^^^^S|||M||2076-8^^CDCREC|^^^^02130^^^^25025|||||||||||2186-5^^CDCREC
PV1|1||||||||||||||||||1111_001^^^^VN|||||||||||||||||01||||||||201002200830
DG1|1||481^Pneumococcal pneumonia [Streptococcus pneumoniae pneumonia]^I9CDX|||F
DG1|2||487^Influenza^I9CDX|||F
OBX|1|CWE|SS003^^PHINQUESTION||261QU0200X^Urgent Care^NUCC||||||F
OBX|2|NM|21612-7^^LN||0|a^^UCUM|||||F
OBX|3|CWE|8661-1^^LN||^^^^^^^^Fever, cough||||||F


MSH|^~\&||MidTwnUrgentC^2231231234^NPI|||201208171430||ADT^A03^ADT_A03|NIST-SS-001.22|P|2.5.1|||||||||PH_SS-NoAck^SS Sender^2.16.840.1.114222.4.10.3^ISO
EVN||201208171300|||||MidTwnUrgentC^2231231234^NPI
PID|1||2222^^^^MR||^^^^^^~^^^^^^S|||F||2106-3^^CDCREC|^^^^30303^^^^13121|||||||||||2135-2^^CDCREC
PV1|1||||||||||||||||||2222_001^^^^VN|||||||||||||||||01||||||||201208171130
DG1|1||5990^Urinary tract infection, site not specified^I9CDX|||F
OBX|1|CWE|SS003^^PHINQUESTION||261QU0200X^Urgent Care^NUCC||||||F
OBX|2|NM|21612-7^^LN||35|a^^UCUM|||||F
OBX|3|CWE|8661-1^^LN||^^^^^^^^Fever, chills, smelly urine with burning during urination||||||F


MSH|^~\&||SmvUrgentC^3231231234^NPI|||201208251830||ADT^A03^ADT_A03|NIST-SS-001.23|P|2.5.1|||||||||PH_SS-NoAck^SS Sender^2.16.840.1.114222.4.10.3^ISO
EVN||201208251830|||||SmvUrgentC^3231231234^NPI
PID|1||3111^^^^MR||^^^^^^~^^^^^^S|||M||2106-3^^CDCREC|^^^^66733^^^^20133|||||||||||2186-5^^CDCREC
PV1|1||||||||||||||||||3111_001^^^^VN|||||||||||||||||01||||||||201208251300
DG1|1||81322^Closed fracture of shaft of ulna (alone)^I9CDX|||F
OBX|1|CWE|SS003^^PHINQUESTION||261QU0200X^Urgent Care^NUCC||||||F
OBX|2|NM|21612-7^^LN||27|a^^UCUM|||||F
OBX|3|CWE|8661-1^^LN||^^^^^^^^Skateboarding accident possible broken right arm, swelling and painful to move||||||F


MSH|^~\&||WstrnRgnlMedCntr^1231231235^NPI|||201207171700||ADT^A04^ADT_A01|NIST-SS-002.11|P|2.5.1|||||||||PH_SS-NoAck^SS Sender^2.16.840.1.114222.4.10.3^ISO
EVN||201207171700|||||WstrnRgnlMedCntr^1231231235^NPI
PID|1||222^^^^MR||^^^^^^~^^^^^^U|||F||2106-3^^CDCREC
PV1|1||||||||||||||||||20120709_0064^^^^VN|||||||||||||||||||||||||201207171700
OBX|1|CWE|SS003^^PHINQUESTION||261QE0002X^Emergency Care^NUCC||||||F
OBX|2|NM|21612-7^^LN|||UNK^^NULLFL|||||F
OBX|3|CWE|8661-1^^LN||E8126^Other motor vehicle traffic accident involving collision with motor vehicle injuring pedal cyclist^I9CDX||||||F


MSH|^~\&||PacNWHosED^2481227981^NPI|||201208030200||ADT^A04^ADT_A01|NIST-SS-002.12|P|2.5.1|||||||||PH_SS-NoAck^SS Sender^2.16.840.1.114222.4.10.3^ISO
EVN||201208030200|||||PacNWHosED^2481227981^NPI
PID|1||222^^^^MR||^^^^^^~^^^^^^U|||M||2106-3^^CDCREC
PV1|1||||||||||||||||||20120802_0064^^^^VN|||||||||||||||||||||||||201208022345
OBX|1|CWE|SS003^^PHINQUESTION||261QE0002X^Emergency Care^NUCC||||||F
OBX|2|NM|21612-7^^LN|||UNK^^NULLFL|||||F
OBX|3|CWE|8661-1^^LN||E890^Conflagration in private dwelling^I9CDX||||||F


MSH|^~\&||MidWsUnvMC^6462583641^NPI|||201205081600||ADT^A04^ADT_A01|NIST-SS-002.13|P|2.5.1|||||||||PH_SS-NoAck^SS Sender^2.16.840.1.114222.4.10.3^ISO
EVN||201205081600|||||MidWsUnvMC^6462583641^NPI
PID|1||222^^^^MR||^^^^^^~^^^^^^U|||F||2028-9^^CDCREC
PV1|1||||||||||||||||||20120508_0064^^^^VN|||||||||||||||||||||||||201205081525
OBX|1|CWE|SS003^^PHINQUESTION||261QE0002X^Emergency Care^NUCC||||||F
OBX|2|NM|21612-7^^LN|||UNK^^NULLFL|||||F
OBX|3|CWE|8661-1^^LN||E8809^accidental fall on or from other stairs or steps^I9CDX||||||F


MSH|^~\&||WstrnRgnlMedCntr^1231231235^NPI|||201207171730||ADT^A08^ADT_A01|NIST-SS-002.21|P|2.5.1|||||||||PH_SS-NoAck^SS Sender^2.16.840.1.114222.4.10.3^ISO
EVN||201207171720|||||WstrnRgnlMedCntr^1231231235^NPI
PID|1||222^^^^MR||^^^^^^~^^^^^^S|||F||2106-3^^CDCREC|^^^^60601
PV1|1||||||||||||||||||20120709_0064^^^^VN|||||||||||||||||||||||||201207171700
OBX|1|CWE|SS003^^PHINQUESTION||261QE0002X^Emergency Care^NUCC||||||F
OBX|2|NM|21612-7^^LN||35|a^^UCUM|||||F
OBX|3|CWE|8661-1^^LN||E8126^Other motor vehicle traffic accident involving collision with motor vehicle injuring pedal cyclist^I9CDX||||||F
DG1|1||80145^Closed fracture of base of skull with intracranial injury of other and unspecified nature, with prolonged [more than 24 hours] loss of consciousness, without return to pre-existing conscious level^I9CDX|||W


MSH|^~\&||PacNWHosED^2481227981^NPI|||201208030400||ADT^A08^ADT_A01|NIST-SS-002.22|P|2.5.1|||||||||PH_SS-NoAck^SS Sender^2.16.840.1.114222.4.10.3^ISO
EVN||201208030230|||||PacNWHosED^2481227981^NPI
PID|1||222^^^^MR||^^^^^^~^^^^^^S|||M||2106-3^^CDCREC|^^^^97201^^^^41051
PV1|1||||||||||||||||||20120802_0064^^^^VN|||||||||||||||||||||||||201208022345
OBX|1|CWE|SS003^^PHINQUESTION||261QE0002X^Emergency Care^NUCC||||||F
OBX|2|NM|21612-7^^LN||35|a^^UCUM|||||F
OBX|3|CWE|8661-1^^LN||E890^Conflagration in private dwelling^I9CDX||||||F
DG1|1||51881^Acute respiratory failure^I9CDX|||W


MSH|^~\&||MidWsUnvMC^6462583641^NPI|||201205081800||ADT^A08^ADT_A01|NIST-SS-002.23|P|2.5.1|||||||||PH_SS-NoAck^SS Sender^2.16.840.1.114222.4.10.3^ISO
EVN||201205081715|||||MidWsUnvMC^6462583641^NPI
PID|1||222^^^^MR||^^^^^^~^^^^^^S|||F||2028-9^^CDCREC|^^^^48104^^^^26161
PV1|1||||||||||||||||||20120508_0064^^^^VN|||||||||||||||||||||||||201205081525
OBX|1|CWE|SS003^^PHINQUESTION||261QE0002X^Emergency Care^NUCC||||||F
OBX|2|NM|21612-7^^LN||19|a^^UCUM|||||F
OBX|3|CWE|8661-1^^LN||E8809^accidental fall on or from other stairs or steps^I9CDX||||||F
DG1|1||8521^Subarachnoid hemorrhage following injury with open intracranial wound^I9CDX|||W


MSH|^~\&||WstrnRgnlMedCntr^1231231235^NPI|||201207171800||ADT^A03^ADT_A03|NIST-SS-002.31|P|2.5.1|||||||||PH_SS-NoAck^SS Sender^2.16.840.1.114222.4.10.3^ISO
EVN||201207171800|||||WstrnRgnlMedCntr^1231231235^NPI
PID|1||222^^^^MR||^^^^^^~^^^^^^S|||F||2106-3^^CDCREC|^^^^60601||||||||||||||||||201207171741|Y
PV1|1||||||||||||||||||20120709_0064^^^^VN|||||||||||||||||20||||||||201207171700
DG1|1||8505^Concussion with loss of consciousness of unspecified duration [850.5]^I9CDX|||F
OBX|1|CWE|SS003^^PHINQUESTION||261QE0002X^Emergency Care^NUCC||||||F
OBX|2|NM|21612-7^^LN||35|a^^UCUM|||||F
OBX|3|CWE|8661-1^^LN||E8126^Other motor vehicle traffic accident involving collision with motor vehicle injuring pedal cyclist^I9CDX||||||F


MSH|^~\&||PacNWHosED^2481227981^NPI|||201208031000||ADT^A03^ADT_A03|NIST-SS-002.32|P|2.5.1|||||||||PH_SS-NoAck^SS Sender^2.16.840.1.114222.4.10.3^ISO
EVN||201208030855|||||PacNWHosED^2481227981^NPI
PID|1||222^^^^MR||^^^^^^~^^^^^^S|||M||2106-3^^CDCREC|^^^^97201^^^^41051||||||||||||||||||201208030855|Y
PV1|1||||||||||||||||||20120802_0064^^^^VN|||||||||||||||||20||||||||201208022345
DG1|1||4275^Cardiopulmonary arrest^I9CDX|||F
OBX|1|CWE|SS003^^PHINQUESTION||261QE0002X^Emergency Care^NUCC||||||F
OBX|2|NM|21612-7^^LN||35|a^^UCUM|||||F
OBX|3|CWE|8661-1^^LN||E890^Conflagration in private dwelling^I9CDX||||||F


MSH|^~\&||MidWsUnvMC^6462583641^NPI|||201205082000||ADT^A03^ADT_A03|NIST-SS-002.33|P|2.5.1|||||||||PH_SS-NoAck^SS Sender^2.16.840.1.114222.4.10.3^ISO
EVN||201205081830|||||MidWsUnvMC^6462583641^NPI
PID|1||222^^^^MR||^^^^^^~^^^^^^S|||F||2028-9^^CDCREC|^^^^48104^^^^26161||||||||||||||||||201205081830|Y
PV1|1||||||||||||||||||20120508_0064^^^^VN|||||||||||||||||20||||||||201205081525
DG1|1||3484^Compression of the brain^I9CDX|||F
OBX|1|CWE|SS003^^PHINQUESTION||261QE0002X^Emergency Care^NUCC||||||F
OBX|2|NM|21612-7^^LN||19|a^^UCUM|||||F
OBX|3|CWE|8661-1^^LN||E8809^accidental fall on or from other stairs or steps^I9CDX||||||F


MSH|^~\&||SthrnMdwstMedCntr^1231231236^NPI|||201002010745||ADT^A04^ADT_A01|NIST-SS-003.11|P|2.5.1|||||||||PH_SS-NoAck^SS Sender^2.16.840.1.114222.4.10.3^ISO
EVN||201002010745|||||SthrnMdwstMedCntr^1231231236^NPI
PID|1||3333^^^^MR||^^^^^^~^^^^^^S|||M||2106-3^^CDCREC|^^^^74852^^^^40125|||||||||||2186-5^^CDCREC
PV1|1||||||||||||||||||3333_001^^^^VN|||||||||||||||||||||||||201002010730
OBX|1|CWE|SS003^^PHINQUESTION||261QE0002X^Emergency Care^NUCC||||||F
OBX|2|NM|21612-7^^LN||70|a^^UCUM|||||F
OBX|3|CWE|8661-1^^LN||^^^^^^^^headache, nausea and dizziness||||||F


MSH|^~\&||LakeMichMC^9879874000^NPI|||201204012200||ADT^A04^ADT_A01|NIST-SS-003.12|P|2.5.1|||||||||PH_SS-NoAck^SS Sender^2.16.840.1.114222.4.10.3^ISO
EVN||201204012200|||||LakeMichMC^9879874000^NPI
PID|1||33333^^^^MR||^^^^^^~^^^^^^S|||F||2106-3^^CDCREC|^^^^53217^^^^55089|||||||||||2186-5^^CDCREC
PV1|1||||||||||||||||||33333_001^^^^VN|||||||||||||||||||||||||201204012130
OBX|1|CWE|SS003^^PHINQUESTION||261QE0002X^Emergency Care^NUCC||||||F
OBX|2|NM|21612-7^^LN||45|a^^UCUM|||||F
OBX|3|CWE|8661-1^^LN||^^^^^^^^Diarrhea, stomach pain, dehydration||||||F


MSH|^~\&||SwCrnrHsp^7549321000^NPI|||201012271600||ADT^A04^ADT_A01|NIST-SS-003.13|P|2.5.1|||||||||PH_SS-NoAck^SS Sender^2.16.840.1.114222.4.10.3^ISO
EVN||201012271600|||||SwCrnrHsp^7549321000^NPI
PID|1||33333^^^^MR||^^^^^^~^^^^^^S|||M||2106-3^^CDCREC|^^^^85001^^^^04013|||||||||||2135-2^^CDCREC
PV1|1||||||||||||||||||33333_001^^^^VN|||||||||||||||||||||||||201012271530
OBX|1|CWE|SS003^^PHINQUESTION||261QE0002X^Emergency Care^NUCC||||||F
OBX|2|NM|21612-7^^LN||10|a^^UCUM|||||F
OBX|3|CWE|8661-1^^LN||^^^^^^^^fever, cough and difficulty breathing||||||F


MSH|^~\&||SthrnMdwstMedCntr^1231231236^NPI|||201002010815||ADT^A08^ADT_A01|NIST-SS-003.21|P|2.5.1|||||||||PH_SS-NoAck^SS Sender^2.16.840.1.114222.4.10.3^ISO
EVN||201002010810|||||SthrnMdwstMedCntr^1231231236^NPI
PID|1||3333^^^^MR||^^^^^^~^^^^^^S|||M||2106-3^^CDCREC|^^^^74852^^^^40125|||||||||||2186-5^^CDCREC
PV1|1||||||||||||||||||3333_001^^^^VN|||||||||||||||||||||||||201002010730
OBX|1|CWE|SS003^^PHINQUESTION||261QE0002X^Emergency Care^NUCC||||||F
OBX|2|NM|21612-7^^LN||70|a^^UCUM|||||F
OBX|3|CWE|8661-1^^LN||^^^^^^^^headache, nausea and dizziness||||||F
DG1|1||986^Toxic effect of carbon monoxide^I9CDX|||W


MSH|^~\&||LakeMichMC^9879874000^NPI|||201204012230||ADT^A08^ADT_A01|NIST-SS-003.22|P|2.5.1|||||||||PH_SS-NoAck^SS Sender^2.16.840.1.114222.4.10.3^ISO
EVN||201204012215|||||LakeMichMC^9879874000^NPI
PID|1||33333^^^^MR||^^^^^^~^^^^^^S|||F||2106-3^^CDCREC|^^^^53217^^^^55089|||||||||||2186-5^^CDCREC
PV1|1||||||||||||||||||33333_001^^^^VN|||||||||||||||||||||||||201204012130
OBX|1|CWE|SS003^^PHINQUESTION||261QE0002X^Emergency Care^NUCC||||||F
OBX|2|NM|21612-7^^LN||45|a^^UCUM|||||F
OBX|3|CWE|8661-1^^LN||^^^^^^^^Diarrhea, stomach pain, dehydration||||||F
DG1|1||27651^Dehydration^I9CDX|||W
DG1|2||78791^Diarrhea^I9CDX|||W


MSH|^~\&||SwCrnrHsp^7549321000^NPI|||201012271715||ADT^A08^ADT_A01|NIST-SS-003.23|P|2.5.1|||||||||PH_SS-NoAck^SS Sender^2.16.840.1.114222.4.10.3^ISO
EVN||201012271700|||||SwCrnrHsp^7549321000^NPI
PID|1||33333^^^^MR||^^^^^^~^^^^^^S|||M||2106-3^^CDCREC|^^^^85001^^^^04013|||||||||||2135-2^^CDCREC
PV1|1||||||||||||||||||33333_001^^^^VN|||||||||||||||||||||||||201012271530
OBX|1|CWE|SS003^^PHINQUESTION||261QE0002X^Emergency Care^NUCC||||||F
OBX|2|NM|21612-7^^LN||10|a^^UCUM|||||F
OBX|3|CWE|8661-1^^LN||^^^^^^^^fever, cough and difficulty breathing||||||F
DG1|1||78605^shortness of breath^I9CDX|||W
DG1|2||7862^Cough^I9CDX|||W


MSH|^~\&||SthrnMdwstMedCntr^1231231236^NPI|||201002010830||ADT^A03^ADT_A03|NIST-SS-003.31|P|2.5.1|||||||||PH_SS-NoAck^SS Sender^2.16.840.1.114222.4.10.3^ISO
EVN||201002010825|||||SthrnMdwstMedCntr^1231231236^NPI
PID|1||3333^^^^MR||^^^^^^~^^^^^^S|||M||2106-3^^CDCREC|^^^^74852^^^^40125|||||||||||2186-5^^CDCREC
PV1|1||||||||||||||||||3333_001^^^^VN|||||||||||||||||09||||||||201002010730
DG1|1||986^Toxic effect of carbon monoxide^I9CDX|||F
OBX|1|CWE|SS003^^PHINQUESTION||261QE0002X^Emergency Care^NUCC||||||F
OBX|2|NM|21612-7^^LN||70|a^^UCUM|||||F
OBX|3|CWE|8661-1^^LN||^^^^^^^^headache, nausea and dizziness||||||F


MSH|^~\&||LakeMichMC^9879874000^NPI|||201204020040||ADT^A03^ADT_A03|NIST-SS-003.32|P|2.5.1|||||||||PH_SS-NoAck^SS Sender^2.16.840.1.114222.4.10.3^ISO
EVN||201204020030|||||LakeMichMC^9879874000^NPI
PID|1||33333^^^^MR||^^^^^^~^^^^^^S|||F||2106-3^^CDCREC|^^^^53217^^^^55089|||||||||||2186-5^^CDCREC
PV1|1||||||||||||||||||33333_001^^^^VN|||||||||||||||||09||||||||201204012130
DG1|1||0074^Cryptosporidiosis^I9CDX|||F
DG1|2||27651^Dehydration^I9CDX|||F
DG1|3||78791^Diarrhea^I9CDX|||F
OBX|1|CWE|SS003^^PHINQUESTION||261QE0002X^Emergency Care^NUCC||||||F
OBX|2|NM|21612-7^^LN||45|a^^UCUM|||||F
OBX|3|CWE|8661-1^^LN||^^^^^^^^Diarrhea, stomach pain, dehydration||||||F


MSH|^~\&||SwCrnrHsp^7549321000^NPI|||201012271940||ADT^A03^ADT_A03|NIST-SS-003.33|P|2.5.1|||||||||PH_SS-NoAck^SS Sender^2.16.840.1.114222.4.10.3^ISO
EVN||201012272000|||||SwCrnrHsp^7549321000^NPI
PID|1||33333^^^^MR||^^^^^^~^^^^^^S|||M||2106-3^^CDCREC|^^^^85001^^^^04013|||||||||||2135-2^^CDCREC
PV1|1||||||||||||||||||33333_001^^^^VN|||||||||||||||||09||||||||201012271530
DG1|1||4870^Influenza with pneumonia^I9CDX|||F
OBX|1|CWE|SS003^^PHINQUESTION||261QE0002X^Emergency Care^NUCC||||||F
OBX|2|NM|21612-7^^LN||10|a^^UCUM|||||F
OBX|3|CWE|8661-1^^LN||^^^^^^^^fever, cough and difficulty breathing||||||F


MSH|^~\&||SthrnMdwstMedCntr^1231231236^NPI|||201002010835||ADT^A01^ADT_A01|NIST-SS-003.41|P|2.5.1|||||||||PH_SS-NoAck^SS Sender^2.16.840.1.114222.4.10.3^ISO
EVN||201002010835|||||SthrnMdwstMedCntr^1231231236^NPI
PID|1||3333^^^^MR||^^^^^^~^^^^^^S|||M||2106-3^^CDCREC|^^^^74852^^^^40125|||||||||||2186-5^^CDCREC
PV1|1||||||||||||||||||3333_001^^^^VN|||||||||||||||||||||||||201002010730
PV2|||986^Toxic effect of carbon monoxide^I9CDX
OBX|1|CWE|SS003^^PHINQUESTION||261QE0002X^Emergency Care^NUCC||||||F
OBX|2|NM|21612-7^^LN||70|a^^UCUM|||||F
OBX|3|CWE|8661-1^^LN||^^^^^^^^headache, nausea and dizziness||||||F


MSH|^~\&||LakeMichMC^9879874000^NPI|||201204020045||ADT^A01^ADT_A01|NIST-SS-003.42|P|2.5.1|||||||||PH_SS-NoAck^SS Sender^2.16.840.1.114222.4.10.3^ISO
EVN||201204020045|||||LakeMichMC^9879874000^NPI
PID|1||33333^^^^MR||^^^^^^~^^^^^^S|||F||2106-3^^CDCREC|^^^^53217^^^^55089|||||||||||2186-5^^CDCREC
PV1|1||||||||||||||||||33333_001^^^^VN|||||||||||||||||||||||||201204012130
PV2|||0074^Cryptosporidiosis^I9CDX
OBX|1|CWE|SS003^^PHINQUESTION||261QE0002X^Emergency Care^NUCC||||||F
OBX|2|NM|21612-7^^LN||45|a^^UCUM|||||F
OBX|3|CWE|8661-1^^LN||^^^^^^^^Diarrhea, stomach pain, dehydration||||||F


MSH|^~\&||SwCrnrHsp^7549321000^NPI|||201012272015||ADT^A01^ADT_A01|NIST-SS-003.43|P|2.5.1|||||||||PH_SS-NoAck^SS Sender^2.16.840.1.114222.4.10.3^ISO
EVN||201012272000|||||SwCrnrHsp^7549321000^NPI
PID|1||33333^^^^MR||^^^^^^~^^^^^^S|||M||2106-3^^CDCREC|^^^^85001^^^^04013|||||||||||2135-2^^CDCREC
PV1|1||||||||||||||||||33333_001^^^^VN|||||||||||||||||||||||||201012271530
PV2|||4870^Influenza with pneumonia^I9CDX
OBX|1|CWE|SS003^^PHINQUESTION||261QE0002X^Emergency Care^NUCC||||||F
OBX|2|NM|21612-7^^LN||10|a^^UCUM|||||F
OBX|3|CWE|8661-1^^LN||^^^^^^^^fever, cough and difficulty breathing||||||F


